id	sid	tid	token	lemma	pos
admet-905	1	1	metformin	metformin	NOUN
admet-905	1	2	effects	effect	NOUN
admet-905	1	3	on	on	ADP
admet-905	1	4	zonulin	zonulin	PROPN
admet-905	1	5	level	level	NOUN
admet-905	1	6	in	in	ADP
admet-905	1	7	polycystic	polycystic	ADJ
admet-905	1	8	ovarian	ovarian	ADJ
admet-905	1	9	women	woman	NOUN
admet-905	1	10	doi	doi	NOUN
admet-905	1	11	:	:	PUNCT
admet-905	1	12	http://doi.org/10.5599/admet.905	http://doi.org/10.5599/admet.905	VERB
admet-905	1	13	49	49	NUM
admet-905	1	14	admet	admet	PROPN
admet-905	1	15	&	&	CCONJ
admet-905	1	16	dmpk	dmpk	PROPN
admet-905	1	17	9(1	9(1	NUM
admet-905	1	18	)	)	PUNCT
admet-905	1	19	(	(	PUNCT
admet-905	1	20	2021	2021	NUM
admet-905	1	21	)	)	PUNCT
admet-905	1	22	49	49	NUM
admet-905	1	23	-	-	SYM
admet-905	1	24	55	55	NUM
admet-905	1	25	;	;	PUNCT
admet-905	1	26	doi	doi	NOUN
admet-905	1	27	:	:	PUNCT
admet-905	1	28	http://dx.doi.org/10.5599/admet.905	http://dx.doi.org/10.5599/admet.905	VERB
admet-905	1	29	open	open	ADJ
admet-905	1	30	access	access	NOUN
admet-905	1	31	:	:	PUNCT
admet-905	1	32	issn	issn	PROPN
admet-905	1	33	:	:	PUNCT
admet-905	1	34	1848	1848	NUM
admet-905	1	35	-	-	SYM
admet-905	1	36	7718	7718	NUM
admet-905	1	37	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-905	1	38	original	original	ADJ
admet-905	1	39	scientific	scientific	ADJ
admet-905	1	40	paper	paper	NOUN
admet-905	1	41	metformin	metformin	NOUN
admet-905	1	42	effects	effect	NOUN
admet-905	1	43	on	on	ADP
admet-905	1	44	zonulin	zonulin	PROPN
admet-905	1	45	level	level	NOUN
admet-905	1	46	in	in	ADP
admet-905	1	47	polycystic	polycystic	ADJ
admet-905	1	48	ovarian	ovarian	ADJ
admet-905	1	49	women	woman	NOUN
admet-905	1	50	manal	manal	ADJ
admet-905	1	51	ibrahim1	ibrahim1	PROPN
admet-905	1	52	*	*	NOUN
admet-905	1	53	,	,	PUNCT
admet-905	1	54	mutaz	mutaz	NOUN
admet-905	1	55	ahmeid2	ahmeid2	NOUN
admet-905	1	56	1	1	NUM
admet-905	1	57	master	master	NOUN
admet-905	1	58	of	of	ADP
admet-905	1	59	clinical	clinical	ADJ
admet-905	1	60	biochemistry	biochemistry	NOUN
admet-905	1	61	,	,	PUNCT
admet-905	1	62	college	college	NOUN
admet-905	1	63	of	of	ADP
admet-905	1	64	pharmacy	pharmacy	NOUN
admet-905	1	65	/university	/university	PUNCT
admet-905	1	66	of	of	ADP
admet-905	1	67	mosul	mosul	PROPN
admet-905	1	68	,	,	PUNCT
admet-905	1	69	iraq	iraq	PROPN
admet-905	1	70	2	2	NUM
admet-905	1	71	ph.d	ph.d	PROPN
admet-905	1	72	.	.	PUNCT
admet-905	2	1	clinical	clinical	ADJ
admet-905	2	2	biochemistry	biochemistry	NOUN
admet-905	2	3	,	,	PUNCT
admet-905	2	4	college	college	NOUN
admet-905	2	5	of	of	ADP
admet-905	2	6	medicine	medicine	NOUN
admet-905	2	7	/university	/university	PUNCT
admet-905	2	8	of	of	ADP
admet-905	2	9	tikrit	tikrit	NOUN
admet-905	2	10	,	,	PUNCT
admet-905	2	11	iraq	iraq	PROPN
admet-905	2	12	*	*	PUNCT
admet-905	2	13	corresponding	correspond	VERB
admet-905	2	14	author	author	NOUN
admet-905	2	15	:	:	PUNCT
admet-905	2	16	e	e	NOUN
admet-905	2	17	-	-	NOUN
admet-905	2	18	mail	mail	NOUN
admet-905	2	19	:	:	PUNCT
admet-905	2	20	alfarhamanal@gmail.com	alfarhamanal@gmail.com	X
admet-905	2	21	.	.	PROPN
admet-905	2	22	received	receive	VERB
admet-905	2	23	:	:	PUNCT
admet-905	2	24	september	september	PROPN
admet-905	2	25	04	04	NUM
admet-905	2	26	,	,	PUNCT
admet-905	2	27	2020	2020	NUM
admet-905	2	28	;	;	PUNCT
admet-905	2	29	revised	revise	VERB
admet-905	2	30	:	:	PUNCT
admet-905	2	31	october	october	PROPN
admet-905	2	32	22	22	NUM
admet-905	2	33	,	,	PUNCT
admet-905	2	34	2020	2020	NUM
admet-905	2	35	;	;	PUNCT
admet-905	2	36	published	publish	VERB
admet-905	2	37	:	:	PUNCT
admet-905	2	38	december	december	PROPN
admet-905	2	39	09	09	NUM
admet-905	2	40	,	,	PUNCT
admet-905	2	41	2020	2020	NUM
admet-905	2	42	abstract	abstract	ADJ
admet-905	2	43	zonulin	zonulin	NOUN
admet-905	2	44	protein	protein	NOUN
admet-905	2	45	is	be	AUX
admet-905	2	46	a	a	DET
admet-905	2	47	haptoglobin	haptoglobin	NOUN
admet-905	2	48	precursor	precursor	NOUN
admet-905	2	49	and	and	CCONJ
admet-905	2	50	functions	function	NOUN
admet-905	2	51	to	to	PART
admet-905	2	52	modulate	modulate	VERB
admet-905	2	53	the	the	DET
admet-905	2	54	permeability	permeability	NOUN
admet-905	2	55	of	of	ADP
admet-905	2	56	tight	tight	ADJ
admet-905	2	57	junctions	junction	NOUN
admet-905	2	58	between	between	ADP
admet-905	2	59	enterocytes	enterocyte	NOUN
admet-905	2	60	.	.	PUNCT
admet-905	3	1	local	local	ADJ
admet-905	3	2	inflammation	inflammation	NOUN
admet-905	3	3	or	or	CCONJ
admet-905	3	4	systemic	systemic	ADJ
admet-905	3	5	inflammation	inflammation	NOUN
admet-905	3	6	can	can	AUX
admet-905	3	7	trigger	trigger	VERB
admet-905	3	8	zonulin	zonulin	NOUN
admet-905	3	9	expression	expression	NOUN
admet-905	3	10	.	.	PUNCT
admet-905	4	1	while	while	SCONJ
admet-905	4	2	the	the	DET
admet-905	4	3	increased	increase	VERB
admet-905	4	4	zonulin	zonulin	NOUN
admet-905	4	5	level	level	NOUN
admet-905	4	6	causes	cause	VERB
admet-905	4	7	an	an	DET
admet-905	4	8	increase	increase	NOUN
admet-905	4	9	of	of	ADP
admet-905	4	10	intestinal	intestinal	ADJ
admet-905	4	11	permeability	permeability	NOUN
admet-905	4	12	and	and	CCONJ
admet-905	4	13	entrance	entrance	NOUN
admet-905	4	14	of	of	ADP
admet-905	4	15	foreign	foreign	ADJ
admet-905	4	16	antigens	antigen	NOUN
admet-905	4	17	,	,	PUNCT
admet-905	4	18	the	the	DET
admet-905	4	19	latter	latter	ADJ
admet-905	4	20	can	can	AUX
admet-905	4	21	increase	increase	VERB
admet-905	4	22	insulin	insulin	NOUN
admet-905	4	23	resistance	resistance	NOUN
admet-905	4	24	and	and	CCONJ
admet-905	4	25	inflammation	inflammation	NOUN
admet-905	4	26	.	.	PUNCT
admet-905	5	1	polycystic	polycystic	ADJ
admet-905	5	2	ovarian	ovarian	ADJ
admet-905	5	3	syndrome	syndrome	NOUN
admet-905	5	4	affects	affect	VERB
admet-905	5	5	women	woman	NOUN
admet-905	5	6	during	during	ADP
admet-905	5	7	their	their	PRON
admet-905	5	8	reproductive	reproductive	ADJ
admet-905	5	9	age	age	NOUN
admet-905	5	10	characterized	characterize	VERB
admet-905	5	11	by	by	ADP
admet-905	5	12	hyperinsulinemia	hyperinsulinemia	NOUN
admet-905	5	13	and/or	and/or	CCONJ
admet-905	5	14	hyperandrogenemia	hyperandrogenemia	PROPN
admet-905	5	15	and	and	CCONJ
admet-905	5	16	associated	associate	VERB
admet-905	5	17	with	with	ADP
admet-905	5	18	infertility	infertility	NOUN
admet-905	5	19	problems	problem	NOUN
admet-905	5	20	.	.	PUNCT
admet-905	6	1	changes	change	NOUN
admet-905	6	2	in	in	ADP
admet-905	6	3	gut	gut	NOUN
admet-905	6	4	permeability	permeability	NOUN
admet-905	6	5	such	such	ADJ
admet-905	6	6	as	as	ADP
admet-905	6	7	irritable	irritable	ADJ
admet-905	6	8	bowel	bowel	NOUN
admet-905	6	9	syndrome	syndrome	NOUN
admet-905	6	10	are	be	AUX
admet-905	6	11	often	often	ADV
admet-905	6	12	found	find	VERB
admet-905	6	13	in	in	ADP
admet-905	6	14	pcos	pcos	NOUN
admet-905	6	15	patients	patient	NOUN
admet-905	6	16	.	.	PUNCT
admet-905	7	1	while	while	SCONJ
admet-905	7	2	metformin	metformin	NOUN
admet-905	7	3	increases	increase	VERB
admet-905	7	4	insulin	insulin	NOUN
admet-905	7	5	mediates	mediate	NOUN
admet-905	7	6	glucose	glucose	VERB
admet-905	7	7	uptake	uptake	ADJ
admet-905	7	8	and	and	CCONJ
admet-905	7	9	,	,	PUNCT
admet-905	7	10	acts	act	VERB
admet-905	7	11	as	as	ADP
admet-905	7	12	an	an	DET
admet-905	7	13	insulin	insulin	NOUN
admet-905	7	14	-	-	PUNCT
admet-905	7	15	sensitizing	sensitize	VERB
admet-905	7	16	drug	drug	NOUN
admet-905	7	17	used	use	VERB
admet-905	7	18	to	to	PART
admet-905	7	19	treat	treat	VERB
admet-905	7	20	pcos	pcos	ADJ
admet-905	7	21	patients	patient	NOUN
admet-905	7	22	is	be	AUX
admet-905	7	23	recently	recently	ADV
admet-905	7	24	discovered	discover	VERB
admet-905	7	25	to	to	PART
admet-905	7	26	reshape	reshape	VERB
admet-905	7	27	intestinal	intestinal	ADJ
admet-905	7	28	bacteria	bacteria	NOUN
admet-905	7	29	and	and	CCONJ
admet-905	7	30	hence	hence	ADV
admet-905	7	31	may	may	AUX
admet-905	7	32	affect	affect	VERB
admet-905	7	33	intestinal	intestinal	ADJ
admet-905	7	34	action	action	NOUN
admet-905	7	35	.	.	PUNCT
admet-905	8	1	this	this	DET
admet-905	8	2	study	study	NOUN
admet-905	8	3	was	be	AUX
admet-905	8	4	designed	design	VERB
admet-905	8	5	to	to	PART
admet-905	8	6	find	find	VERB
admet-905	8	7	any	any	DET
admet-905	8	8	association	association	NOUN
admet-905	8	9	between	between	ADP
admet-905	8	10	zonulin	zonulin	PROPN
admet-905	8	11	level	level	NOUN
admet-905	8	12	and	and	CCONJ
admet-905	8	13	other	other	ADJ
admet-905	8	14	parameters	parameter	NOUN
admet-905	8	15	in	in	ADP
admet-905	8	16	pcos	pcos	NOUN
admet-905	8	17	patients	patient	NOUN
admet-905	8	18	and	and	CCONJ
admet-905	8	19	to	to	PART
admet-905	8	20	find	find	VERB
admet-905	8	21	metformin	metformin	NOUN
admet-905	8	22	treatment	treatment	NOUN
admet-905	8	23	effects	effect	NOUN
admet-905	8	24	on	on	ADP
admet-905	8	25	zonulin	zonulin	PROPN
admet-905	8	26	in	in	ADP
admet-905	8	27	pcos	pcos	PROPN
admet-905	8	28	patients	patient	NOUN
admet-905	8	29	.	.	PUNCT
admet-905	9	1	thirty	thirty	NUM
admet-905	9	2	-	-	PUNCT
admet-905	9	3	one	one	NUM
admet-905	9	4	newly	newly	ADV
admet-905	9	5	diagnosed	diagnose	VERB
admet-905	9	6	pcos	pcos	NOUN
admet-905	9	7	women	woman	NOUN
admet-905	9	8	agree	agree	VERB
admet-905	9	9	to	to	PART
admet-905	9	10	take	take	VERB
admet-905	9	11	metformin	metformin	NOUN
admet-905	9	12	850	850	NUM
admet-905	9	13	mg	mg	NOUN
admet-905	9	14	twice	twice	ADV
admet-905	9	15	daily	daily	ADV
admet-905	9	16	for	for	ADP
admet-905	9	17	three	three	NUM
admet-905	9	18	months	month	NOUN
admet-905	9	19	and	and	CCONJ
admet-905	9	20	,	,	PUNCT
admet-905	9	21	and	and	CCONJ
admet-905	9	22	to	to	PART
admet-905	9	23	give	give	VERB
admet-905	9	24	fasting	fast	VERB
admet-905	9	25	serum	serum	NOUN
admet-905	9	26	samples	sample	NOUN
admet-905	9	27	to	to	PART
admet-905	9	28	measure	measure	VERB
admet-905	9	29	zonulin	zonulin	PROPN
admet-905	9	30	,	,	PUNCT
admet-905	9	31	fsh	fsh	PROPN
admet-905	9	32	,	,	PUNCT
admet-905	9	33	lh	lh	NOUN
admet-905	9	34	,	,	PUNCT
admet-905	9	35	total	total	ADJ
admet-905	9	36	testosterone	testosterone	NOUN
admet-905	9	37	,	,	PUNCT
admet-905	9	38	free	free	ADJ
admet-905	9	39	testosterone	testosterone	NOUN
admet-905	9	40	,	,	PUNCT
admet-905	9	41	shbg	shbg	NOUN
admet-905	9	42	,	,	PUNCT
admet-905	9	43	fasting	fast	VERB
admet-905	9	44	insulin	insulin	NOUN
admet-905	9	45	,	,	PUNCT
admet-905	9	46	and	and	CCONJ
admet-905	9	47	fasting	fast	VERB
admet-905	9	48	serum	serum	NOUN
admet-905	9	49	glucose	glucose	NOUN
admet-905	9	50	before	before	ADP
admet-905	9	51	and	and	CCONJ
admet-905	9	52	after	after	ADP
admet-905	9	53	treatment	treatment	NOUN
admet-905	9	54	.	.	PUNCT
admet-905	10	1	the	the	DET
admet-905	10	2	free	free	ADJ
admet-905	10	3	testosterone	testosterone	NOUN
admet-905	10	4	and	and	CCONJ
admet-905	10	5	zonulin	zonulin	NOUN
admet-905	10	6	are	be	AUX
admet-905	10	7	determined	determine	VERB
admet-905	10	8	by	by	ADP
admet-905	10	9	the	the	DET
admet-905	10	10	elisa	elisa	NOUN
admet-905	10	11	technique	technique	NOUN
admet-905	10	12	while	while	SCONJ
admet-905	10	13	the	the	DET
admet-905	10	14	other	other	ADJ
admet-905	10	15	parameters	parameter	NOUN
admet-905	10	16	are	be	AUX
admet-905	10	17	determined	determine	VERB
admet-905	10	18	by	by	ADP
admet-905	10	19	the	the	DET
admet-905	10	20	cobas	cobas	ADJ
admet-905	10	21	technique	technique	NOUN
admet-905	10	22	.	.	PUNCT
admet-905	11	1	according	accord	VERB
admet-905	11	2	to	to	ADP
admet-905	11	3	patients	patient	NOUN
admet-905	11	4	’	'	PUNCT
admet-905	11	5	homeostatic	homeostatic	ADJ
admet-905	11	6	model	model	NOUN
admet-905	11	7	assessment	assessment	NOUN
admet-905	11	8	(	(	PUNCT
admet-905	11	9	homa	homa	NOUN
admet-905	11	10	-	-	PUNCT
admet-905	11	11	ir	ir	NOUN
admet-905	11	12	)	)	PUNCT
admet-905	11	13	,	,	PUNCT
admet-905	11	14	the	the	DET
admet-905	11	15	patients	patient	NOUN
admet-905	11	16	were	be	AUX
admet-905	11	17	divided	divide	VERB
admet-905	11	18	into	into	ADP
admet-905	11	19	two	two	NUM
admet-905	11	20	sub	sub	NOUN
admet-905	11	21	-	-	NOUN
admet-905	11	22	groups	group	NOUN
admet-905	11	23	:	:	PUNCT
admet-905	11	24	the	the	DET
admet-905	11	25	first	first	ADJ
admet-905	11	26	group	group	NOUN
admet-905	11	27	consisting	consist	VERB
admet-905	11	28	of	of	ADP
admet-905	11	29	those	those	PRON
admet-905	11	30	with	with	ADP
admet-905	11	31	initial	initial	ADJ
admet-905	11	32	homa	homa	NOUN
admet-905	11	33	-	-	PUNCT
admet-905	11	34	ir	ir	NOUN
admet-905	11	35	less	less	ADJ
admet-905	11	36	than	than	ADP
admet-905	11	37	two	two	NUM
admet-905	11	38	and	and	CCONJ
admet-905	11	39	the	the	DET
admet-905	11	40	second	second	ADJ
admet-905	11	41	group	group	NOUN
admet-905	11	42	was	be	AUX
admet-905	11	43	those	those	PRON
admet-905	11	44	of	of	ADP
admet-905	11	45	an	an	DET
admet-905	11	46	initial	initial	ADJ
admet-905	11	47	homa	homa	NOUN
admet-905	11	48	-	-	PUNCT
admet-905	11	49	ir	ir	PROPN
admet-905	11	50	of	of	ADP
admet-905	11	51	between	between	ADP
admet-905	11	52	two	two	NUM
admet-905	11	53	to	to	PART
admet-905	11	54	four	four	NUM
admet-905	11	55	.	.	PUNCT
admet-905	12	1	whereas	whereas	SCONJ
admet-905	12	2	the	the	DET
admet-905	12	3	first	first	ADJ
admet-905	12	4	group	group	NOUN
admet-905	12	5	showed	show	VERB
admet-905	12	6	no	no	DET
admet-905	12	7	significant	significant	ADJ
admet-905	12	8	response	response	NOUN
admet-905	12	9	to	to	ADP
admet-905	12	10	treatment	treatment	NOUN
admet-905	12	11	,	,	PUNCT
admet-905	12	12	the	the	DET
admet-905	12	13	second	second	ADJ
admet-905	12	14	group	group	NOUN
admet-905	12	15	showed	show	VERB
admet-905	12	16	a	a	DET
admet-905	12	17	better	well	ADJ
admet-905	12	18	response	response	NOUN
admet-905	12	19	to	to	ADP
admet-905	12	20	metformin	metformin	NOUN
admet-905	12	21	treatment	treatment	NOUN
admet-905	12	22	,	,	PUNCT
admet-905	12	23	as	as	SCONJ
admet-905	12	24	demonstrated	demonstrate	VERB
admet-905	12	25	by	by	ADP
admet-905	12	26	their	their	PRON
admet-905	12	27	lh	lh	PROPN
admet-905	12	28	,	,	PUNCT
admet-905	12	29	total	total	ADJ
admet-905	12	30	testosterone	testosterone	NOUN
admet-905	12	31	,	,	PUNCT
admet-905	12	32	free	free	ADJ
admet-905	12	33	testosterone	testosterone	NOUN
admet-905	12	34	,	,	PUNCT
admet-905	12	35	fasting	fast	VERB
admet-905	12	36	insulin	insulin	NOUN
admet-905	12	37	,	,	PUNCT
admet-905	12	38	zonulin	zonulin	NOUN
admet-905	12	39	,	,	PUNCT
admet-905	12	40	and	and	CCONJ
admet-905	12	41	glucose	glucose	NOUN
admet-905	12	42	levels	level	NOUN
admet-905	12	43	.	.	PUNCT
admet-905	13	1	these	these	DET
admet-905	13	2	parameters	parameter	NOUN
admet-905	13	3	markedly	markedly	ADV
admet-905	13	4	improved	improve	VERB
admet-905	13	5	after	after	ADP
admet-905	13	6	metformin	metformin	NOUN
admet-905	13	7	treatment	treatment	NOUN
admet-905	13	8	with	with	ADP
admet-905	13	9	pvalues	pvalue	NOUN
admet-905	13	10	of	of	ADP
admet-905	13	11	0.08	0.08	NUM
admet-905	13	12	,	,	PUNCT
admet-905	13	13	0.09	0.09	NUM
admet-905	13	14	,	,	PUNCT
admet-905	13	15	0.07	0.07	NUM
admet-905	13	16	.	.	PUNCT
admet-905	14	1	0.04	0.04	NUM
admet-905	14	2	,	,	PUNCT
admet-905	14	3	0.01	0.01	NUM
admet-905	14	4	and	and	CCONJ
admet-905	14	5	0.06	0.06	NUM
admet-905	14	6	,	,	PUNCT
admet-905	14	7	respectively	respectively	ADV
admet-905	14	8	.	.	PUNCT
admet-905	15	1	©	©	NOUN
admet-905	15	2	2021	2021	NUM
admet-905	15	3	by	by	ADP
admet-905	15	4	the	the	DET
admet-905	15	5	authors	author	NOUN
admet-905	15	6	.	.	PUNCT
admet-905	16	1	this	this	DET
admet-905	16	2	article	article	NOUN
admet-905	16	3	is	be	AUX
admet-905	16	4	an	an	DET
admet-905	16	5	open	open	ADJ
admet-905	16	6	-	-	PUNCT
admet-905	16	7	access	access	NOUN
admet-905	16	8	article	article	NOUN
admet-905	16	9	distributed	distribute	VERB
admet-905	16	10	under	under	ADP
admet-905	16	11	the	the	DET
admet-905	16	12	terms	term	NOUN
admet-905	16	13	and	and	CCONJ
admet-905	16	14	conditions	condition	NOUN
admet-905	16	15	of	of	ADP
admet-905	16	16	the	the	DET
admet-905	16	17	creative	creative	ADJ
admet-905	16	18	commons	common	NOUN
admet-905	16	19	attribution	attribution	NOUN
admet-905	16	20	license	license	NOUN
admet-905	16	21	(	(	PUNCT
admet-905	16	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-905	16	23	)	)	PUNCT
admet-905	16	24	.	.	PUNCT
admet-905	17	1	keywords	keyword	VERB
admet-905	17	2	homa	homa	NOUN
admet-905	17	3	-	-	PUNCT
admet-905	17	4	ir	ir	NOUN
admet-905	17	5	;	;	PUNCT
admet-905	17	6	homeostatic	homeostatic	ADJ
admet-905	17	7	model	model	NOUN
admet-905	17	8	assessment	assessment	NOUN
admet-905	17	9	for	for	ADP
admet-905	17	10	insulin	insulin	NOUN
admet-905	17	11	resistance	resistance	NOUN
admet-905	17	12	;	;	PUNCT
admet-905	17	13	pcos	pco	NOUN
admet-905	17	14	;	;	PUNCT
admet-905	17	15	polycystic	polycystic	ADJ
admet-905	17	16	ovarian	ovarian	ADJ
admet-905	17	17	syndrome	syndrome	NOUN
admet-905	17	18	;	;	PUNCT
admet-905	17	19	fsh	fsh	NOUN
admet-905	17	20	;	;	PUNCT
admet-905	17	21	follicle	follicle	VERB
admet-905	17	22	stimulating	stimulate	VERB
admet-905	17	23	hormone	hormone	NOUN
admet-905	17	24	;	;	PUNCT
admet-905	17	25	lh	lh	PROPN
admet-905	17	26	;	;	PUNCT
admet-905	17	27	luteinizing	luteinize	VERB
admet-905	17	28	hormone	hormone	NOUN
admet-905	17	29	,	,	PUNCT
admet-905	17	30	shbg	shbg	NOUN
admet-905	17	31	;	;	PUNCT
admet-905	17	32	sex	sex	NOUN
admet-905	17	33	hormone	hormone	NOUN
admet-905	17	34	binding	bind	VERB
admet-905	17	35	globulin	globulin	NOUN
admet-905	17	36	introduction	introduction	NOUN
admet-905	17	37	the	the	DET
admet-905	17	38	polycystic	polycystic	ADJ
admet-905	17	39	ovarian	ovarian	ADJ
admet-905	17	40	syndrome	syndrome	NOUN
admet-905	17	41	can	can	AUX
admet-905	17	42	affect	affect	VERB
admet-905	17	43	women	woman	NOUN
admet-905	17	44	during	during	ADP
admet-905	17	45	their	their	PRON
admet-905	17	46	reproductive	reproductive	ADJ
admet-905	17	47	age	age	NOUN
admet-905	17	48	at	at	ADP
admet-905	17	49	an	an	DET
admet-905	17	50	incidence	incidence	ADJ
admet-905	17	51	rate	rate	NOUN
admet-905	17	52	of	of	ADP
admet-905	17	53	3	3	NUM
admet-905	17	54	-	-	SYM
admet-905	17	55	10	10	NUM
admet-905	17	56	%	%	NOUN
admet-905	17	57	and	and	CCONJ
admet-905	17	58	characterized	characterize	VERB
admet-905	17	59	by	by	ADP
admet-905	17	60	sex	sex	NOUN
admet-905	17	61	hormone	hormone	NOUN
admet-905	17	62	imbalance	imbalance	NOUN
admet-905	17	63	[	[	X
admet-905	17	64	1,2	1,2	NUM
admet-905	17	65	]	]	PUNCT
admet-905	17	66	.	.	PUNCT
admet-905	18	1	irregular	irregular	ADJ
admet-905	18	2	menstrual	menstrual	ADJ
admet-905	18	3	cycle	cycle	NOUN
admet-905	18	4	,	,	PUNCT
admet-905	18	5	polycystic	polycystic	ADJ
admet-905	18	6	ovary	ovary	ADJ
admet-905	18	7	morphology	morphology	NOUN
admet-905	18	8	,	,	PUNCT
admet-905	18	9	and	and	CCONJ
admet-905	18	10	hirsutism	hirsutism	NOUN
admet-905	18	11	are	be	AUX
admet-905	18	12	the	the	DET
admet-905	18	13	most	most	ADV
admet-905	18	14	frequent	frequent	ADJ
admet-905	18	15	symptoms	symptom	NOUN
admet-905	18	16	,	,	PUNCT
admet-905	18	17	with	with	ADP
admet-905	18	18	features	feature	NOUN
admet-905	18	19	of	of	ADP
admet-905	18	20	infertility	infertility	NOUN
admet-905	18	21	and	and	CCONJ
admet-905	18	22	insulin	insulin	NOUN
admet-905	18	23	resistance	resistance	NOUN
admet-905	18	24	[	[	X
admet-905	18	25	3,4	3,4	NUM
admet-905	18	26	]	]	PUNCT
admet-905	18	27	.	.	PUNCT
admet-905	19	1	insulin	insulin	NOUN
admet-905	19	2	resistance	resistance	NOUN
admet-905	19	3	and	and	CCONJ
admet-905	19	4	obesity	obesity	NOUN
admet-905	19	5	play	play	NOUN
admet-905	19	6	roles	role	NOUN
admet-905	19	7	in	in	ADP
admet-905	19	8	pcos	pcos	PROPN
admet-905	19	9	pathophysiology	pathophysiology	NOUN
admet-905	19	10	[	[	X
admet-905	19	11	5,6	5,6	NUM
admet-905	19	12	]	]	X
admet-905	19	13	.	.	PUNCT
admet-905	20	1	insulin	insulin	NOUN
admet-905	20	2	resistance	resistance	NOUN
admet-905	20	3	http://dx.doi.org/10.5599/admet.905	http://dx.doi.org/10.5599/admet.905	VERB
admet-905	20	4	http://dx.doi.org/10.5599/admet.905	http://dx.doi.org/10.5599/admet.905	VERB
admet-905	20	5	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	PROPN
admet-905	20	6	mailto:alfarhamanal@gmail.com	mailto:alfarhamanal@gmail.com	X
admet-905	21	1	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-905	21	2	m.	m.	PROPN
admet-905	21	3	ibrahim	ibrahim	PROPN
admet-905	21	4	,	,	PUNCT
admet-905	21	5	m.	m.	NOUN
admet-905	21	6	ahmeid	ahmeid	PROPN
admet-905	21	7	admet	admet	PROPN
admet-905	21	8	&	&	CCONJ
admet-905	21	9	dmpk	dmpk	PROPN
admet-905	21	10	9(1	9(1	NUM
admet-905	21	11	)	)	PUNCT
admet-905	21	12	(	(	PUNCT
admet-905	21	13	2021	2021	NUM
admet-905	21	14	)	)	PUNCT
admet-905	21	15	49	49	NUM
admet-905	21	16	-	-	SYM
admet-905	21	17	55	55	NUM
admet-905	21	18	50	50	NUM
admet-905	21	19	gives	give	VERB
admet-905	21	20	rise	rise	NOUN
admet-905	21	21	to	to	ADP
admet-905	21	22	hyperinsulinemia	hyperinsulinemia	NOUN
admet-905	21	23	[	[	X
admet-905	21	24	7	7	NUM
admet-905	21	25	]	]	PUNCT
admet-905	21	26	,	,	PUNCT
admet-905	21	27	which	which	PRON
admet-905	21	28	directs	direct	VERB
admet-905	21	29	ovarian	ovarian	ADJ
admet-905	21	30	steroidogenic	steroidogenic	ADJ
admet-905	21	31	enzymes	enzyme	NOUN
admet-905	21	32	to	to	PART
admet-905	21	33	produce	produce	VERB
admet-905	21	34	more	more	ADJ
admet-905	21	35	androgen	androgen	NOUN
admet-905	21	36	and	and	CCONJ
admet-905	21	37	abolish	abolish	VERB
admet-905	21	38	ovulation	ovulation	NOUN
admet-905	21	39	[	[	X
admet-905	21	40	8,9	8,9	NUM
admet-905	21	41	]	]	PUNCT
admet-905	21	42	.	.	PUNCT
admet-905	22	1	therefore	therefore	ADV
admet-905	22	2	,	,	PUNCT
admet-905	22	3	insulin	insulin	NOUN
admet-905	22	4	-	-	PUNCT
admet-905	22	5	resistant	resistant	ADJ
admet-905	22	6	pcos	pcos	NOUN
admet-905	22	7	patients	patient	NOUN
admet-905	22	8	show	show	VERB
admet-905	22	9	more	more	ADJ
admet-905	22	10	metabolic	metabolic	ADJ
admet-905	22	11	lipogenic	lipogenic	NOUN
admet-905	22	12	changes	change	NOUN
admet-905	22	13	,	,	PUNCT
admet-905	22	14	and	and	CCONJ
admet-905	22	15	abnormal	abnormal	ADJ
admet-905	22	16	steroidogenesis	steroidogenesis	NOUN
admet-905	22	17	because	because	SCONJ
admet-905	22	18	of	of	ADP
admet-905	22	19	a	a	DET
admet-905	22	20	decrease	decrease	NOUN
admet-905	22	21	in	in	ADP
admet-905	22	22	insulin	insulin	NOUN
admet-905	22	23	signaling	signal	VERB
admet-905	22	24	,	,	PUNCT
admet-905	22	25	while	while	SCONJ
admet-905	22	26	non	non	ADJ
admet-905	22	27	-	-	ADJ
admet-905	22	28	insulin	insulin	ADJ
admet-905	22	29	resistant	resistant	ADJ
admet-905	22	30	pcos	pcos	NOUN
admet-905	22	31	patients	patient	NOUN
admet-905	22	32	show	show	VERB
admet-905	22	33	abnormality	abnormality	NOUN
admet-905	22	34	in	in	ADP
admet-905	22	35	steroidogenesis	steroidogenesis	NOUN
admet-905	22	36	only	only	ADV
admet-905	22	37	[	[	X
admet-905	22	38	10,11	10,11	NOUN
admet-905	22	39	]	]	PUNCT
admet-905	22	40	.	.	PUNCT
admet-905	23	1	the	the	DET
admet-905	23	2	homa	homa	PROPN
admet-905	23	3	-	-	PUNCT
admet-905	23	4	ir	ir	PROPN
admet-905	23	5	is	be	AUX
admet-905	23	6	a	a	DET
admet-905	23	7	technique	technique	NOUN
admet-905	23	8	used	use	VERB
admet-905	23	9	to	to	PART
admet-905	23	10	assess	assess	VERB
admet-905	23	11	the	the	DET
admet-905	23	12	β	β	NOUN
admet-905	23	13	-	-	NOUN
admet-905	23	14	cell	cell	NOUN
admet-905	23	15	function	function	NOUN
admet-905	23	16	and	and	CCONJ
admet-905	23	17	insulin	insulin	NOUN
admet-905	23	18	resistance	resistance	NOUN
admet-905	23	19	from	from	ADP
admet-905	23	20	basal	basal	ADJ
admet-905	23	21	glucose	glucose	NOUN
admet-905	23	22	and	and	CCONJ
admet-905	23	23	insulin	insulin	NOUN
admet-905	23	24	and	and	CCONJ
admet-905	23	25	it	it	PRON
admet-905	23	26	equalizes	equalize	VERB
admet-905	23	27	(	(	PUNCT
admet-905	23	28	(	(	PUNCT
admet-905	23	29	fasting	fast	VERB
admet-905	23	30	insulin	insulin	NOUN
admet-905	23	31	multiplied	multiply	VERB
admet-905	23	32	by	by	ADP
admet-905	23	33	fasting	fast	VERB
admet-905	23	34	glucose	glucose	NOUN
admet-905	23	35	)	)	PUNCT
admet-905	23	36	divided	divide	VERB
admet-905	23	37	by	by	ADP
admet-905	23	38	22.5	22.5	NUM
admet-905	23	39	)	)	PUNCT
admet-905	23	40	,	,	PUNCT
admet-905	23	41	normal	normal	ADJ
admet-905	23	42	homa	homa	PROPN
admet-905	23	43	ir	ir	PROPN
admet-905	23	44	is	be	AUX
admet-905	23	45	1	1	NUM
admet-905	23	46	[	[	X
admet-905	23	47	12,13	12,13	NUM
admet-905	23	48	]	]	PUNCT
admet-905	23	49	.	.	PUNCT
admet-905	24	1	insulin	insulin	NOUN
admet-905	24	2	resistance	resistance	NOUN
admet-905	24	3	occurs	occur	VERB
admet-905	24	4	when	when	SCONJ
admet-905	24	5	fasting	fast	VERB
admet-905	24	6	insulin	insulin	NOUN
admet-905	24	7	is	be	AUX
admet-905	24	8	homa	homa	NOUN
admet-905	24	9	-	-	PUNCT
admet-905	24	10	ir>2	ir>2	NOUN
admet-905	24	11	[	[	X
admet-905	24	12	14	14	NUM
admet-905	24	13	]	]	PUNCT
admet-905	24	14	.	.	PUNCT
admet-905	25	1	zonulin	zonulin	PROPN
admet-905	25	2	is	be	AUX
admet-905	25	3	a	a	DET
admet-905	25	4	haptoglobin	haptoglobin	NOUN
admet-905	25	5	precursor	precursor	NOUN
admet-905	25	6	that	that	PRON
admet-905	25	7	has	have	VERB
admet-905	25	8	a	a	DET
admet-905	25	9	molecular	molecular	ADJ
admet-905	25	10	-	-	PUNCT
admet-905	25	11	weight	weight	NOUN
admet-905	25	12	of	of	ADP
admet-905	25	13	47	47	NUM
admet-905	25	14	kda	kda	NOUN
admet-905	25	15	and	and	CCONJ
admet-905	25	16	modulates	modulate	VERB
admet-905	25	17	the	the	DET
admet-905	25	18	permeability	permeability	NOUN
admet-905	25	19	of	of	ADP
admet-905	25	20	tight	tight	ADJ
admet-905	25	21	junction	junction	NOUN
admet-905	25	22	(	(	PUNCT
admet-905	25	23	tj	tj	NOUN
admet-905	25	24	)	)	PUNCT
admet-905	25	25	between	between	ADP
admet-905	25	26	cells	cell	NOUN
admet-905	25	27	of	of	ADP
admet-905	25	28	the	the	DET
admet-905	25	29	digestive	digestive	ADJ
admet-905	25	30	tract	tract	NOUN
admet-905	25	31	[	[	X
admet-905	25	32	15,16	15,16	NUM
admet-905	25	33	]	]	PUNCT
admet-905	25	34	.	.	PUNCT
admet-905	26	1	an	an	DET
admet-905	26	2	increase	increase	NOUN
admet-905	26	3	in	in	ADP
admet-905	26	4	zonulin	zonulin	PROPN
admet-905	26	5	is	be	AUX
admet-905	26	6	associated	associate	VERB
admet-905	26	7	with	with	ADP
admet-905	26	8	an	an	DET
admet-905	26	9	increase	increase	NOUN
admet-905	26	10	in	in	ADP
admet-905	26	11	gut	gut	NOUN
admet-905	26	12	permeability	permeability	NOUN
admet-905	26	13	.	.	PUNCT
admet-905	27	1	zonulin	zonulin	PROPN
admet-905	27	2	expression	expression	NOUN
admet-905	27	3	is	be	AUX
admet-905	27	4	triggered	trigger	VERB
admet-905	27	5	by	by	ADP
admet-905	27	6	either	either	CCONJ
admet-905	27	7	local	local	ADJ
admet-905	27	8	inflammation	inflammation	NOUN
admet-905	27	9	or	or	CCONJ
admet-905	27	10	systemic	systemic	ADJ
admet-905	27	11	sub	sub	ADJ
admet-905	27	12	-	-	ADJ
admet-905	27	13	clinical	clinical	ADJ
admet-905	27	14	inflammation	inflammation	NOUN
admet-905	27	15	[	[	X
admet-905	27	16	17	17	NUM
admet-905	27	17	]	]	PUNCT
admet-905	27	18	and	and	CCONJ
admet-905	27	19	is	be	AUX
admet-905	27	20	suggested	suggest	VERB
admet-905	27	21	to	to	PART
admet-905	27	22	have	have	VERB
admet-905	27	23	a	a	DET
admet-905	27	24	role	role	NOUN
admet-905	27	25	in	in	ADP
admet-905	27	26	the	the	DET
admet-905	27	27	production	production	NOUN
admet-905	27	28	of	of	ADP
admet-905	27	29	metabolic	metabolic	NOUN
admet-905	27	30	syndrome	syndrome	NOUN
admet-905	27	31	and	and	CCONJ
admet-905	27	32	insulin	insulin	NOUN
admet-905	27	33	resistance	resistance	NOUN
admet-905	28	1	[	[	X
admet-905	28	2	18	18	NUM
admet-905	28	3	]	]	PUNCT
admet-905	28	4	.	.	PUNCT
admet-905	29	1	in	in	ADP
admet-905	29	2	pcos	pcos	PROPN
admet-905	29	3	women	woman	NOUN
admet-905	29	4	,	,	PUNCT
admet-905	29	5	zonulin	zonulin	PROPN
admet-905	29	6	is	be	AUX
admet-905	29	7	correlated	correlate	VERB
admet-905	29	8	with	with	ADP
admet-905	29	9	insulin	insulin	NOUN
admet-905	29	10	resistance	resistance	NOUN
admet-905	29	11	and	and	CCONJ
admet-905	29	12	the	the	DET
admet-905	29	13	severity	severity	NOUN
admet-905	29	14	of	of	ADP
admet-905	29	15	the	the	DET
admet-905	29	16	menstrual	menstrual	ADJ
admet-905	29	17	disorder	disorder	NOUN
admet-905	29	18	[	[	X
admet-905	29	19	19	19	NUM
admet-905	29	20	]	]	PUNCT
admet-905	29	21	.	.	PUNCT
admet-905	30	1	moreover	moreover	ADV
admet-905	30	2	,	,	PUNCT
admet-905	30	3	irritable	irritable	ADJ
admet-905	30	4	bowel	bowel	NOUN
admet-905	30	5	syndrome	syndrome	NOUN
admet-905	30	6	and	and	CCONJ
admet-905	30	7	chronic	chronic	ADJ
admet-905	30	8	fatigue	fatigue	NOUN
admet-905	30	9	syndrome	syndrome	NOUN
admet-905	30	10	,	,	PUNCT
admet-905	30	11	two	two	NUM
admet-905	30	12	conditions	condition	NOUN
admet-905	30	13	common	common	ADJ
admet-905	30	14	in	in	ADP
admet-905	30	15	pcos	pcos	PROPN
admet-905	30	16	are	be	AUX
admet-905	30	17	linked	link	VERB
admet-905	30	18	to	to	ADP
admet-905	30	19	an	an	DET
admet-905	30	20	increase	increase	NOUN
admet-905	30	21	in	in	ADP
admet-905	30	22	gut	gut	NOUN
admet-905	30	23	permeability	permeability	NOUN
admet-905	30	24	[	[	X
admet-905	30	25	20,21	20,21	NUM
admet-905	30	26	]	]	PUNCT
admet-905	30	27	.	.	PUNCT
admet-905	31	1	metformin	metformin	NOUN
admet-905	31	2	drug	drug	NOUN
admet-905	31	3	used	use	VERB
admet-905	31	4	in	in	ADP
admet-905	31	5	pcos	pcos	PROPN
admet-905	31	6	treatment	treatment	NOUN
admet-905	31	7	can	can	AUX
admet-905	31	8	decrease	decrease	VERB
admet-905	31	9	hepatic	hepatic	ADJ
admet-905	31	10	gluconeogenesis	gluconeogenesis	NOUN
admet-905	31	11	by	by	ADP
admet-905	31	12	different	different	ADJ
admet-905	31	13	mechanisms	mechanism	NOUN
admet-905	31	14	[	[	X
admet-905	31	15	22	22	NUM
admet-905	31	16	]	]	X
admet-905	31	17	:	:	PUNCT
admet-905	31	18	delay	delay	VERB
admet-905	31	19	intestinal	intestinal	ADJ
admet-905	31	20	glucose	glucose	NOUN
admet-905	31	21	absorption	absorption	NOUN
admet-905	32	1	[	[	X
admet-905	32	2	23	23	NUM
admet-905	32	3	]	]	PUNCT
admet-905	32	4	,	,	PUNCT
admet-905	32	5	reshape	reshape	VERB
admet-905	32	6	microbiota	microbiota	NOUN
admet-905	32	7	in	in	ADP
admet-905	32	8	the	the	DET
admet-905	32	9	intestine	intestine	NOUN
admet-905	32	10	[	[	X
admet-905	32	11	24,25	24,25	NUM
admet-905	32	12	]	]	PUNCT
admet-905	32	13	,	,	PUNCT
admet-905	32	14	increase	increase	VERB
admet-905	32	15	insulin	insulin	NOUN
admet-905	32	16	-	-	PUNCT
admet-905	32	17	mediated	mediate	VERB
admet-905	32	18	glucose	glucose	NOUN
admet-905	32	19	uptake	uptake	NOUN
admet-905	32	20	in	in	ADP
admet-905	32	21	the	the	DET
admet-905	32	22	liver	liver	NOUN
admet-905	32	23	,	,	PUNCT
admet-905	32	24	visceral	visceral	ADJ
admet-905	32	25	fat	fat	NOUN
admet-905	32	26	,	,	PUNCT
admet-905	32	27	and	and	CCONJ
admet-905	32	28	muscle	muscle	NOUN
admet-905	32	29	[	[	X
admet-905	32	30	26	26	NUM
admet-905	32	31	]	]	PUNCT
admet-905	32	32	,	,	PUNCT
admet-905	32	33	and	and	CCONJ
admet-905	32	34	stimulates	stimulate	VERB
admet-905	32	35	insulin	insulin	NOUN
admet-905	32	36	signaling	signal	VERB
admet-905	32	37	pathway	pathway	NOUN
admet-905	32	38	in	in	ADP
admet-905	32	39	human	human	ADJ
admet-905	32	40	granulosa	granulosa	NOUN
admet-905	32	41	cells	cell	NOUN
admet-905	32	42	and	and	CCONJ
admet-905	32	43	other	other	ADJ
admet-905	32	44	cells	cell	NOUN
admet-905	32	45	of	of	ADP
admet-905	32	46	the	the	DET
admet-905	32	47	body	body	NOUN
admet-905	32	48	[	[	X
admet-905	32	49	27	27	NUM
admet-905	32	50	]	]	PUNCT
admet-905	32	51	.	.	PUNCT
admet-905	33	1	this	this	DET
admet-905	33	2	insulin	insulin	NOUN
admet-905	33	3	-	-	PUNCT
admet-905	33	4	sensitizing	sensitize	VERB
admet-905	33	5	drug	drug	NOUN
admet-905	33	6	,	,	PUNCT
admet-905	33	7	promises	promise	VERB
admet-905	33	8	pcos	pcos	PROPN
admet-905	33	9	patients	patient	NOUN
admet-905	33	10	,	,	PUNCT
admet-905	33	11	may	may	AUX
admet-905	33	12	play	play	VERB
admet-905	33	13	a	a	DET
admet-905	33	14	role	role	NOUN
admet-905	33	15	in	in	ADP
admet-905	33	16	zonulin	zonulin	PROPN
admet-905	33	17	level	level	NOUN
admet-905	33	18	and	and	CCONJ
admet-905	33	19	gut	gut	NOUN
admet-905	33	20	permeability	permeability	NOUN
admet-905	33	21	.	.	PUNCT
admet-905	34	1	therefore	therefore	ADV
admet-905	34	2	,	,	PUNCT
admet-905	34	3	the	the	DET
admet-905	34	4	study	study	NOUN
admet-905	34	5	is	be	AUX
admet-905	34	6	designed	design	VERB
admet-905	34	7	to	to	PART
admet-905	34	8	find	find	VERB
admet-905	34	9	the	the	DET
admet-905	34	10	metformin	metformin	NOUN
admet-905	34	11	effects	effect	NOUN
admet-905	34	12	on	on	ADP
admet-905	34	13	zonulin	zonulin	PROPN
admet-905	34	14	level	level	NOUN
admet-905	34	15	in	in	ADP
admet-905	34	16	pcos	pcos	NOUN
admet-905	34	17	patients	patient	NOUN
admet-905	34	18	and	and	CCONJ
admet-905	34	19	its	its	PRON
admet-905	34	20	association	association	NOUN
admet-905	34	21	with	with	ADP
admet-905	34	22	other	other	ADJ
admet-905	34	23	parameters	parameter	NOUN
admet-905	34	24	.	.	PUNCT
admet-905	35	1	experimental	experimental	ADJ
admet-905	35	2	thirty	thirty	NUM
admet-905	35	3	-	-	PUNCT
admet-905	35	4	one	one	NUM
admet-905	35	5	newly	newly	ADV
admet-905	35	6	diagnosed	diagnose	VERB
admet-905	35	7	pcos	pcos	NOUN
admet-905	35	8	women	woman	NOUN
admet-905	35	9	according	accord	VERB
admet-905	35	10	to	to	ADP
admet-905	35	11	rotterdam	rotterdam	PROPN
admet-905	35	12	criteria	criterion	NOUN
admet-905	35	13	are	be	AUX
admet-905	35	14	included	include	VERB
admet-905	35	15	in	in	ADP
admet-905	35	16	this	this	DET
admet-905	35	17	study	study	NOUN
admet-905	35	18	.	.	PUNCT
admet-905	36	1	patients	patient	NOUN
admet-905	36	2	with	with	ADP
admet-905	36	3	adrenal	adrenal	ADJ
admet-905	36	4	dysfunction	dysfunction	NOUN
admet-905	36	5	,	,	PUNCT
admet-905	36	6	thyroid	thyroid	NOUN
admet-905	36	7	dysfunction	dysfunction	NOUN
admet-905	36	8	,	,	PUNCT
admet-905	36	9	diabetics	diabetic	NOUN
admet-905	36	10	,	,	PUNCT
admet-905	36	11	and	and	CCONJ
admet-905	36	12	those	those	PRON
admet-905	36	13	on	on	ADP
admet-905	36	14	oral	oral	ADJ
admet-905	36	15	contraceptives	contraceptive	NOUN
admet-905	36	16	are	be	AUX
admet-905	36	17	excluded	exclude	VERB
admet-905	36	18	from	from	ADP
admet-905	36	19	the	the	DET
admet-905	36	20	study	study	NOUN
admet-905	36	21	.	.	PUNCT
admet-905	37	1	fasting	fast	VERB
admet-905	37	2	insulin	insulin	NOUN
admet-905	37	3	,	,	PUNCT
admet-905	37	4	fasting	fast	VERB
admet-905	37	5	glucose	glucose	NOUN
admet-905	37	6	,	,	PUNCT
admet-905	37	7	fsh	fsh	NOUN
admet-905	37	8	,	,	PUNCT
admet-905	37	9	lh	lh	NOUN
admet-905	37	10	,	,	PUNCT
admet-905	37	11	testosterone	testosterone	NOUN
admet-905	37	12	,	,	PUNCT
admet-905	37	13	free	free	ADJ
admet-905	37	14	testosterone	testosterone	NOUN
admet-905	37	15	,	,	PUNCT
admet-905	37	16	shbg	shbg	NOUN
admet-905	37	17	,	,	PUNCT
admet-905	37	18	and	and	CCONJ
admet-905	37	19	serum	serum	NOUN
admet-905	37	20	zonulin	zonulin	PROPN
admet-905	37	21	are	be	AUX
admet-905	37	22	measured	measure	VERB
admet-905	37	23	before	before	ADV
admet-905	37	24	and	and	CCONJ
admet-905	37	25	after	after	ADP
admet-905	37	26	intake	intake	NOUN
admet-905	37	27	of	of	ADP
admet-905	37	28	metformin	metformin	PROPN
admet-905	37	29	(	(	PUNCT
admet-905	37	30	bigomet	bigomet	NOUN
admet-905	37	31	®	®	PROPN
admet-905	37	32	)	)	PUNCT
admet-905	37	33	,	,	PUNCT
admet-905	37	34	850	850	NUM
admet-905	37	35	mg	mg	NOUN
admet-905	37	36	twice	twice	ADV
admet-905	37	37	daily	daily	ADV
admet-905	37	38	for	for	ADP
admet-905	37	39	three	three	NUM
admet-905	37	40	months	month	NOUN
admet-905	37	41	.	.	PUNCT
admet-905	38	1	the	the	DET
admet-905	38	2	research	research	NOUN
admet-905	38	3	plan	plan	NOUN
admet-905	38	4	was	be	AUX
admet-905	38	5	approved	approve	VERB
admet-905	38	6	by	by	ADP
admet-905	38	7	the	the	DET
admet-905	38	8	scientific	scientific	ADJ
admet-905	38	9	committee	committee	NOUN
admet-905	38	10	of	of	ADP
admet-905	38	11	the	the	DET
admet-905	38	12	college	college	NOUN
admet-905	38	13	of	of	ADP
admet-905	38	14	medicine	medicine	NOUN
admet-905	38	15	,	,	PUNCT
admet-905	38	16	tikrit	tikrit	NOUN
admet-905	38	17	university	university	NOUN
admet-905	38	18	,	,	PUNCT
admet-905	38	19	on	on	ADP
admet-905	38	20	24	24	NUM
admet-905	38	21	/	/	SYM
admet-905	38	22	october/	october/	NUM
admet-905	38	23	2018	2018	NUM
admet-905	38	24	.	.	PUNCT
admet-905	39	1	the	the	DET
admet-905	39	2	parameters	parameter	NOUN
admet-905	39	3	of	of	ADP
admet-905	39	4	fsh	fsh	NOUN
admet-905	39	5	,	,	PUNCT
admet-905	39	6	lh	lh	NOUN
admet-905	39	7	,	,	PUNCT
admet-905	39	8	total	total	ADJ
admet-905	39	9	testosterone	testosterone	NOUN
admet-905	39	10	,	,	PUNCT
admet-905	39	11	shbg	shbg	NOUN
admet-905	39	12	,	,	PUNCT
admet-905	39	13	and	and	CCONJ
admet-905	39	14	insulin	insulin	NOUN
admet-905	39	15	are	be	AUX
admet-905	39	16	determined	determine	VERB
admet-905	39	17	by	by	ADP
admet-905	39	18	cobas	cobas	ADJ
admet-905	39	19	technique	technique	NOUN
admet-905	39	20	(	(	PUNCT
admet-905	39	21	cobas	cobas	X
admet-905	39	22	e	e	NOUN
admet-905	39	23	411	411	NUM
admet-905	39	24	systems	system	NOUN
admet-905	39	25	)	)	PUNCT
admet-905	39	26	;	;	PUNCT
admet-905	39	27	fasting	fast	VERB
admet-905	39	28	serum	serum	NOUN
admet-905	39	29	glucose	glucose	NOUN
admet-905	39	30	was	be	AUX
admet-905	39	31	determined	determine	VERB
admet-905	39	32	by	by	ADP
admet-905	39	33	cobas	cobas	PROPN
admet-905	39	34	c	c	PROPN
admet-905	39	35	311analyzers	311analyzers	PROPN
admet-905	39	36	.	.	PUNCT
admet-905	40	1	serum	serum	PROPN
admet-905	40	2	zonulin	zonulin	PROPN
admet-905	40	3	has	have	AUX
admet-905	40	4	been	be	AUX
admet-905	40	5	determined	determine	VERB
admet-905	40	6	according	accord	VERB
admet-905	40	7	to	to	ADP
admet-905	40	8	“	"	PUNCT
admet-905	40	9	human	human	PROPN
admet-905	40	10	zonulin	zonulin	PROPN
admet-905	40	11	elisa	elisa	PROPN
admet-905	40	12	kit	kit	PROPN
admet-905	40	13	cat	cat	PROPN
admet-905	40	14	no	no	PROPN
admet-905	40	15	.	.	PUNCT
admet-905	40	16	mbs2607261	mbs2607261	NOUN
admet-905	40	17	“	"	PUNCT
admet-905	40	18	supplied	supply	VERB
admet-905	40	19	by	by	ADP
admet-905	40	20	mybiosource	mybiosource	PROPN
admet-905	40	21	/	/	SYM
admet-905	40	22	usa	usa	PROPN
admet-905	40	23	company	company	NOUN
admet-905	40	24	.	.	PUNCT
admet-905	41	1	free	free	ADJ
admet-905	41	2	testosterone	testosterone	NOUN
admet-905	41	3	is	be	AUX
admet-905	41	4	determined	determine	VERB
admet-905	41	5	by	by	ADP
admet-905	41	6	the	the	DET
admet-905	41	7	elisa	elisa	NOUN
admet-905	41	8	technique	technique	NOUN
admet-905	41	9	.	.	PUNCT
admet-905	42	1	statistical	statistical	ADJ
admet-905	42	2	analysis	analysis	NOUN
admet-905	42	3	performed	perform	VERB
admet-905	42	4	by	by	ADP
admet-905	42	5	spss	spss	PROPN
admet-905	42	6	and	and	CCONJ
admet-905	42	7	the	the	DET
admet-905	42	8	significant	significant	ADJ
admet-905	42	9	changes	change	NOUN
admet-905	42	10	was	be	AUX
admet-905	42	11	considered	consider	VERB
admet-905	42	12	when	when	SCONJ
admet-905	42	13	p	p	NOUN
admet-905	42	14	-	-	PUNCT
admet-905	42	15	value	value	NOUN
admet-905	42	16	less	less	ADJ
admet-905	42	17	0.05	0.05	NUM
admet-905	42	18	.	.	PUNCT
admet-905	43	1	the	the	DET
admet-905	43	2	patients	patient	NOUN
admet-905	43	3	are	be	AUX
admet-905	43	4	divided	divide	VERB
admet-905	43	5	into	into	ADP
admet-905	43	6	two	two	NUM
admet-905	43	7	subgroups	subgroup	NOUN
admet-905	43	8	according	accord	VERB
admet-905	43	9	to	to	ADP
admet-905	43	10	their	their	PRON
admet-905	43	11	initial	initial	ADJ
admet-905	43	12	homeostatic	homeostatic	ADJ
admet-905	43	13	model	model	NOUN
admet-905	43	14	assessment	assessment	NOUN
admet-905	43	15	(	(	PUNCT
admet-905	43	16	homa	homa	NOUN
admet-905	43	17	-	-	PUNCT
admet-905	43	18	ir	ir	NOUN
admet-905	43	19	)	)	PUNCT
admet-905	43	20	that	that	PRON
admet-905	43	21	is	be	AUX
admet-905	43	22	determined	determine	VERB
admet-905	43	23	before	before	ADP
admet-905	43	24	starting	start	VERB
admet-905	43	25	metformin	metformin	NOUN
admet-905	43	26	treatment	treatment	NOUN
admet-905	43	27	.	.	PUNCT
admet-905	44	1	first	first	ADJ
admet-905	44	2	group	group	PROPN
admet-905	44	3	sixteen	sixteen	NUM
admet-905	44	4	patients	patient	NOUN
admet-905	44	5	have	have	VERB
admet-905	44	6	initial	initial	ADJ
admet-905	44	7	homa	homa	NOUN
admet-905	44	8	-	-	PUNCT
admet-905	44	9	ir	ir	NOUN
admet-905	44	10	less	less	ADJ
admet-905	44	11	than	than	ADP
admet-905	44	12	two	two	NUM
admet-905	44	13	,	,	PUNCT
admet-905	44	14	eleven	eleven	NUM
admet-905	44	15	of	of	ADP
admet-905	44	16	them	they	PRON
admet-905	44	17	have	have	VERB
admet-905	44	18	primary	primary	ADJ
admet-905	44	19	infertility	infertility	NOUN
admet-905	44	20	and	and	CCONJ
admet-905	44	21	only	only	ADV
admet-905	44	22	five	five	NUM
admet-905	44	23	women	woman	NOUN
admet-905	44	24	have	have	VERB
admet-905	44	25	secondary	secondary	ADJ
admet-905	44	26	infertility	infertility	NOUN
admet-905	44	27	,	,	PUNCT
admet-905	44	28	and	and	CCONJ
admet-905	44	29	their	their	PRON
admet-905	44	30	mean	mean	ADJ
admet-905	44	31	age	age	NOUN
admet-905	44	32	was	be	AUX
admet-905	44	33	28.81	28.81	NUM
admet-905	44	34	years	year	NOUN
admet-905	44	35	.	.	PUNCT
admet-905	45	1	second	second	ADJ
admet-905	45	2	group	group	NOUN
admet-905	45	3	fifteen	fifteen	NUM
admet-905	45	4	patients	patient	NOUN
admet-905	45	5	have	have	VERB
admet-905	45	6	initial	initial	ADJ
admet-905	45	7	homa	homa	NOUN
admet-905	45	8	-	-	PUNCT
admet-905	45	9	ir	ir	PROPN
admet-905	45	10	two	two	NUM
admet-905	45	11	to	to	PART
admet-905	45	12	four	four	NUM
admet-905	45	13	,	,	PUNCT
admet-905	45	14	twelve	twelve	NUM
admet-905	45	15	of	of	ADP
admet-905	45	16	them	they	PRON
admet-905	45	17	have	have	VERB
admet-905	45	18	primary	primary	ADJ
admet-905	45	19	infertility	infertility	NOUN
admet-905	45	20	and	and	CCONJ
admet-905	45	21	only	only	ADV
admet-905	45	22	three	three	NUM
admet-905	45	23	of	of	ADP
admet-905	45	24	them	they	PRON
admet-905	45	25	have	have	VERB
admet-905	45	26	secondary	secondary	ADJ
admet-905	45	27	infertility	infertility	NOUN
admet-905	45	28	,	,	PUNCT
admet-905	45	29	and	and	CCONJ
admet-905	45	30	their	their	PRON
admet-905	45	31	mean	mean	ADJ
admet-905	45	32	age	age	NOUN
admet-905	45	33	was	be	AUX
admet-905	45	34	26.93	26.93	NUM
admet-905	45	35	years	year	NOUN
admet-905	45	36	.	.	PUNCT
admet-905	46	1	results	result	NOUN
admet-905	46	2	and	and	CCONJ
admet-905	46	3	discussion	discussion	NOUN
admet-905	46	4	first	first	ADJ
admet-905	46	5	group	group	NOUN
admet-905	46	6	,	,	PUNCT
admet-905	46	7	those	those	PRON
admet-905	46	8	of	of	ADP
admet-905	46	9	initial	initial	ADJ
admet-905	46	10	homa	homa	NOUN
admet-905	46	11	-	-	PUNCT
admet-905	46	12	ir	ir	PROPN
admet-905	46	13	<	<	PROPN
admet-905	46	14	2	2	NUM
admet-905	46	15	,	,	PUNCT
admet-905	46	16	did	do	AUX
admet-905	46	17	not	not	PART
admet-905	46	18	show	show	VERB
admet-905	46	19	any	any	DET
admet-905	46	20	significant	significant	ADJ
admet-905	46	21	difference	difference	NOUN
admet-905	46	22	in	in	ADP
admet-905	46	23	any	any	PRON
admet-905	46	24	of	of	ADP
admet-905	46	25	the	the	DET
admet-905	46	26	parameters	parameter	NOUN
admet-905	46	27	admet	admet	PROPN
admet-905	46	28	&	&	CCONJ
admet-905	46	29	dmpk	dmpk	PROPN
admet-905	46	30	9(1	9(1	NUM
admet-905	46	31	)	)	PUNCT
admet-905	46	32	(	(	PUNCT
admet-905	46	33	2021	2021	NUM
admet-905	46	34	)	)	PUNCT
admet-905	46	35	49	49	NUM
admet-905	46	36	-	-	SYM
admet-905	46	37	55	55	NUM
admet-905	46	38	metformin	metformin	NOUN
admet-905	46	39	effects	effect	NOUN
admet-905	46	40	on	on	ADP
admet-905	46	41	zonulin	zonulin	PROPN
admet-905	46	42	level	level	NOUN
admet-905	46	43	in	in	ADP
admet-905	46	44	polycystic	polycystic	ADJ
admet-905	46	45	ovarian	ovarian	ADJ
admet-905	46	46	women	woman	NOUN
admet-905	46	47	doi	doi	NOUN
admet-905	46	48	:	:	PUNCT
admet-905	46	49	http://doi.org/10.5599/admet.905	http://doi.org/10.5599/admet.905	VERB
admet-905	46	50	51	51	NUM
admet-905	46	51	that	that	PRON
admet-905	46	52	measured	measure	VERB
admet-905	46	53	including	include	VERB
admet-905	46	54	bmi	bmi	NOUN
admet-905	46	55	,	,	PUNCT
admet-905	46	56	fsh	fsh	NOUN
admet-905	46	57	,	,	PUNCT
admet-905	46	58	lh	lh	NOUN
admet-905	46	59	,	,	PUNCT
admet-905	46	60	testosterone	testosterone	NOUN
admet-905	46	61	,	,	PUNCT
admet-905	46	62	free	free	ADJ
admet-905	46	63	testosterone	testosterone	NOUN
admet-905	46	64	,	,	PUNCT
admet-905	46	65	shbg	shbg	NOUN
admet-905	46	66	,	,	PUNCT
admet-905	46	67	fasting	fast	VERB
admet-905	46	68	insulin	insulin	NOUN
admet-905	46	69	,	,	PUNCT
admet-905	46	70	fasting	fast	VERB
admet-905	46	71	glucose	glucose	NOUN
admet-905	46	72	,	,	PUNCT
admet-905	46	73	homa	homa	PROPN
admet-905	46	74	ir	ir	PROPN
admet-905	46	75	,	,	PUNCT
admet-905	46	76	and	and	CCONJ
admet-905	46	77	zonulin	zonulin	PROPN
admet-905	46	78	as	as	SCONJ
admet-905	46	79	seen	see	VERB
admet-905	46	80	in	in	ADP
admet-905	46	81	table	table	NOUN
admet-905	46	82	1	1	NUM
admet-905	46	83	.	.	PUNCT
admet-905	46	84	table	table	NOUN
admet-905	46	85	1	1	NUM
admet-905	46	86	.	.	PUNCT
admet-905	47	1	statistical	statistical	ADJ
admet-905	47	2	analysis	analysis	NOUN
admet-905	47	3	of	of	ADP
admet-905	47	4	parameters	parameter	NOUN
admet-905	47	5	and	and	CCONJ
admet-905	47	6	zonulin	zonulin	NOUN
admet-905	47	7	before	before	ADP
admet-905	47	8	metformin	metformin	NOUN
admet-905	47	9	therapy	therapy	NOUN
admet-905	47	10	in	in	ADP
admet-905	47	11	pcos	pcos	PROPN
admet-905	47	12	with	with	ADP
admet-905	47	13	initial	initial	ADJ
admet-905	47	14	(	(	PUNCT
admet-905	47	15	before	before	ADP
admet-905	47	16	treatment	treatment	NOUN
admet-905	47	17	)	)	PUNCT
admet-905	47	18	homa	homa	NOUN
admet-905	47	19	-	-	PUNCT
admet-905	47	20	ir	ir	PROPN
admet-905	47	21	<	<	PROPN
admet-905	47	22	2	2	NUM
admet-905	47	23	initial	initial	ADJ
admet-905	47	24	homa	homa	NOUN
admet-905	47	25	-	-	PUNCT
admet-905	47	26	ir<2	ir<2	NOUN
admet-905	47	27	mean	mean	VERB
admet-905	48	1	+	+	ADP
admet-905	48	2	sd	sd	ADJ
admet-905	48	3	p	p	ADJ
admet-905	48	4	-	-	PUNCT
admet-905	48	5	value	value	NOUN
admet-905	48	6	bmi	bmi	NOUN
admet-905	48	7	before	before	ADP
admet-905	48	8	28.26	28.26	NUM
admet-905	48	9	+	+	NUM
admet-905	48	10	5.93	5.93	NUM
admet-905	48	11	0.4	0.4	NUM
admet-905	48	12	after	after	ADP
admet-905	48	13	26.6	26.6	NUM
admet-905	48	14	+	+	SYM
admet-905	48	15	4.13	4.13	NUM
admet-905	48	16	fsh(uiu	fsh(uiu	NOUN
admet-905	48	17	/	/	SYM
admet-905	48	18	ml	ml	NOUN
admet-905	48	19	)	)	PUNCT
admet-905	48	20	before	before	ADP
admet-905	48	21	6.16	6.16	NUM
admet-905	48	22	+	+	PROPN
admet-905	48	23	1.69	1.69	NUM
admet-905	48	24	0.28	0.28	NUM
admet-905	48	25	after	after	ADP
admet-905	48	26	7.66	7.66	NUM
admet-905	48	27	+	+	NOUN
admet-905	48	28	4.15	4.15	NUM
admet-905	48	29	lh(uiu	lh(uiu	NOUN
admet-905	48	30	/	/	SYM
admet-905	48	31	ml	ml	NOUN
admet-905	48	32	)	)	PUNCT
admet-905	48	33	before	before	ADP
admet-905	48	34	10.26	10.26	NUM
admet-905	48	35	+	+	PROPN
admet-905	48	36	5.04	5.04	NUM
admet-905	48	37	0.25	0.25	NUM
admet-905	48	38	after	after	ADP
admet-905	48	39	7.83	7.83	NUM
admet-905	48	40	+	+	SYM
admet-905	48	41	5.47	5.47	NUM
admet-905	48	42	testosterone(ng	testosterone(ng	NOUN
admet-905	48	43	/	/	SYM
admet-905	48	44	ml	ml	NOUN
admet-905	48	45	)	)	PUNCT
admet-905	48	46	before	before	ADP
admet-905	48	47	0.55	0.55	NUM
admet-905	48	48	+	+	NUM
admet-905	48	49	0.4	0.4	NUM
admet-905	48	50	0.13	0.13	NUM
admet-905	48	51	after	after	ADP
admet-905	48	52	0.36	0.36	NUM
admet-905	48	53	+	+	SYM
admet-905	48	54	0.26	0.26	NUM
admet-905	48	55	free	free	ADJ
admet-905	48	56	testosterone	testosterone	NOUN
admet-905	48	57	(	(	PUNCT
admet-905	48	58	pg	pg	NOUN
admet-905	48	59	/	/	SYM
admet-905	48	60	ml	ml	NOUN
admet-905	48	61	)	)	PUNCT
admet-905	48	62	before	before	ADP
admet-905	48	63	2.86	2.86	NUM
admet-905	48	64	+	+	NOUN
admet-905	48	65	0.74	0.74	NUM
admet-905	48	66	0.12	0.12	NUM
admet-905	48	67	after	after	ADP
admet-905	48	68	2.4	2.4	NUM
admet-905	48	69	+	+	SYM
admet-905	48	70	0.72	0.72	NUM
admet-905	48	71	shbg	shbg	NOUN
admet-905	48	72	(	(	PUNCT
admet-905	48	73	nmol	nmol	NOUN
admet-905	48	74	/	/	SYM
admet-905	48	75	l	l	NOUN
admet-905	48	76	)	)	PUNCT
admet-905	48	77	before	before	ADP
admet-905	48	78	34.01	34.01	NUM
admet-905	48	79	+	+	NUM
admet-905	48	80	33.82	33.82	NUM
admet-905	48	81	0.9	0.9	NUM
admet-905	48	82	after	after	ADP
admet-905	48	83	35.26	35.26	NUM
admet-905	48	84	+	+	SYM
admet-905	48	85	15.12	15.12	NUM
admet-905	48	86	fasting	fast	VERB
admet-905	48	87	insulin	insulin	NOUN
admet-905	48	88	(	(	PUNCT
admet-905	48	89	uiu	uiu	PROPN
admet-905	48	90	/	/	SYM
admet-905	48	91	ml	ml	NOUN
admet-905	48	92	)	)	PUNCT
admet-905	48	93	before	before	ADP
admet-905	48	94	4.29	4.29	NUM
admet-905	48	95	+	+	NOUN
admet-905	48	96	2.72	2.72	NUM
admet-905	48	97	0.15	0.15	NUM
admet-905	48	98	after	after	ADP
admet-905	48	99	9.13	9.13	NUM
admet-905	48	100	+	+	SYM
admet-905	48	101	10.11	10.11	NUM
admet-905	48	102	fasting	fasting	NOUN
admet-905	48	103	glucose	glucose	NOUN
admet-905	48	104	(	(	PUNCT
admet-905	48	105	mg	mg	PROPN
admet-905	48	106	/	/	SYM
admet-905	48	107	dl	dl	NOUN
admet-905	48	108	)	)	PUNCT
admet-905	48	109	before	before	ADP
admet-905	48	110	89.63	89.63	NUM
admet-905	48	111	+	+	PROPN
admet-905	48	112	11.86	11.86	NUM
admet-905	48	113	0.27	0.27	NUM
admet-905	48	114	after	after	ADP
admet-905	48	115	95.33	95.33	NUM
admet-905	48	116	+	+	SYM
admet-905	48	117	13.66	13.66	NUM
admet-905	48	118	homa	homa	NOUN
admet-905	48	119	-	-	PUNCT
admet-905	48	120	ir	ir	NOUN
admet-905	48	121	before	before	ADP
admet-905	48	122	0.96	0.96	NUM
admet-905	48	123	+	+	NOUN
admet-905	48	124	0.62	0.62	NUM
admet-905	48	125	0.13	0.13	NUM
admet-905	48	126	after	after	ADP
admet-905	48	127	2.43	2.43	NUM
admet-905	48	128	+	+	NOUN
admet-905	48	129	2.93	2.93	NUM
admet-905	48	130	serum	serum	NOUN
admet-905	48	131	zonulin	zonulin	PROPN
admet-905	48	132	(	(	PUNCT
admet-905	48	133	ng	ng	PROPN
admet-905	48	134	/	/	SYM
admet-905	48	135	ml	ml	NOUN
admet-905	48	136	)	)	PUNCT
admet-905	48	137	before	before	ADP
admet-905	48	138	20.83	20.83	NUM
admet-905	48	139	+	+	NOUN
admet-905	48	140	15.46	15.46	NUM
admet-905	48	141	0.52	0.52	NUM
admet-905	48	142	after	after	ADP
admet-905	48	143	16.90	16.90	NUM
admet-905	48	144	+	+	SYM
admet-905	48	145	15.21	15.21	NUM
admet-905	48	146	table	table	NOUN
admet-905	48	147	2	2	NUM
admet-905	48	148	.	.	PUNCT
admet-905	48	149	statistical	statistical	ADJ
admet-905	48	150	analysis	analysis	NOUN
admet-905	48	151	of	of	ADP
admet-905	48	152	parameters	parameter	NOUN
admet-905	48	153	and	and	CCONJ
admet-905	48	154	zonulin	zonulin	NOUN
admet-905	48	155	before	before	ADP
admet-905	48	156	and	and	CCONJ
admet-905	48	157	after	after	ADP
admet-905	48	158	metformin	metformin	NOUN
admet-905	48	159	therapy	therapy	NOUN
admet-905	48	160	in	in	ADP
admet-905	48	161	pcos	pcos	PROPN
admet-905	48	162	with	with	ADP
admet-905	48	163	initial	initial	ADJ
admet-905	48	164	(	(	PUNCT
admet-905	48	165	before	before	ADP
admet-905	48	166	treatment	treatment	NOUN
admet-905	48	167	)	)	PUNCT
admet-905	48	168	homa	homa	NOUN
admet-905	48	169	-	-	PUNCT
admet-905	48	170	ir	ir	NOUN
admet-905	49	1	=	=	NOUN
admet-905	49	2	2	2	NUM
admet-905	49	3	-	-	SYM
admet-905	49	4	4	4	NUM
admet-905	49	5	initial	initial	ADJ
admet-905	49	6	homa	homa	NOUN
admet-905	49	7	-	-	PUNCT
admet-905	49	8	ir=2	ir=2	PROPN
admet-905	49	9	–	–	PUNCT
admet-905	49	10	4	4	NUM
admet-905	49	11	mean	mean	NOUN
admet-905	49	12	+	+	ADP
admet-905	49	13	sd	sd	ADJ
admet-905	49	14	p	p	ADJ
admet-905	49	15	-	-	PUNCT
admet-905	49	16	value	value	NOUN
admet-905	49	17	bmi	bmi	NOUN
admet-905	49	18	before	before	ADP
admet-905	49	19	28.95	28.95	NUM
admet-905	49	20	+	+	NUM
admet-905	49	21	8.55	8.55	NUM
admet-905	49	22	0.3	0.3	NUM
admet-905	49	23	after	after	ADP
admet-905	49	24	27.04	27.04	NUM
admet-905	49	25	+	+	SYM
admet-905	49	26	4.48	4.48	NUM
admet-905	49	27	fsh	fsh	NOUN
admet-905	49	28	(	(	PUNCT
admet-905	49	29	uiu	uiu	PROPN
admet-905	49	30	/	/	SYM
admet-905	49	31	ml	ml	NOUN
admet-905	49	32	)	)	PUNCT
admet-905	49	33	before	before	ADP
admet-905	49	34	5.94	5.94	NUM
admet-905	49	35	+	+	NOUN
admet-905	49	36	2.39	2.39	NUM
admet-905	49	37	0.11	0.11	NUM
admet-905	49	38	after	after	ADP
admet-905	49	39	4.68	4.68	NUM
admet-905	49	40	+	+	SYM
admet-905	49	41	1.89	1.89	NUM
admet-905	49	42	lh	lh	NOUN
admet-905	49	43	(	(	PUNCT
admet-905	49	44	uiu	uiu	PROPN
admet-905	49	45	/	/	SYM
admet-905	49	46	ml	ml	NOUN
admet-905	49	47	)	)	PUNCT
admet-905	49	48	before	before	ADP
admet-905	49	49	12.11	12.11	NUM
admet-905	49	50	+	+	NUM
admet-905	49	51	8.08	8.08	NUM
admet-905	49	52	0.08	0.08	NUM
admet-905	49	53	after	after	ADP
admet-905	49	54	7.24	7.24	NUM
admet-905	49	55	+	+	SYM
admet-905	49	56	6.01	6.01	NUM
admet-905	49	57	testosterone(ng	testosterone(ng	NOUN
admet-905	49	58	/	/	SYM
admet-905	49	59	ml	ml	NOUN
admet-905	49	60	)	)	PUNCT
admet-905	49	61	before	before	ADP
admet-905	49	62	0.65	0.65	NUM
admet-905	49	63	+	+	NOUN
admet-905	49	64	0.48	0.48	NUM
admet-905	49	65	0.09	0.09	NUM
admet-905	49	66	after	after	ADP
admet-905	49	67	0.39	0.39	NUM
admet-905	49	68	+	+	NOUN
admet-905	49	69	0.28	0.28	NUM
admet-905	49	70	free	free	ADJ
admet-905	49	71	testosterone	testosterone	NOUN
admet-905	49	72	(	(	PUNCT
admet-905	49	73	pg	pg	NOUN
admet-905	49	74	/	/	SYM
admet-905	49	75	ml	ml	NOUN
admet-905	49	76	)	)	PUNCT
admet-905	49	77	before	before	ADP
admet-905	49	78	2.84	2.84	NUM
admet-905	49	79	+	+	NOUN
admet-905	49	80	0.92	0.92	NUM
admet-905	49	81	0.07	0.07	NUM
admet-905	49	82	after	after	ADP
admet-905	49	83	2.38	2.38	NUM
admet-905	49	84	+	+	SYM
admet-905	49	85	0.6	0.6	NUM
admet-905	49	86	shbg	shbg	NOUN
admet-905	49	87	(	(	PUNCT
admet-905	49	88	nmol	nmol	NOUN
admet-905	49	89	/	/	SYM
admet-905	49	90	l	l	NOUN
admet-905	49	91	)	)	PUNCT
admet-905	49	92	before	before	ADP
admet-905	49	93	27.27	27.27	NUM
admet-905	49	94	+	+	PROPN
admet-905	49	95	18.04	18.04	NUM
admet-905	49	96	0.2	0.2	NUM
admet-905	49	97	after	after	ADP
admet-905	49	98	38.12	38.12	NUM
admet-905	49	99	+	+	SYM
admet-905	49	100	22.64	22.64	NUM
admet-905	49	101	fasting	fast	VERB
admet-905	49	102	insulin(uiu	insulin(uiu	NOUN
admet-905	49	103	/	/	SYM
admet-905	49	104	ml	ml	NOUN
admet-905	49	105	)	)	PUNCT
admet-905	49	106	before	before	ADP
admet-905	49	107	12.74	12.74	NUM
admet-905	49	108	+	+	PROPN
admet-905	49	109	4.29	4.29	NUM
admet-905	49	110	0.04	0.04	NUM
admet-905	49	111	*	*	PUNCT
admet-905	49	112	after	after	ADP
admet-905	49	113	8.7	8.7	NUM
admet-905	49	114	+	+	NOUN
admet-905	49	115	5.33	5.33	NUM
admet-905	49	116	fasting	fast	VERB
admet-905	49	117	glucose	glucose	NOUN
admet-905	49	118	(	(	PUNCT
admet-905	49	119	mg	mg	PROPN
admet-905	49	120	/	/	SYM
admet-905	49	121	dl	dl	NOUN
admet-905	49	122	)	)	PUNCT
admet-905	49	123	before	before	ADP
admet-905	49	124	89.73	89.73	NUM
admet-905	49	125	+	+	PROPN
admet-905	49	126	24.2	24.2	NUM
admet-905	49	127	0.06	0.06	NUM
admet-905	49	128	after	after	ADP
admet-905	49	129	82.91	82.91	NUM
admet-905	49	130	+	+	NOUN
admet-905	49	131	8.37	8.37	NUM
admet-905	49	132	homa	homa	NOUN
admet-905	49	133	-	-	PUNCT
admet-905	49	134	ir	ir	NOUN
admet-905	49	135	before	before	ADP
admet-905	49	136	2.8	2.8	NUM
admet-905	49	137	+	+	PROPN
admet-905	49	138	0.93	0.93	NUM
admet-905	49	139	0.02	0.02	NUM
admet-905	49	140	*	*	PUNCT
admet-905	49	141	after	after	ADP
admet-905	49	142	1.79	1.79	NUM
admet-905	49	143	+	+	SYM
admet-905	49	144	1.17	1.17	NUM
admet-905	49	145	serum	serum	NOUN
admet-905	49	146	zonulin	zonulin	PROPN
admet-905	49	147	(	(	PUNCT
admet-905	49	148	ng	ng	PROPN
admet-905	49	149	/	/	SYM
admet-905	49	150	ml	ml	NOUN
admet-905	49	151	)	)	PUNCT
admet-905	49	152	before	before	ADP
admet-905	49	153	16.26	16.26	NUM
admet-905	49	154	+	+	NUM
admet-905	49	155	10.10	10.10	NUM
admet-905	49	156	0.01	0.01	NUM
admet-905	49	157	*	*	PUNCT
admet-905	49	158	after	after	ADP
admet-905	49	159	7.92	7.92	NUM
admet-905	49	160	+	+	SYM
admet-905	49	161	5.09	5.09	NUM
admet-905	49	162	*	*	PUNCT
admet-905	49	163	p	p	NOUN
admet-905	49	164	-	-	PUNCT
admet-905	49	165	value	value	NOUN
admet-905	49	166	less	less	ADJ
admet-905	49	167	than	than	ADP
admet-905	49	168	0.05	0.05	NUM
admet-905	49	169	http://dx.doi.org/10.5599/admet.905	http://dx.doi.org/10.5599/admet.905	VERB
admet-905	49	170	m.	m.	NOUN
admet-905	49	171	ibrahim	ibrahim	PROPN
admet-905	49	172	,	,	PUNCT
admet-905	49	173	m.	m.	NOUN
admet-905	49	174	ahmeid	ahmeid	PROPN
admet-905	49	175	admet	admet	PROPN
admet-905	49	176	&	&	CCONJ
admet-905	49	177	dmpk	dmpk	PROPN
admet-905	49	178	9(1	9(1	NUM
admet-905	49	179	)	)	PUNCT
admet-905	49	180	(	(	PUNCT
admet-905	49	181	2021	2021	NUM
admet-905	49	182	)	)	PUNCT
admet-905	49	183	49	49	NUM
admet-905	49	184	-	-	SYM
admet-905	49	185	55	55	NUM
admet-905	49	186	52	52	NUM
admet-905	49	187	the	the	DET
admet-905	49	188	second	second	ADJ
admet-905	49	189	group	group	NOUN
admet-905	49	190	those	those	PRON
admet-905	49	191	of	of	ADP
admet-905	49	192	initial	initial	ADJ
admet-905	49	193	homa	homa	NOUN
admet-905	49	194	-	-	PUNCT
admet-905	49	195	ir	ir	PROPN
admet-905	49	196	2	2	NUM
admet-905	49	197	-	-	SYM
admet-905	49	198	4	4	NUM
admet-905	49	199	(	(	PUNCT
admet-905	49	200	insulin	insulin	NOUN
admet-905	49	201	resistance	resistance	NOUN
admet-905	49	202	group	group	NOUN
admet-905	49	203	)	)	PUNCT
admet-905	49	204	,	,	PUNCT
admet-905	49	205	showed	show	VERB
admet-905	49	206	better	well	ADJ
admet-905	49	207	response	response	NOUN
admet-905	49	208	to	to	ADP
admet-905	49	209	metformin	metformin	NOUN
admet-905	49	210	treatment	treatment	NOUN
admet-905	49	211	(	(	PUNCT
admet-905	49	212	table	table	NOUN
admet-905	49	213	2	2	NUM
admet-905	49	214	)	)	PUNCT
admet-905	49	215	.	.	PUNCT
admet-905	50	1	this	this	DET
admet-905	50	2	group	group	NOUN
admet-905	50	3	exhibits	exhibit	VERB
admet-905	50	4	a	a	DET
admet-905	50	5	marked	mark	VERB
admet-905	50	6	decrease	decrease	NOUN
admet-905	50	7	in	in	ADP
admet-905	50	8	lh	lh	PROPN
admet-905	50	9	,	,	PUNCT
admet-905	50	10	total	total	ADJ
admet-905	50	11	testosterone	testosterone	NOUN
admet-905	50	12	,	,	PUNCT
admet-905	50	13	free	free	ADJ
admet-905	50	14	testosterone	testosterone	NOUN
admet-905	50	15	,	,	PUNCT
admet-905	50	16	fasting	fast	VERB
admet-905	50	17	glucose	glucose	NOUN
admet-905	50	18	with	with	ADP
admet-905	50	19	a	a	DET
admet-905	50	20	p	p	NOUN
admet-905	50	21	-	-	PUNCT
admet-905	50	22	value	value	NOUN
admet-905	50	23	of	of	ADP
admet-905	50	24	0.08	0.08	NUM
admet-905	50	25	,	,	PUNCT
admet-905	50	26	0.09	0.09	NUM
admet-905	50	27	,	,	PUNCT
admet-905	50	28	0.07	0.07	NUM
admet-905	50	29	and	and	CCONJ
admet-905	50	30	0.06	0.06	NUM
admet-905	50	31	respectively	respectively	ADV
admet-905	50	32	,	,	PUNCT
admet-905	50	33	and	and	CCONJ
admet-905	50	34	a	a	DET
admet-905	50	35	significant	significant	ADJ
admet-905	50	36	decrease	decrease	NOUN
admet-905	50	37	in	in	ADP
admet-905	50	38	fasting	fast	VERB
admet-905	50	39	insulin	insulin	NOUN
admet-905	50	40	,	,	PUNCT
admet-905	50	41	homa	homa	NOUN
admet-905	50	42	-	-	PUNCT
admet-905	50	43	ir	ir	PROPN
admet-905	50	44	,	,	PUNCT
admet-905	50	45	and	and	CCONJ
admet-905	50	46	zonulin	zonulin	NOUN
admet-905	50	47	with	with	ADP
admet-905	50	48	p	p	NOUN
admet-905	50	49	-	-	PUNCT
admet-905	50	50	values	value	NOUN
admet-905	50	51	of	of	ADP
admet-905	50	52	0.04	0.04	NUM
admet-905	50	53	,	,	PUNCT
admet-905	50	54	0.02	0.02	NUM
admet-905	50	55	and	and	CCONJ
admet-905	50	56	0.01	0.01	NUM
admet-905	50	57	respectively	respectively	ADV
admet-905	50	58	.	.	PUNCT
admet-905	51	1	the	the	DET
admet-905	51	2	study	study	NOUN
admet-905	51	3	showed	show	VERB
admet-905	51	4	no	no	DET
admet-905	51	5	change	change	NOUN
admet-905	51	6	in	in	ADP
admet-905	51	7	body	body	NOUN
admet-905	51	8	mass	mass	NOUN
admet-905	51	9	index	index	NOUN
admet-905	51	10	(	(	PUNCT
admet-905	51	11	bmi	bmi	PROPN
admet-905	51	12	)	)	PUNCT
admet-905	51	13	(	(	PUNCT
admet-905	51	14	tables	table	NOUN
admet-905	51	15	1	1	NUM
admet-905	51	16	and	and	CCONJ
admet-905	51	17	2	2	NUM
admet-905	51	18	)	)	PUNCT
admet-905	51	19	,	,	PUNCT
admet-905	51	20	which	which	PRON
admet-905	51	21	is	be	AUX
admet-905	51	22	in	in	ADP
admet-905	51	23	agreement	agreement	NOUN
admet-905	51	24	with	with	ADP
admet-905	51	25	sharma	sharma	PROPN
admet-905	51	26	et	et	PROPN
admet-905	51	27	al	al	PROPN
admet-905	51	28	2019	2019	NUM
admet-905	51	29	study	study	NOUN
admet-905	51	30	[	[	X
admet-905	51	31	28	28	NUM
admet-905	51	32	]	]	PUNCT
admet-905	51	33	.	.	PUNCT
admet-905	52	1	it	it	PRON
admet-905	52	2	is	be	AUX
admet-905	52	3	well	well	ADV
admet-905	52	4	known	know	VERB
admet-905	52	5	that	that	SCONJ
admet-905	52	6	most	most	ADJ
admet-905	52	7	pcos	pcos	ADJ
admet-905	52	8	women	woman	NOUN
admet-905	52	9	are	be	AUX
admet-905	52	10	obese	obese	ADJ
admet-905	52	11	,	,	PUNCT
admet-905	52	12	and	and	CCONJ
admet-905	52	13	they	they	PRON
admet-905	52	14	have	have	VERB
admet-905	52	15	an	an	DET
admet-905	52	16	increase	increase	NOUN
admet-905	52	17	in	in	ADP
admet-905	52	18	blood	blood	NOUN
admet-905	52	19	volume	volume	NOUN
admet-905	52	20	and	and	CCONJ
admet-905	52	21	the	the	DET
admet-905	52	22	volume	volume	NOUN
admet-905	52	23	of	of	ADP
admet-905	52	24	distribution	distribution	NOUN
admet-905	52	25	of	of	ADP
admet-905	52	26	any	any	DET
admet-905	52	27	drug	drug	NOUN
admet-905	52	28	[	[	X
admet-905	52	29	29	29	NUM
admet-905	52	30	]	]	PUNCT
admet-905	52	31	.	.	PUNCT
admet-905	53	1	therefore	therefore	ADV
admet-905	53	2	,	,	PUNCT
admet-905	53	3	a	a	DET
admet-905	53	4	higher	high	ADJ
admet-905	53	5	dose	dose	NOUN
admet-905	53	6	of	of	ADP
admet-905	53	7	any	any	DET
admet-905	53	8	drug	drug	NOUN
admet-905	53	9	is	be	AUX
admet-905	53	10	required	require	VERB
admet-905	53	11	to	to	PART
admet-905	53	12	do	do	VERB
admet-905	53	13	equivalent	equivalent	ADJ
admet-905	53	14	action	action	NOUN
admet-905	53	15	in	in	ADP
admet-905	53	16	non	non	ADJ
admet-905	53	17	-	-	ADJ
admet-905	53	18	obese	obese	ADJ
admet-905	53	19	patients	patient	NOUN
admet-905	53	20	[	[	X
admet-905	53	21	30	30	NUM
admet-905	53	22	]	]	PUNCT
admet-905	53	23	.	.	PUNCT
admet-905	54	1	the	the	DET
admet-905	54	2	first	first	ADJ
admet-905	54	3	group	group	NOUN
admet-905	54	4	,	,	PUNCT
admet-905	54	5	those	those	PRON
admet-905	54	6	of	of	ADP
admet-905	54	7	initial	initial	ADJ
admet-905	54	8	homa	homa	NOUN
admet-905	54	9	-	-	PUNCT
admet-905	54	10	ir	ir	NOUN
admet-905	54	11	less	less	ADJ
admet-905	54	12	than	than	ADP
admet-905	54	13	two	two	NUM
admet-905	54	14	(	(	PUNCT
admet-905	54	15	table	table	NOUN
admet-905	54	16	1	1	NUM
admet-905	54	17	)	)	PUNCT
admet-905	54	18	,	,	PUNCT
admet-905	54	19	exhibited	exhibit	VERB
admet-905	54	20	no	no	DET
admet-905	54	21	significant	significant	ADJ
admet-905	54	22	decrease	decrease	NOUN
admet-905	54	23	in	in	ADP
admet-905	54	24	their	their	PRON
admet-905	54	25	homa	homa	NOUN
admet-905	54	26	-	-	PUNCT
admet-905	54	27	ir	ir	PROPN
admet-905	54	28	and	and	CCONJ
admet-905	54	29	fasting	fast	VERB
admet-905	54	30	glucose	glucose	NOUN
admet-905	54	31	after	after	ADP
admet-905	54	32	metformin	metformin	PROPN
admet-905	54	33	treatment	treatment	PROPN
admet-905	54	34	,	,	PUNCT
admet-905	54	35	while	while	SCONJ
admet-905	54	36	the	the	DET
admet-905	54	37	second	second	ADJ
admet-905	54	38	group	group	NOUN
admet-905	54	39	,	,	PUNCT
admet-905	54	40	those	those	PRON
admet-905	54	41	of	of	ADP
admet-905	54	42	initial	initial	ADJ
admet-905	54	43	homa	homa	NOUN
admet-905	54	44	-	-	PUNCT
admet-905	54	45	ir	ir	PROPN
admet-905	54	46	two	two	NUM
admet-905	54	47	to	to	PART
admet-905	54	48	four	four	NUM
admet-905	54	49	(	(	PUNCT
admet-905	54	50	table	table	NOUN
admet-905	54	51	2	2	NUM
admet-905	54	52	)	)	PUNCT
admet-905	54	53	exhibited	exhibit	VERB
admet-905	54	54	a	a	DET
admet-905	54	55	significant	significant	ADJ
admet-905	54	56	decrease	decrease	NOUN
admet-905	54	57	in	in	ADP
admet-905	54	58	homa	homa	NOUN
admet-905	54	59	-	-	PUNCT
admet-905	54	60	ir	ir	PROPN
admet-905	54	61	after	after	ADP
admet-905	54	62	the	the	DET
admet-905	54	63	end	end	NOUN
admet-905	54	64	of	of	ADP
admet-905	54	65	three	three	NUM
admet-905	54	66	months	month	NOUN
admet-905	54	67	therapy	therapy	NOUN
admet-905	54	68	with	with	ADP
admet-905	54	69	a	a	DET
admet-905	54	70	p	p	NOUN
admet-905	54	71	-	-	PUNCT
admet-905	54	72	value	value	NOUN
admet-905	54	73	of	of	ADP
admet-905	54	74	0.04	0.04	NUM
admet-905	54	75	,	,	PUNCT
admet-905	54	76	and	and	CCONJ
admet-905	54	77	a	a	DET
admet-905	54	78	marked	mark	VERB
admet-905	54	79	decrease	decrease	NOUN
admet-905	54	80	in	in	ADP
admet-905	54	81	fasting	fast	VERB
admet-905	54	82	glucose	glucose	NOUN
admet-905	54	83	,	,	PUNCT
admet-905	54	84	with	with	ADP
admet-905	54	85	a	a	DET
admet-905	54	86	p	p	NOUN
admet-905	54	87	-	-	PUNCT
admet-905	54	88	value	value	NOUN
admet-905	54	89	of	of	ADP
admet-905	54	90	0.06	0.06	NUM
admet-905	54	91	.	.	PUNCT
admet-905	55	1	this	this	DET
admet-905	55	2	result	result	NOUN
admet-905	55	3	agrees	agree	VERB
admet-905	55	4	with	with	ADP
admet-905	55	5	the	the	DET
admet-905	55	6	study	study	NOUN
admet-905	55	7	of	of	ADP
admet-905	55	8	nawrocka	nawrocka	NOUN
admet-905	55	9	and	and	CCONJ
admet-905	55	10	starczewski	starczewski	NOUN
admet-905	55	11	,	,	PUNCT
admet-905	55	12	who	who	PRON
admet-905	55	13	showed	show	VERB
admet-905	55	14	that	that	SCONJ
admet-905	55	15	metformin	metformin	NOUN
admet-905	55	16	can	can	AUX
admet-905	55	17	significantly	significantly	ADV
admet-905	55	18	decrease	decrease	VERB
admet-905	55	19	homa	homa	NOUN
admet-905	55	20	-	-	PUNCT
admet-905	55	21	ir	ir	PROPN
admet-905	55	22	only	only	ADV
admet-905	55	23	in	in	ADP
admet-905	55	24	insulin	insulin	NOUN
admet-905	55	25	-	-	PUNCT
admet-905	55	26	resistant	resistant	ADJ
admet-905	55	27	pcos	pcos	NOUN
admet-905	55	28	patients	patient	NOUN
admet-905	55	29	[	[	X
admet-905	55	30	31	31	NUM
admet-905	55	31	]	]	PUNCT
admet-905	55	32	.	.	PUNCT
admet-905	56	1	moreover	moreover	ADV
admet-905	56	2	,	,	PUNCT
admet-905	56	3	the	the	DET
admet-905	56	4	first	first	ADJ
admet-905	56	5	group	group	NOUN
admet-905	56	6	(	(	PUNCT
admet-905	56	7	table	table	NOUN
admet-905	56	8	1	1	NUM
admet-905	56	9	)	)	PUNCT
admet-905	56	10	showed	show	VERB
admet-905	56	11	no	no	DET
admet-905	56	12	significant	significant	ADJ
admet-905	56	13	changes	change	NOUN
admet-905	56	14	in	in	ADP
admet-905	56	15	zonulin	zonulin	PROPN
admet-905	56	16	value	value	NOUN
admet-905	56	17	after	after	ADP
admet-905	56	18	treatment	treatment	NOUN
admet-905	56	19	,	,	PUNCT
admet-905	56	20	while	while	SCONJ
admet-905	56	21	the	the	DET
admet-905	56	22	second	second	ADJ
admet-905	56	23	group	group	NOUN
admet-905	56	24	(	(	PUNCT
admet-905	56	25	table	table	NOUN
admet-905	56	26	2	2	NUM
admet-905	56	27	)	)	PUNCT
admet-905	56	28	,	,	PUNCT
admet-905	56	29	showed	show	VERB
admet-905	56	30	a	a	DET
admet-905	56	31	significant	significant	ADJ
admet-905	56	32	decrease	decrease	NOUN
admet-905	56	33	in	in	ADP
admet-905	56	34	zonulin	zonulin	PROPN
admet-905	56	35	with	with	ADP
admet-905	56	36	a	a	DET
admet-905	56	37	p	p	NOUN
admet-905	56	38	-	-	PUNCT
admet-905	56	39	value	value	NOUN
admet-905	56	40	of	of	ADP
admet-905	56	41	0.01	0.01	NUM
admet-905	56	42	,	,	PUNCT
admet-905	56	43	suggesting	suggest	VERB
admet-905	56	44	that	that	SCONJ
admet-905	56	45	metformin	metformin	NOUN
admet-905	56	46	can	can	AUX
admet-905	56	47	decrease	decrease	VERB
admet-905	56	48	zonulin	zonulin	NOUN
admet-905	56	49	in	in	ADP
admet-905	56	50	insulinresistant	insulinresistant	NOUN
admet-905	56	51	patients	patient	NOUN
admet-905	56	52	with	with	ADP
admet-905	56	53	no	no	DET
admet-905	56	54	menstrual	menstrual	ADJ
admet-905	56	55	disturbances	disturbance	NOUN
admet-905	56	56	.	.	PUNCT
admet-905	57	1	ilhan	ilhan	PROPN
admet-905	57	2	and	and	CCONJ
admet-905	57	3	yildizhan	yildizhan	PROPN
admet-905	57	4	study	study	NOUN
admet-905	57	5	suggested	suggest	VERB
admet-905	57	6	that	that	SCONJ
admet-905	57	7	zonulin	zonulin	PROPN
admet-905	57	8	is	be	AUX
admet-905	57	9	a	a	DET
admet-905	57	10	pathogenic	pathogenic	ADJ
admet-905	57	11	novel	novel	NOUN
admet-905	57	12	biomarker	biomarker	NOUN
admet-905	57	13	in	in	ADP
admet-905	57	14	pcos	pcos	ADJ
admet-905	57	15	women	woman	NOUN
admet-905	57	16	and	and	CCONJ
admet-905	57	17	there	there	PRON
admet-905	57	18	is	be	VERB
admet-905	57	19	a	a	DET
admet-905	57	20	strong	strong	ADJ
admet-905	57	21	correlation	correlation	NOUN
admet-905	57	22	between	between	ADP
admet-905	57	23	homa	homa	NOUN
admet-905	57	24	-	-	PUNCT
admet-905	57	25	ir	ir	PROPN
admet-905	57	26	and	and	CCONJ
admet-905	57	27	zonulin	zonulin	PROPN
admet-905	57	28	in	in	ADP
admet-905	57	29	pcos	pcos	PROPN
admet-905	57	30	patients	patient	NOUN
admet-905	57	31	[	[	X
admet-905	57	32	32	32	NUM
admet-905	57	33	]	]	PUNCT
admet-905	57	34	.	.	PUNCT
admet-905	58	1	also	also	ADV
admet-905	58	2	,	,	PUNCT
admet-905	58	3	zhang	zhang	PROPN
admet-905	58	4	et	et	PROPN
admet-905	58	5	al	al	PROPN
admet-905	58	6	suggested	suggest	VERB
admet-905	58	7	that	that	SCONJ
admet-905	58	8	zonulin	zonulin	PROPN
admet-905	58	9	plays	play	VERB
admet-905	58	10	a	a	DET
admet-905	58	11	role	role	NOUN
admet-905	58	12	in	in	ADP
admet-905	58	13	pcos	pcos	NOUN
admet-905	58	14	pathogenesis	pathogenesis	NOUN
admet-905	58	15	and	and	CCONJ
admet-905	58	16	can	can	AUX
admet-905	58	17	be	be	AUX
admet-905	58	18	used	use	VERB
admet-905	58	19	as	as	ADP
admet-905	58	20	a	a	DET
admet-905	58	21	marker	marker	NOUN
admet-905	58	22	for	for	ADP
admet-905	58	23	detection	detection	NOUN
admet-905	58	24	of	of	ADP
admet-905	58	25	the	the	DET
admet-905	58	26	severity	severity	NOUN
admet-905	58	27	of	of	ADP
admet-905	58	28	disease	disease	NOUN
admet-905	58	29	and	and	CCONJ
admet-905	58	30	in	in	ADP
admet-905	58	31	the	the	DET
admet-905	58	32	prognosis	prognosis	NOUN
admet-905	58	33	of	of	ADP
admet-905	58	34	pcos	pcos	PROPN
admet-905	58	35	treatment	treatment	NOUN
admet-905	58	36	[	[	X
admet-905	58	37	19	19	NUM
admet-905	58	38	]	]	PUNCT
admet-905	58	39	.	.	PUNCT
admet-905	59	1	this	this	PRON
admet-905	59	2	is	be	AUX
admet-905	59	3	obvious	obvious	ADJ
admet-905	59	4	,	,	PUNCT
admet-905	59	5	especially	especially	ADV
admet-905	59	6	that	that	DET
admet-905	59	7	increase	increase	NOUN
admet-905	59	8	zonulin	zonulin	NOUN
admet-905	59	9	leads	lead	VERB
admet-905	59	10	to	to	ADP
admet-905	59	11	alteration	alteration	NOUN
admet-905	59	12	in	in	ADP
admet-905	59	13	gut	gut	NOUN
admet-905	59	14	permeability	permeability	NOUN
admet-905	59	15	,	,	PUNCT
admet-905	59	16	decrease	decrease	VERB
admet-905	59	17	the	the	DET
admet-905	59	18	integrity	integrity	NOUN
admet-905	59	19	of	of	ADP
admet-905	59	20	the	the	DET
admet-905	59	21	intestinal	intestinal	ADJ
admet-905	59	22	barrier	barrier	NOUN
admet-905	59	23	allowing	allow	VERB
admet-905	59	24	an	an	DET
admet-905	59	25	excess	excess	NOUN
admet-905	59	26	of	of	ADP
admet-905	59	27	the	the	DET
admet-905	59	28	infectious	infectious	ADJ
admet-905	59	29	agent	agent	NOUN
admet-905	59	30	and	and	CCONJ
admet-905	59	31	dietary	dietary	ADJ
admet-905	59	32	antigen	antigen	NOUN
admet-905	59	33	to	to	PART
admet-905	59	34	facilitate	facilitate	VERB
admet-905	59	35	mucosal	mucosal	ADJ
admet-905	59	36	immune	immune	ADJ
admet-905	59	37	elements	element	NOUN
admet-905	59	38	such	such	ADJ
admet-905	59	39	as	as	ADP
admet-905	59	40	il-6	il-6	NUM
admet-905	59	41	which	which	PRON
admet-905	59	42	can	can	AUX
admet-905	59	43	lead	lead	VERB
admet-905	59	44	to	to	ADP
admet-905	59	45	insulin	insulin	NOUN
admet-905	59	46	resistance	resistance	NOUN
admet-905	59	47	[	[	X
admet-905	59	48	33	33	NUM
admet-905	59	49	]	]	PUNCT
admet-905	59	50	.	.	PUNCT
admet-905	60	1	we	we	PRON
admet-905	60	2	proposed	propose	VERB
admet-905	60	3	that	that	SCONJ
admet-905	60	4	the	the	DET
admet-905	60	5	metformin	metformin	NOUN
admet-905	60	6	effect	effect	NOUN
admet-905	60	7	on	on	ADP
admet-905	60	8	zonulin	zonulin	PROPN
admet-905	60	9	is	be	AUX
admet-905	60	10	related	relate	VERB
admet-905	60	11	to	to	ADP
admet-905	60	12	the	the	DET
admet-905	60	13	antibiotic	antibiotic	ADJ
admet-905	60	14	effect	effect	NOUN
admet-905	60	15	of	of	ADP
admet-905	60	16	metformin	metformin	NOUN
admet-905	60	17	on	on	ADP
admet-905	60	18	the	the	DET
admet-905	60	19	gut	gut	NOUN
admet-905	60	20	and	and	CCONJ
admet-905	60	21	modulation	modulation	NOUN
admet-905	60	22	of	of	ADP
admet-905	60	23	intestinal	intestinal	ADJ
admet-905	60	24	microbiota	microbiota	NOUN
admet-905	60	25	.	.	PUNCT
admet-905	61	1	however	however	ADV
admet-905	61	2	,	,	PUNCT
admet-905	61	3	the	the	DET
admet-905	61	4	first	first	ADJ
admet-905	61	5	group	group	NOUN
admet-905	61	6	of	of	ADP
admet-905	61	7	those	those	PRON
admet-905	61	8	of	of	ADP
admet-905	61	9	initial	initial	ADJ
admet-905	61	10	(	(	PUNCT
admet-905	61	11	homa	homa	NOUN
admet-905	61	12	-	-	PUNCT
admet-905	61	13	ir	ir	PROPN
admet-905	61	14	<	<	NOUN
admet-905	61	15	2	2	NUM
admet-905	61	16	)	)	PUNCT
admet-905	61	17	exhibited	exhibit	VERB
admet-905	61	18	no	no	DET
admet-905	61	19	changes	change	NOUN
admet-905	61	20	in	in	ADP
admet-905	61	21	zonulin	zonulin	PROPN
admet-905	61	22	value	value	NOUN
admet-905	61	23	as	as	SCONJ
admet-905	61	24	there	there	PRON
admet-905	61	25	is	be	VERB
admet-905	61	26	no	no	DET
admet-905	61	27	difference	difference	NOUN
admet-905	61	28	in	in	ADP
admet-905	61	29	gut	gut	NOUN
admet-905	61	30	permeability	permeability	NOUN
admet-905	61	31	and	and	CCONJ
admet-905	61	32	microbiota	microbiota	NOUN
admet-905	61	33	composition	composition	NOUN
admet-905	61	34	before	before	ADV
admet-905	61	35	and	and	CCONJ
admet-905	61	36	after	after	ADP
admet-905	61	37	treatment	treatment	NOUN
admet-905	61	38	,	,	PUNCT
admet-905	61	39	as	as	ADP
admet-905	61	40	non	non	ADJ
admet-905	61	41	-	-	ADJ
admet-905	61	42	insulin	insulin	ADJ
admet-905	61	43	resistance	resistance	NOUN
admet-905	61	44	associated	associate	VERB
admet-905	61	45	with	with	ADP
admet-905	61	46	no	no	DET
admet-905	61	47	alteration	alteration	NOUN
admet-905	61	48	in	in	ADP
admet-905	61	49	intestinal	intestinal	ADJ
admet-905	61	50	permeability	permeability	NOUN
admet-905	61	51	.	.	PUNCT
admet-905	62	1	this	this	PRON
admet-905	62	2	agrees	agree	VERB
admet-905	62	3	to	to	ADP
admet-905	62	4	a	a	DET
admet-905	62	5	certain	certain	ADJ
admet-905	62	6	degree	degree	NOUN
admet-905	62	7	with	with	ADP
admet-905	62	8	cetin	cetin	PROPN
admet-905	62	9	’s	’s	PART
admet-905	62	10	study	study	NOUN
admet-905	62	11	conclusion	conclusion	NOUN
admet-905	62	12	,	,	PUNCT
admet-905	62	13	who	who	PRON
admet-905	62	14	included	include	VERB
admet-905	62	15	non	non	ADJ
admet-905	62	16	-	-	ADJ
admet-905	62	17	obese	obese	ADJ
admet-905	62	18	,	,	PUNCT
admet-905	62	19	normal	normal	ADJ
admet-905	62	20	homa	homa	NOUN
admet-905	62	21	-	-	PUNCT
admet-905	62	22	ir	ir	PROPN
admet-905	62	23	pcos	pcos	PROPN
admet-905	62	24	patients	patient	NOUN
admet-905	62	25	in	in	ADP
admet-905	62	26	his	his	PRON
admet-905	62	27	study	study	NOUN
admet-905	62	28	and	and	CCONJ
admet-905	62	29	suggested	suggest	VERB
admet-905	62	30	that	that	SCONJ
admet-905	62	31	insulin	insulin	NOUN
admet-905	62	32	resistance	resistance	NOUN
admet-905	62	33	is	be	AUX
admet-905	62	34	not	not	PART
admet-905	62	35	triggered	trigger	VERB
admet-905	62	36	if	if	SCONJ
admet-905	62	37	there	there	PRON
admet-905	62	38	is	be	VERB
admet-905	62	39	integrity	integrity	NOUN
admet-905	62	40	in	in	ADP
admet-905	62	41	the	the	DET
admet-905	62	42	gut	gut	NOUN
admet-905	62	43	permeability	permeability	NOUN
admet-905	62	44	[	[	X
admet-905	62	45	34	34	NUM
admet-905	62	46	]	]	PUNCT
admet-905	62	47	.	.	PUNCT
admet-905	63	1	it	it	PRON
admet-905	63	2	seems	seem	VERB
admet-905	63	3	that	that	SCONJ
admet-905	63	4	this	this	DET
admet-905	63	5	study	study	NOUN
admet-905	63	6	is	be	AUX
admet-905	63	7	the	the	DET
admet-905	63	8	first	first	ADJ
admet-905	63	9	study	study	NOUN
admet-905	63	10	to	to	PART
admet-905	63	11	show	show	VERB
admet-905	63	12	the	the	DET
admet-905	63	13	effect	effect	NOUN
admet-905	63	14	of	of	ADP
admet-905	63	15	metformin	metformin	NOUN
admet-905	63	16	on	on	ADP
admet-905	63	17	zonulin	zonulin	PROPN
admet-905	63	18	in	in	ADP
admet-905	63	19	pcos	pcos	PROPN
admet-905	63	20	patients	patient	NOUN
admet-905	63	21	.	.	PUNCT
admet-905	64	1	we	we	PRON
admet-905	64	2	found	find	VERB
admet-905	64	3	that	that	SCONJ
admet-905	64	4	metformin	metformin	NOUN
admet-905	64	5	can	can	AUX
admet-905	64	6	decrease	decrease	VERB
admet-905	64	7	zonulin	zonulin	PROPN
admet-905	64	8	in	in	ADP
admet-905	64	9	insulin	insulin	NOUN
admet-905	64	10	-	-	PUNCT
admet-905	64	11	resistant	resistant	ADJ
admet-905	64	12	pcos	pcos	NOUN
admet-905	64	13	patients	patient	NOUN
admet-905	64	14	with	with	ADP
admet-905	64	15	no	no	DET
admet-905	64	16	menstrual	menstrual	ADJ
admet-905	64	17	irregularities	irregularity	NOUN
admet-905	64	18	and	and	CCONJ
admet-905	64	19	not	not	PART
admet-905	64	20	prone	prone	ADJ
admet-905	64	21	to	to	PART
admet-905	64	22	have	have	VERB
admet-905	64	23	diabetes	diabetes	NOUN
admet-905	64	24	,	,	PUNCT
admet-905	64	25	and	and	CCONJ
admet-905	64	26	we	we	PRON
admet-905	64	27	suggest	suggest	VERB
admet-905	64	28	that	that	SCONJ
admet-905	64	29	metformin	metformin	NOUN
admet-905	64	30	effects	effect	NOUN
admet-905	64	31	on	on	ADP
admet-905	64	32	zonulin	zonulin	PROPN
admet-905	64	33	are	be	AUX
admet-905	64	34	not	not	PART
admet-905	64	35	related	relate	VERB
admet-905	64	36	to	to	ADP
admet-905	64	37	insulin	insulin	NOUN
admet-905	64	38	-	-	PUNCT
admet-905	64	39	sensitizing	sensitize	VERB
admet-905	64	40	activity	activity	NOUN
admet-905	64	41	but	but	CCONJ
admet-905	64	42	may	may	AUX
admet-905	64	43	be	be	AUX
admet-905	64	44	due	due	ADJ
admet-905	64	45	to	to	ADP
admet-905	64	46	the	the	DET
admet-905	64	47	modulation	modulation	NOUN
admet-905	64	48	of	of	ADP
admet-905	64	49	intestinal	intestinal	ADJ
admet-905	64	50	bacteria	bacteria	NOUN
admet-905	64	51	.	.	PUNCT
admet-905	65	1	testosterone	testosterone	NOUN
admet-905	65	2	and	and	CCONJ
admet-905	65	3	free	free	ADJ
admet-905	65	4	testosterone	testosterone	NOUN
admet-905	65	5	showed	show	VERB
admet-905	65	6	no	no	DET
admet-905	65	7	significant	significant	ADJ
admet-905	65	8	decrease	decrease	NOUN
admet-905	65	9	in	in	ADP
admet-905	65	10	the	the	DET
admet-905	65	11	non	non	ADJ
admet-905	65	12	-	-	ADJ
admet-905	65	13	insulin	insulin	ADJ
admet-905	65	14	resistant	resistant	ADJ
admet-905	65	15	group	group	NOUN
admet-905	65	16	(	(	PUNCT
admet-905	65	17	table	table	NOUN
admet-905	65	18	1	1	NUM
admet-905	65	19	)	)	PUNCT
admet-905	65	20	p	p	NOUN
admet-905	65	21	-	-	PUNCT
admet-905	65	22	value	value	NOUN
admet-905	65	23	0.13	0.13	NUM
admet-905	65	24	and	and	CCONJ
admet-905	65	25	0.12	0.12	NUM
admet-905	65	26	respectively	respectively	ADV
admet-905	65	27	,	,	PUNCT
admet-905	65	28	while	while	SCONJ
admet-905	65	29	the	the	DET
admet-905	65	30	second	second	ADJ
admet-905	65	31	group	group	NOUN
admet-905	65	32	showed	show	VERB
admet-905	65	33	a	a	DET
admet-905	65	34	marked	marked	ADJ
admet-905	65	35	but	but	CCONJ
admet-905	65	36	insignificant	insignificant	ADJ
admet-905	65	37	decrease	decrease	NOUN
admet-905	65	38	in	in	ADP
admet-905	65	39	total	total	ADJ
admet-905	65	40	testosterone	testosterone	NOUN
admet-905	66	1	p	p	NOUN
admet-905	66	2	-	-	PUNCT
admet-905	66	3	value	value	NOUN
admet-905	66	4	0.09	0.09	NUM
admet-905	66	5	and	and	CCONJ
admet-905	66	6	free	free	ADJ
admet-905	66	7	testosterone	testosterone	NOUN
admet-905	66	8	p	p	NOUN
admet-905	66	9	-	-	PUNCT
admet-905	66	10	value	value	NOUN
admet-905	66	11	0.07	0.07	NUM
admet-905	66	12	.	.	PUNCT
admet-905	67	1	this	this	DET
admet-905	67	2	result	result	NOUN
admet-905	67	3	agrees	agree	VERB
admet-905	67	4	with	with	ADP
admet-905	67	5	baqer	baqer	PROPN
admet-905	67	6	et	et	PROPN
admet-905	67	7	al	al	PROPN
admet-905	67	8	study	study	PROPN
admet-905	67	9	in	in	ADP
admet-905	67	10	2018	2018	NUM
admet-905	67	11	when	when	SCONJ
admet-905	67	12	they	they	PRON
admet-905	67	13	administer	administer	VERB
admet-905	67	14	metformin	metformin	NOUN
admet-905	67	15	500	500	NUM
admet-905	67	16	mg	mg	NUM
admet-905	67	17	three	three	NUM
admet-905	67	18	times	time	NOUN
admet-905	67	19	for	for	ADP
admet-905	67	20	three	three	NUM
admet-905	67	21	months	month	NOUN
admet-905	67	22	and	and	CCONJ
admet-905	67	23	showed	show	VERB
admet-905	67	24	an	an	DET
admet-905	67	25	insignificant	insignificant	ADJ
admet-905	67	26	decrease	decrease	NOUN
admet-905	67	27	in	in	ADP
admet-905	67	28	total	total	ADJ
admet-905	67	29	testosterone	testosterone	NOUN
admet-905	68	1	[	[	X
admet-905	68	2	35	35	NUM
admet-905	68	3	]	]	PUNCT
admet-905	68	4	.	.	PUNCT
admet-905	69	1	metformin	metformin	NOUN
admet-905	69	2	can	can	AUX
admet-905	69	3	suppress	suppress	VERB
admet-905	69	4	androgen	androgen	NOUN
admet-905	69	5	production	production	NOUN
admet-905	69	6	by	by	ADP
admet-905	69	7	its	its	PRON
admet-905	69	8	action	action	NOUN
admet-905	69	9	on	on	ADP
admet-905	69	10	the	the	DET
admet-905	69	11	ovary	ovary	ADJ
admet-905	69	12	and	and	CCONJ
admet-905	69	13	adrenal	adrenal	ADJ
admet-905	69	14	gland	gland	NOUN
admet-905	69	15	and	and	CCONJ
admet-905	69	16	increase	increase	VERB
admet-905	69	17	shbg	shbg	ADJ
admet-905	69	18	production	production	NOUN
admet-905	69	19	by	by	ADP
admet-905	69	20	the	the	DET
admet-905	69	21	liver	liver	NOUN
admet-905	69	22	[	[	X
admet-905	69	23	23	23	NUM
admet-905	69	24	]	]	PUNCT
admet-905	69	25	.	.	PUNCT
admet-905	70	1	different	different	ADJ
admet-905	70	2	studies	study	NOUN
admet-905	70	3	revealed	reveal	VERB
admet-905	70	4	that	that	SCONJ
admet-905	70	5	metformin	metformin	NOUN
admet-905	70	6	causes	cause	VERB
admet-905	70	7	a	a	DET
admet-905	70	8	reduction	reduction	NOUN
admet-905	70	9	in	in	ADP
admet-905	70	10	androgen	androgen	NOUN
admet-905	70	11	,	,	PUNCT
admet-905	70	12	an	an	DET
admet-905	70	13	increase	increase	NOUN
admet-905	70	14	of	of	ADP
admet-905	70	15	shbg	shbg	NOUN
admet-905	70	16	,	,	PUNCT
admet-905	70	17	and	and	CCONJ
admet-905	70	18	a	a	DET
admet-905	70	19	restoration	restoration	NOUN
admet-905	70	20	of	of	ADP
admet-905	70	21	the	the	DET
admet-905	70	22	normal	normal	ADJ
admet-905	70	23	menstrual	menstrual	ADJ
admet-905	70	24	cycle	cycle	NOUN
admet-905	71	1	[	[	X
admet-905	71	2	36	36	NUM
admet-905	71	3	-	-	SYM
admet-905	71	4	40	40	NUM
admet-905	71	5	]	]	PUNCT
admet-905	71	6	but	but	CCONJ
admet-905	71	7	this	this	DET
admet-905	71	8	study	study	NOUN
admet-905	71	9	reveals	reveal	VERB
admet-905	71	10	a	a	DET
admet-905	71	11	slight	slight	ADJ
admet-905	71	12	insignificant	insignificant	ADJ
admet-905	71	13	increase	increase	NOUN
admet-905	71	14	in	in	ADP
admet-905	71	15	shbg	shbg	NOUN
admet-905	71	16	in	in	ADP
admet-905	71	17	both	both	DET
admet-905	71	18	groups	group	NOUN
admet-905	71	19	,	,	PUNCT
admet-905	71	20	which	which	PRON
admet-905	71	21	agree	agree	VERB
admet-905	71	22	with	with	ADP
admet-905	71	23	singh	singh	PROPN
admet-905	71	24	et	et	PROPN
admet-905	71	25	al	al	PROPN
admet-905	71	26	.	.	PROPN
admet-905	71	27	study	study	PROPN
admet-905	71	28	who	who	PRON
admet-905	71	29	show	show	VERB
admet-905	71	30	no	no	DET
admet-905	71	31	significant	significant	ADJ
admet-905	71	32	decrease	decrease	NOUN
admet-905	71	33	in	in	ADP
admet-905	71	34	serum	serum	NOUN
admet-905	71	35	testosterone	testosterone	NOUN
admet-905	71	36	,	,	PUNCT
admet-905	71	37	fasting	fast	VERB
admet-905	71	38	plasma	plasma	NOUN
admet-905	71	39	glucose	glucose	NOUN
admet-905	71	40	and	and	CCONJ
admet-905	71	41	bmi	bmi	NOUN
admet-905	71	42	with	with	ADP
admet-905	71	43	a	a	DET
admet-905	71	44	significant	significant	ADJ
admet-905	71	45	decrease	decrease	NOUN
admet-905	71	46	in	in	ADP
admet-905	71	47	homa	homa	NOUN
admet-905	71	48	-	-	PUNCT
admet-905	71	49	ir	ir	PROPN
admet-905	71	50	,	,	PUNCT
admet-905	71	51	after	after	ADP
admet-905	71	52	intake	intake	NOUN
admet-905	71	53	of	of	ADP
admet-905	71	54	metformin	metformin	PROPN
admet-905	71	55	500	500	NUM
admet-905	71	56	mg	mg	NOUN
admet-905	71	57	twice	twice	ADV
admet-905	71	58	daily	daily	ADV
admet-905	71	59	for	for	ADP
admet-905	71	60	3	3	NUM
admet-905	71	61	months	month	NOUN
admet-905	71	62	[	[	X
admet-905	71	63	41	41	NUM
admet-905	71	64	]	]	PUNCT
admet-905	71	65	.	.	PUNCT
admet-905	72	1	on	on	ADP
admet-905	72	2	the	the	DET
admet-905	72	3	other	other	ADJ
admet-905	72	4	hand	hand	NOUN
admet-905	72	5	,	,	PUNCT
admet-905	72	6	upadhyaya	upadhyaya	NOUN
admet-905	72	7	and	and	CCONJ
admet-905	72	8	rehan	rehan	PROPN
admet-905	72	9	study	study	NOUN
admet-905	72	10	has	have	AUX
admet-905	72	11	reported	report	VERB
admet-905	72	12	that	that	SCONJ
admet-905	72	13	women	woman	NOUN
admet-905	72	14	of	of	ADP
admet-905	72	15	pcos	pcos	PROPN
admet-905	72	16	admet	admet	PROPN
admet-905	72	17	&	&	CCONJ
admet-905	72	18	dmpk	dmpk	PROPN
admet-905	72	19	9(1	9(1	NUM
admet-905	72	20	)	)	PUNCT
admet-905	72	21	(	(	PUNCT
admet-905	72	22	2021	2021	NUM
admet-905	72	23	)	)	PUNCT
admet-905	72	24	49	49	NUM
admet-905	72	25	-	-	SYM
admet-905	72	26	55	55	NUM
admet-905	72	27	metformin	metformin	NOUN
admet-905	72	28	effects	effect	NOUN
admet-905	72	29	on	on	ADP
admet-905	72	30	zonulin	zonulin	PROPN
admet-905	72	31	level	level	NOUN
admet-905	72	32	in	in	ADP
admet-905	72	33	polycystic	polycystic	ADJ
admet-905	72	34	ovarian	ovarian	ADJ
admet-905	72	35	women	woman	NOUN
admet-905	72	36	doi	doi	NOUN
admet-905	72	37	:	:	PUNCT
admet-905	72	38	http://doi.org/10.5599/admet.905	http://doi.org/10.5599/admet.905	VERB
admet-905	72	39	53	53	NUM
admet-905	72	40	with	with	ADP
admet-905	72	41	hyperinsulinemia	hyperinsulinemia	NOUN
admet-905	72	42	show	show	VERB
admet-905	72	43	a	a	DET
admet-905	72	44	significant	significant	ADJ
admet-905	72	45	reduction	reduction	NOUN
admet-905	72	46	in	in	ADP
admet-905	72	47	testosterone	testosterone	NOUN
admet-905	72	48	in	in	ADP
admet-905	72	49	compare	compare	NOUN
admet-905	72	50	to	to	ADP
admet-905	72	51	the	the	DET
admet-905	72	52	normo	normo	NOUN
admet-905	72	53	-	-	PUNCT
admet-905	72	54	insulinemic	insulinemic	ADJ
admet-905	72	55	group	group	NOUN
admet-905	72	56	after	after	ADP
admet-905	72	57	metformin	metformin	NOUN
admet-905	72	58	treatment	treatment	NOUN
admet-905	72	59	and	and	CCONJ
admet-905	72	60	they	they	PRON
admet-905	72	61	suggested	suggest	VERB
admet-905	72	62	that	that	SCONJ
admet-905	72	63	hyperinsulinemic	hyperinsulinemic	ADJ
admet-905	72	64	,	,	PUNCT
admet-905	72	65	normo	normo	NOUN
admet-905	72	66	-	-	PUNCT
admet-905	72	67	androgenic	androgenic	ADJ
admet-905	72	68	pcos	pcos	NOUN
admet-905	72	69	is	be	AUX
admet-905	72	70	a	a	DET
admet-905	72	71	favorable	favorable	ADJ
admet-905	72	72	condition	condition	NOUN
admet-905	72	73	for	for	ADP
admet-905	72	74	metformin	metformin	NOUN
admet-905	72	75	response	response	NOUN
admet-905	72	76	[	[	X
admet-905	72	77	42	42	NUM
admet-905	72	78	]	]	PUNCT
admet-905	72	79	,	,	PUNCT
admet-905	72	80	also	also	ADV
admet-905	72	81	moghetti	moghetti	AUX
admet-905	72	82	et	et	NOUN
admet-905	72	83	al	al	PROPN
admet-905	72	84	reveal	reveal	VERB
admet-905	72	85	that	that	SCONJ
admet-905	72	86	metformin	metformin	NOUN
admet-905	72	87	responders	responder	NOUN
admet-905	72	88	usually	usually	ADV
admet-905	72	89	had	have	VERB
admet-905	72	90	higher	high	ADJ
admet-905	72	91	fasting	fast	VERB
admet-905	72	92	plasma	plasma	NOUN
admet-905	72	93	insulin	insulin	NOUN
admet-905	72	94	[	[	X
admet-905	72	95	43	43	NUM
admet-905	72	96	]	]	PUNCT
admet-905	72	97	.	.	PUNCT
admet-905	73	1	concerning	concern	VERB
admet-905	73	2	the	the	DET
admet-905	73	3	level	level	NOUN
admet-905	73	4	of	of	ADP
admet-905	73	5	lh	lh	PROPN
admet-905	73	6	,	,	PUNCT
admet-905	73	7	the	the	DET
admet-905	73	8	second	second	ADJ
admet-905	73	9	group	group	NOUN
admet-905	73	10	(	(	PUNCT
admet-905	73	11	table	table	NOUN
admet-905	73	12	2	2	NUM
admet-905	73	13	)	)	PUNCT
admet-905	73	14	showed	show	VERB
admet-905	73	15	a	a	DET
admet-905	73	16	decrease	decrease	NOUN
admet-905	73	17	in	in	ADP
admet-905	73	18	lh	lh	PROPN
admet-905	73	19	with	with	ADP
admet-905	73	20	a	a	DET
admet-905	73	21	p	p	NOUN
admet-905	73	22	-	-	PUNCT
admet-905	73	23	value	value	NOUN
admet-905	73	24	of	of	ADP
admet-905	73	25	0.08	0.08	NUM
admet-905	73	26	,	,	PUNCT
admet-905	73	27	while	while	SCONJ
admet-905	73	28	the	the	DET
admet-905	73	29	first	first	ADJ
admet-905	73	30	group	group	NOUN
admet-905	73	31	of	of	ADP
admet-905	73	32	less	less	ADJ
admet-905	73	33	insulin	insulin	NOUN
admet-905	73	34	-	-	PUNCT
admet-905	73	35	resistant	resistant	ADJ
admet-905	73	36	patients	patient	NOUN
admet-905	73	37	(	(	PUNCT
admet-905	73	38	table	table	NOUN
admet-905	73	39	1	1	NUM
admet-905	73	40	)	)	PUNCT
admet-905	73	41	exhibited	exhibit	VERB
admet-905	73	42	a	a	DET
admet-905	73	43	p	p	NOUN
admet-905	73	44	-	-	PUNCT
admet-905	73	45	value	value	NOUN
admet-905	73	46	of	of	ADP
admet-905	73	47	0.25	0.25	NUM
admet-905	73	48	.	.	PUNCT
admet-905	74	1	this	this	PRON
admet-905	74	2	is	be	AUX
admet-905	74	3	attributed	attribute	VERB
admet-905	74	4	to	to	ADP
admet-905	74	5	that	that	SCONJ
admet-905	74	6	the	the	DET
admet-905	74	7	hyperinsulinemia	hyperinsulinemia	NOUN
admet-905	74	8	increased	increase	VERB
admet-905	74	9	androgen	androgen	NOUN
admet-905	74	10	production	production	NOUN
admet-905	74	11	by	by	ADP
admet-905	74	12	augmenting	augment	VERB
admet-905	74	13	the	the	DET
admet-905	74	14	lh	lh	ADJ
admet-905	74	15	effect	effect	NOUN
admet-905	74	16	for	for	ADP
admet-905	74	17	androgen	androgen	NOUN
admet-905	74	18	production	production	NOUN
admet-905	74	19	,	,	PUNCT
admet-905	74	20	while	while	SCONJ
admet-905	74	21	metformin	metformin	NOUN
admet-905	74	22	can	can	AUX
admet-905	74	23	reverse	reverse	VERB
admet-905	74	24	this	this	PRON
admet-905	74	25	by	by	ADP
admet-905	74	26	decrease	decrease	NOUN
admet-905	74	27	insulin	insulin	NOUN
admet-905	74	28	level	level	NOUN
admet-905	74	29	[	[	X
admet-905	74	30	44	44	NUM
admet-905	74	31	]	]	PUNCT
admet-905	74	32	.	.	PUNCT
admet-905	75	1	conclusions	conclusion	NOUN
admet-905	75	2	metformin	metformin	PROPN
admet-905	75	3	alone	alone	ADV
admet-905	75	4	does	do	AUX
admet-905	75	5	not	not	PART
admet-905	75	6	affect	affect	VERB
admet-905	75	7	body	body	NOUN
admet-905	75	8	mass	mass	NOUN
admet-905	75	9	index	index	NOUN
admet-905	75	10	within	within	ADP
admet-905	75	11	three	three	NUM
admet-905	75	12	months	month	NOUN
admet-905	75	13	of	of	ADP
admet-905	75	14	treatment	treatment	NOUN
admet-905	75	15	and	and	CCONJ
admet-905	75	16	has	have	VERB
admet-905	75	17	no	no	DET
admet-905	75	18	effect	effect	NOUN
admet-905	75	19	on	on	ADP
admet-905	75	20	insulin	insulin	NOUN
admet-905	75	21	level	level	NOUN
admet-905	75	22	in	in	ADP
admet-905	75	23	non	non	ADJ
admet-905	75	24	-	-	ADJ
admet-905	75	25	insulin	insulin	ADJ
admet-905	75	26	resistant	resistant	ADJ
admet-905	75	27	pcos	pcos	NOUN
admet-905	75	28	patients	patient	NOUN
admet-905	75	29	,	,	PUNCT
admet-905	75	30	but	but	CCONJ
admet-905	75	31	can	can	AUX
admet-905	75	32	decrease	decrease	VERB
admet-905	75	33	insulin	insulin	NOUN
admet-905	75	34	in	in	ADP
admet-905	75	35	insulin	insulin	NOUN
admet-905	75	36	-	-	PUNCT
admet-905	75	37	resistant	resistant	ADJ
admet-905	75	38	pcos	pcos	NOUN
admet-905	75	39	patients	patient	NOUN
admet-905	75	40	.	.	PUNCT
admet-905	76	1	concerning	concern	VERB
admet-905	76	2	zonulin	zonulin	PROPN
admet-905	76	3	,	,	PUNCT
admet-905	76	4	the	the	DET
admet-905	76	5	significant	significant	ADJ
admet-905	76	6	decrease	decrease	NOUN
admet-905	76	7	in	in	ADP
admet-905	76	8	zonulin	zonulin	NOUN
admet-905	76	9	in	in	ADP
admet-905	76	10	women	woman	NOUN
admet-905	76	11	with	with	ADP
admet-905	76	12	higher	high	ADJ
admet-905	76	13	insulin	insulin	NOUN
admet-905	76	14	resistance	resistance	NOUN
admet-905	76	15	may	may	AUX
admet-905	76	16	be	be	AUX
admet-905	76	17	attributed	attribute	VERB
admet-905	76	18	to	to	ADP
admet-905	76	19	the	the	DET
admet-905	76	20	metformin	metformin	NOUN
admet-905	76	21	effect	effect	NOUN
admet-905	76	22	on	on	ADP
admet-905	76	23	intestinal	intestinal	ADJ
admet-905	76	24	bacterial	bacterial	ADJ
admet-905	76	25	distribution	distribution	NOUN
admet-905	76	26	.	.	PUNCT
admet-905	77	1	these	these	DET
admet-905	77	2	results	result	NOUN
admet-905	77	3	give	give	VERB
admet-905	77	4	rise	rise	NOUN
admet-905	77	5	to	to	PART
admet-905	77	6	conclude	conclude	VERB
admet-905	77	7	that	that	SCONJ
admet-905	77	8	patients	patient	NOUN
admet-905	77	9	with	with	ADP
admet-905	77	10	higher	high	ADJ
admet-905	77	11	homa	homa	NOUN
admet-905	77	12	-	-	PUNCT
admet-905	77	13	ir	ir	NOUN
admet-905	77	14	value	value	NOUN
admet-905	77	15	before	before	ADP
admet-905	77	16	treatment	treatment	NOUN
admet-905	77	17	(	(	PUNCT
admet-905	77	18	insulin	insulin	NOUN
admet-905	77	19	resistant	resistant	ADJ
admet-905	77	20	)	)	PUNCT
admet-905	77	21	are	be	AUX
admet-905	77	22	better	well	ADJ
admet-905	77	23	metformin	metformin	NOUN
admet-905	77	24	responders	responder	NOUN
admet-905	77	25	.	.	PUNCT
admet-905	78	1	conflict	conflict	NOUN
admet-905	78	2	of	of	ADP
admet-905	78	3	interest	interest	NOUN
admet-905	78	4	:	:	PUNCT
admet-905	78	5	authors	author	NOUN
admet-905	78	6	declare	declare	VERB
admet-905	78	7	no	no	DET
admet-905	78	8	conflict	conflict	NOUN
admet-905	78	9	of	of	ADP
admet-905	78	10	interest	interest	NOUN
admet-905	78	11	.	.	PUNCT
admet-905	79	1	references	reference	NOUN
admet-905	79	2	[	[	X
admet-905	79	3	1	1	NUM
admet-905	79	4	]	]	X
admet-905	79	5	r.p	r.p	PROPN
admet-905	79	6	.	.	PROPN
admet-905	79	7	kauffman	kauffman	PROPN
admet-905	79	8	,	,	PUNCT
admet-905	79	9	v.m	v.m	PROPN
admet-905	79	10	.	.	PROPN
admet-905	79	11	baker	baker	PROPN
admet-905	79	12	,	,	PUNCT
admet-905	79	13	p.	p.	NOUN
admet-905	79	14	dimarino	dimarino	PROPN
admet-905	79	15	,	,	PUNCT
admet-905	79	16	t.	t.	PROPN
admet-905	79	17	gimpel	gimpel	PROPN
admet-905	79	18	,	,	PUNCT
admet-905	79	19	v.d	v.d	PROPN
admet-905	79	20	.	.	PROPN
admet-905	79	21	castracane	castracane	NOUN
admet-905	79	22	.	.	PUNCT
admet-905	80	1	polycystic	polycystic	ADJ
admet-905	80	2	ovarian	ovarian	ADJ
admet-905	80	3	syndrome	syndrome	NOUN
admet-905	80	4	and	and	CCONJ
admet-905	80	5	insulin	insulin	NOUN
admet-905	80	6	resistance	resistance	NOUN
admet-905	80	7	in	in	ADP
admet-905	80	8	white	white	ADJ
admet-905	80	9	and	and	CCONJ
admet-905	80	10	mexican	mexican	ADJ
admet-905	80	11	american	american	ADJ
admet-905	80	12	women	woman	NOUN
admet-905	80	13	:	:	PUNCT
admet-905	80	14	a	a	DET
admet-905	80	15	comparison	comparison	NOUN
admet-905	80	16	of	of	ADP
admet-905	80	17	two	two	NUM
admet-905	80	18	distinct	distinct	ADJ
admet-905	80	19	populations	population	NOUN
admet-905	80	20	.	.	PUNCT
admet-905	81	1	am	be	AUX
admet-905	81	2	.	.	PUNCT
admet-905	82	1	j.	j.	PROPN
admet-905	82	2	obstet	obstet	PROPN
admet-905	82	3	.	.	PUNCT
admet-905	83	1	gynecol	gynecol	PROPN
admet-905	83	2	.	.	PUNCT
admet-905	84	1	187	187	NUM
admet-905	84	2	(	(	PUNCT
admet-905	84	3	2002	2002	NUM
admet-905	84	4	)	)	PUNCT
admet-905	84	5	1362	1362	NUM
admet-905	84	6	-	-	SYM
admet-905	84	7	1369	1369	NUM
admet-905	84	8	.	.	PUNCT
admet-905	85	1	[	[	X
admet-905	85	2	2	2	X
admet-905	85	3	]	]	X
admet-905	85	4	e.m	e.m	PROPN
admet-905	85	5	.	.	PROPN
admet-905	85	6	okoroh	okoroh	PROPN
admet-905	85	7	,	,	PUNCT
admet-905	85	8	w.c	w.c	PROPN
admet-905	85	9	.	.	PROPN
admet-905	85	10	hooper	hooper	PROPN
admet-905	85	11	,	,	PUNCT
admet-905	85	12	h.k	h.k	PROPN
admet-905	85	13	.	.	PROPN
admet-905	85	14	atrash	atrash	PROPN
admet-905	85	15	,	,	PUNCT
admet-905	85	16	h.r	h.r	PROPN
admet-905	85	17	.	.	PROPN
admet-905	85	18	yusuf	yusuf	PROPN
admet-905	85	19	,	,	PUNCT
admet-905	85	20	s.l	s.l	PROPN
admet-905	85	21	.	.	PROPN
admet-905	85	22	boulet	boulet	PROPN
admet-905	85	23	.	.	PUNCT
admet-905	86	1	prevalence	prevalence	NOUN
admet-905	86	2	of	of	ADP
admet-905	86	3	polycystic	polycystic	ADJ
admet-905	86	4	ovary	ovary	ADJ
admet-905	86	5	syndrome	syndrome	NOUN
admet-905	86	6	among	among	ADP
admet-905	86	7	the	the	DET
admet-905	86	8	privately	privately	ADV
admet-905	86	9	insured	insure	VERB
admet-905	86	10	,	,	PUNCT
admet-905	86	11	united	united	PROPN
admet-905	86	12	states	states	PROPN
admet-905	86	13	,	,	PUNCT
admet-905	86	14	2003	2003	NUM
admet-905	86	15	-	-	SYM
admet-905	86	16	2008	2008	NUM
admet-905	86	17	.	.	PUNCT
admet-905	87	1	am	be	AUX
admet-905	87	2	.	.	PUNCT
admet-905	88	1	j.	j.	PROPN
admet-905	88	2	obstet	obstet	PROPN
admet-905	88	3	.	.	PUNCT
admet-905	89	1	gynecol	gynecol	PROPN
admet-905	89	2	.	.	PROPN
admet-905	89	3	207	207	NUM
admet-905	89	4	(	(	PUNCT
admet-905	89	5	2012	2012	NUM
admet-905	89	6	)	)	PUNCT
admet-905	90	1	299.e1	299.e1	NOUN
admet-905	90	2	-	-	SYM
admet-905	90	3	7	7	NUM
admet-905	90	4	.	.	PUNCT
admet-905	91	1	[	[	X
admet-905	91	2	3	3	NUM
admet-905	91	3	]	]	X
admet-905	91	4	w.a	w.a	PROPN
admet-905	91	5	.	.	PROPN
admet-905	91	6	march	march	PROPN
admet-905	91	7	,	,	PUNCT
admet-905	91	8	v.m	v.m	PROPN
admet-905	91	9	.	.	PROPN
admet-905	91	10	moore	moore	PROPN
admet-905	91	11	,	,	PUNCT
admet-905	91	12	k.j	k.j	PROPN
admet-905	91	13	.	.	PROPN
admet-905	91	14	willson	willson	PROPN
admet-905	91	15	,	,	PUNCT
admet-905	91	16	d.i	d.i	PROPN
admet-905	91	17	.	.	PROPN
admet-905	91	18	phillips	phillips	PROPN
admet-905	91	19	,	,	PUNCT
admet-905	91	20	r.j	r.j	PROPN
admet-905	91	21	.	.	PROPN
admet-905	91	22	norman	norman	PROPN
admet-905	91	23	,	,	PUNCT
admet-905	91	24	m.j	m.j	PROPN
admet-905	91	25	.	.	PROPN
admet-905	91	26	davies	davy	NOUN
admet-905	91	27	.	.	PUNCT
admet-905	92	1	the	the	DET
admet-905	92	2	prevalence	prevalence	NOUN
admet-905	92	3	of	of	ADP
admet-905	92	4	polycystic	polycystic	ADJ
admet-905	92	5	ovary	ovary	ADJ
admet-905	92	6	syndrome	syndrome	NOUN
admet-905	92	7	in	in	ADP
admet-905	92	8	a	a	DET
admet-905	92	9	community	community	NOUN
admet-905	92	10	sample	sample	NOUN
admet-905	92	11	assessed	assess	VERB
admet-905	92	12	under	under	ADP
admet-905	92	13	contrasting	contrast	VERB
admet-905	92	14	diagnostic	diagnostic	ADJ
admet-905	92	15	criteria	criterion	NOUN
admet-905	92	16	.	.	PUNCT
admet-905	93	1	hum	hum	ADJ
admet-905	93	2	.	.	PUNCT
admet-905	94	1	reprod	reprod	PROPN
admet-905	94	2	.	.	PUNCT
admet-905	95	1	25	25	NUM
admet-905	95	2	(	(	PUNCT
admet-905	95	3	2010	2010	NUM
admet-905	95	4	)	)	PUNCT
admet-905	95	5	544	544	NUM
admet-905	95	6	-	-	SYM
admet-905	95	7	551	551	NUM
admet-905	95	8	.	.	PUNCT
admet-905	96	1	[	[	X
admet-905	96	2	4	4	NUM
admet-905	96	3	]	]	PUNCT
admet-905	96	4	r.	r.	PROPN
admet-905	96	5	azziz	azziz	PROPN
admet-905	96	6	,	,	PUNCT
admet-905	96	7	e.	e.	PROPN
admet-905	96	8	carmina	carmina	PROPN
admet-905	96	9	,	,	PUNCT
admet-905	96	10	d.	d.	PROPN
admet-905	96	11	dewailly	dewailly	PROPN
admet-905	96	12	,	,	PUNCT
admet-905	96	13	e.	e.	PROPN
admet-905	96	14	diamanti	diamanti	PROPN
admet-905	96	15	-	-	PUNCT
admet-905	96	16	kandarakis	kandarakis	PROPN
admet-905	96	17	,	,	PUNCT
admet-905	96	18	h.f	h.f	PROPN
admet-905	96	19	.	.	PROPN
admet-905	96	20	escobar	escobar	PROPN
admet-905	96	21	-	-	PUNCT
admet-905	96	22	morreale	morreale	PROPN
admet-905	96	23	,	,	PUNCT
admet-905	96	24	w.	w.	PROPN
admet-905	96	25	futterweit	futterweit	PROPN
admet-905	96	26	,	,	PUNCT
admet-905	96	27	o.e	o.e	PROPN
admet-905	96	28	.	.	PROPN
admet-905	96	29	janssen	janssen	PROPN
admet-905	96	30	,	,	PUNCT
admet-905	96	31	r.s	r.s	PROPN
admet-905	96	32	.	.	PROPN
admet-905	96	33	legro	legro	PROPN
admet-905	96	34	,	,	PUNCT
admet-905	96	35	r.j	r.j	PROPN
admet-905	96	36	.	.	PROPN
admet-905	96	37	norman	norman	PROPN
admet-905	96	38	,	,	PUNCT
admet-905	96	39	a.e	a.e	PROPN
admet-905	96	40	.	.	PROPN
admet-905	96	41	taylor	taylor	PROPN
admet-905	96	42	,	,	PUNCT
admet-905	96	43	s.f	s.f	PROPN
admet-905	96	44	.	.	PROPN
admet-905	96	45	witchel	witchel	PROPN
admet-905	96	46	.	.	PUNCT
admet-905	97	1	the	the	DET
admet-905	97	2	androgen	androgen	NOUN
admet-905	97	3	excess	excess	NOUN
admet-905	97	4	and	and	CCONJ
admet-905	97	5	pcos	pcos	NOUN
admet-905	97	6	society	society	NOUN
admet-905	97	7	criteria	criterion	NOUN
admet-905	97	8	for	for	ADP
admet-905	97	9	the	the	DET
admet-905	97	10	polycystic	polycystic	ADJ
admet-905	97	11	ovary	ovary	ADJ
admet-905	97	12	syndrome	syndrome	NOUN
admet-905	97	13	:	:	PUNCT
admet-905	97	14	the	the	DET
admet-905	97	15	complete	complete	ADJ
admet-905	97	16	task	task	PROPN
admet-905	97	17	force	force	PROPN
admet-905	97	18	report	report	NOUN
admet-905	97	19	.	.	PUNCT
admet-905	98	1	fertil	fertil	PROPN
admet-905	98	2	.	.	PUNCT
admet-905	99	1	steril	steril	PROPN
admet-905	99	2	.	.	PROPN
admet-905	100	1	91	91	NUM
admet-905	100	2	(	(	PUNCT
admet-905	100	3	2009	2009	NUM
admet-905	100	4	)	)	PUNCT
admet-905	100	5	456	456	NUM
admet-905	100	6	-	-	SYM
admet-905	100	7	488	488	NUM
admet-905	100	8	.	.	PUNCT
admet-905	101	1	[	[	X
admet-905	101	2	5	5	X
admet-905	101	3	]	]	PUNCT
admet-905	101	4	s.	s.	PROPN
admet-905	101	5	franks	franks	PROPN
admet-905	101	6	,	,	PUNCT
admet-905	101	7	l.j	l.j	PROPN
admet-905	101	8	.	.	PROPN
admet-905	101	9	webber	webber	PROPN
admet-905	101	10	,	,	PUNCT
admet-905	101	11	m.	m.	PROPN
admet-905	101	12	goh	goh	PROPN
admet-905	101	13	,	,	PUNCT
admet-905	101	14	a.	a.	PROPN
admet-905	101	15	valentine	valentine	PROPN
admet-905	101	16	,	,	PUNCT
admet-905	101	17	d.m	d.m	PROPN
admet-905	101	18	.	.	PROPN
admet-905	101	19	white	white	PROPN
admet-905	101	20	,	,	PUNCT
admet-905	101	21	g.s	g.s	PROPN
admet-905	101	22	.	.	PROPN
admet-905	101	23	conway	conway	PROPN
admet-905	101	24	,	,	PUNCT
admet-905	101	25	s.	s.	PROPN
admet-905	101	26	wiltshire	wiltshire	PROPN
admet-905	101	27	,	,	PUNCT
admet-905	101	28	m.i	m.i	PROPN
admet-905	101	29	.	.	PROPN
admet-905	101	30	mccarthy	mccarthy	PROPN
admet-905	101	31	.	.	PUNCT
admet-905	102	1	ovarian	ovarian	ADJ
admet-905	102	2	morphology	morphology	NOUN
admet-905	102	3	is	be	AUX
admet-905	102	4	a	a	DET
admet-905	102	5	marker	marker	NOUN
admet-905	102	6	of	of	ADP
admet-905	102	7	heritable	heritable	ADJ
admet-905	102	8	biochemical	biochemical	ADJ
admet-905	102	9	traits	trait	NOUN
admet-905	102	10	in	in	ADP
admet-905	102	11	sisters	sister	NOUN
admet-905	102	12	with	with	ADP
admet-905	102	13	polycystic	polycystic	ADJ
admet-905	102	14	ovaries	ovary	NOUN
admet-905	102	15	.	.	PUNCT
admet-905	103	1	j.	j.	PROPN
admet-905	103	2	clin	clin	PROPN
admet-905	103	3	.	.	PUNCT
admet-905	104	1	endocrinol	endocrinol	NOUN
admet-905	104	2	.	.	PUNCT
admet-905	105	1	metab	metab	NOUN
admet-905	105	2	.	.	PUNCT
admet-905	106	1	93	93	NUM
admet-905	106	2	(	(	PUNCT
admet-905	106	3	2008	2008	NUM
admet-905	106	4	)	)	PUNCT
admet-905	106	5	3396	3396	NUM
admet-905	106	6	-	-	SYM
admet-905	106	7	3402	3402	NUM
admet-905	106	8	.	.	PUNCT
admet-905	107	1	[	[	X
admet-905	107	2	6	6	NUM
admet-905	107	3	]	]	SYM
admet-905	107	4	c.m	c.m	PROPN
admet-905	107	5	.	.	PROPN
admet-905	107	6	povel	povel	PROPN
admet-905	107	7	,	,	PUNCT
admet-905	107	8	j.m	j.m	PROPN
admet-905	107	9	.	.	PROPN
admet-905	107	10	boer	boer	PROPN
admet-905	107	11	,	,	PUNCT
admet-905	107	12	e.j	e.j	PROPN
admet-905	107	13	.	.	PROPN
admet-905	107	14	feskens	fesken	NOUN
admet-905	107	15	.	.	PUNCT
admet-905	108	1	shared	share	VERB
admet-905	108	2	genetic	genetic	ADJ
admet-905	108	3	variance	variance	NOUN
admet-905	108	4	between	between	ADP
admet-905	108	5	the	the	DET
admet-905	108	6	features	feature	NOUN
admet-905	108	7	of	of	ADP
admet-905	108	8	the	the	DET
admet-905	108	9	metabolic	metabolic	NOUN
admet-905	108	10	syndrome	syndrome	NOUN
admet-905	108	11	:	:	PUNCT
admet-905	108	12	heritability	heritability	NOUN
admet-905	108	13	studies	study	NOUN
admet-905	108	14	.	.	PUNCT
admet-905	109	1	mol	mol	PROPN
admet-905	109	2	.	.	PUNCT
admet-905	110	1	genet	genet	NOUN
admet-905	110	2	.	.	PUNCT
admet-905	111	1	metab	metab	PROPN
admet-905	111	2	.	.	PUNCT
admet-905	112	1	104	104	NUM
admet-905	112	2	(	(	PUNCT
admet-905	112	3	2011	2011	NUM
admet-905	112	4	)	)	PUNCT
admet-905	112	5	666	666	NUM
admet-905	112	6	-	-	PUNCT
admet-905	112	7	669	669	NUM
admet-905	112	8	.	.	PUNCT
admet-905	113	1	[	[	X
admet-905	113	2	7	7	X
admet-905	113	3	]	]	PUNCT
admet-905	113	4	j.	j.	PROPN
admet-905	113	5	holte	holte	PROPN
admet-905	113	6	.	.	PUNCT
admet-905	114	1	disturbances	disturbance	NOUN
admet-905	114	2	in	in	ADP
admet-905	114	3	insulin	insulin	NOUN
admet-905	114	4	secretion	secretion	NOUN
admet-905	114	5	and	and	CCONJ
admet-905	114	6	sensitivity	sensitivity	NOUN
admet-905	114	7	in	in	ADP
admet-905	114	8	women	woman	NOUN
admet-905	114	9	with	with	ADP
admet-905	114	10	the	the	DET
admet-905	114	11	polycystic	polycystic	ADJ
admet-905	114	12	ovary	ovary	ADJ
admet-905	114	13	syndrome	syndrome	NOUN
admet-905	114	14	.	.	PUNCT
admet-905	115	1	baillieres	bailliere	NOUN
admet-905	115	2	.	.	PUNCT
admet-905	116	1	clin	clin	PROPN
admet-905	116	2	.	.	PUNCT
admet-905	116	3	endocrinol	endocrinol	NOUN
admet-905	116	4	.	.	PUNCT
admet-905	117	1	metab	metab	NOUN
admet-905	117	2	.	.	PUNCT
admet-905	118	1	10(2	10(2	NUM
admet-905	118	2	)	)	PUNCT
admet-905	118	3	(	(	PUNCT
admet-905	118	4	1996	1996	NUM
admet-905	118	5	)	)	PUNCT
admet-905	119	1	221–247	221–247	NUM
admet-905	119	2	.	.	PUNCT
admet-905	120	1	[	[	X
admet-905	120	2	8	8	NUM
admet-905	120	3	]	]	X
admet-905	120	4	z.t	z.t	PROPN
admet-905	120	5	.	.	PROPN
admet-905	120	6	bloomgarden	bloomgarden	PROPN
admet-905	120	7	.	.	PUNCT
admet-905	121	1	world	world	PROPN
admet-905	121	2	congress	congress	PROPN
admet-905	121	3	on	on	ADP
admet-905	121	4	the	the	DET
admet-905	121	5	insulin	insulin	NOUN
admet-905	121	6	resistance	resistance	NOUN
admet-905	121	7	syndrome	syndrome	NOUN
admet-905	121	8	:	:	PUNCT
admet-905	121	9	insulin	insulin	NOUN
admet-905	121	10	resistance	resistance	NOUN
admet-905	121	11	mechanisms	mechanism	NOUN
admet-905	121	12	,	,	PUNCT
admet-905	121	13	the	the	DET
admet-905	121	14	brain	brain	NOUN
admet-905	121	15	,	,	PUNCT
admet-905	121	16	and	and	CCONJ
admet-905	121	17	insulin	insulin	NOUN
admet-905	121	18	resistance	resistance	NOUN
admet-905	121	19	in	in	ADP
admet-905	121	20	youth	youth	NOUN
admet-905	121	21	and	and	CCONJ
admet-905	121	22	in	in	ADP
admet-905	121	23	the	the	DET
admet-905	121	24	polycystic	polycystic	ADJ
admet-905	121	25	ovary	ovary	ADJ
admet-905	121	26	syndrome	syndrome	NOUN
admet-905	121	27	.	.	PUNCT
admet-905	122	1	diabetes	diabetes	NOUN
admet-905	122	2	care	care	VERB
admet-905	122	3	33(10	33(10	NUM
admet-905	122	4	)	)	PUNCT
admet-905	122	5	(	(	PUNCT
admet-905	122	6	2010	2010	NUM
admet-905	122	7	)	)	PUNCT
admet-905	123	1	e124	e124	PROPN
admet-905	123	2	-	-	PUNCT
admet-905	123	3	e130	e130	PROPN
admet-905	123	4	.	.	PUNCT
admet-905	124	1	[	[	X
admet-905	124	2	9	9	NUM
admet-905	124	3	]	]	X
admet-905	124	4	r.s	r.s	PROPN
admet-905	124	5	.	.	PROPN
admet-905	124	6	legro	legro	PROPN
admet-905	124	7	,	,	PUNCT
admet-905	124	8	c.l	c.l	PROPN
admet-905	124	9	.	.	PROPN
admet-905	124	10	gnatuk	gnatuk	PROPN
admet-905	124	11	,	,	PUNCT
admet-905	124	12	a.r	a.r	PROPN
admet-905	124	13	.	.	PROPN
admet-905	124	14	kunselman	kunselman	NOUN
admet-905	124	15	,	,	PUNCT
admet-905	124	16	a.	a.	NOUN
admet-905	124	17	dunaif	dunaif	NOUN
admet-905	124	18	.	.	PUNCT
admet-905	125	1	changes	change	NOUN
admet-905	125	2	in	in	ADP
admet-905	125	3	glucose	glucose	NOUN
admet-905	125	4	tolerance	tolerance	NOUN
admet-905	125	5	over	over	ADP
admet-905	125	6	time	time	NOUN
admet-905	125	7	in	in	ADP
admet-905	125	8	women	woman	NOUN
admet-905	125	9	with	with	ADP
admet-905	125	10	polycystic	polycystic	ADJ
admet-905	125	11	ovary	ovary	ADJ
admet-905	125	12	syndrome	syndrome	NOUN
admet-905	125	13	:	:	PUNCT
admet-905	125	14	a	a	DET
admet-905	125	15	controlled	control	VERB
admet-905	125	16	study	study	NOUN
admet-905	125	17	.	.	PUNCT
admet-905	126	1	j.	j.	PROPN
admet-905	126	2	clin	clin	PROPN
admet-905	126	3	.	.	PUNCT
admet-905	127	1	endocrinol	endocrinol	NOUN
admet-905	127	2	.	.	PUNCT
admet-905	128	1	metab	metab	NOUN
admet-905	128	2	.	.	PUNCT
admet-905	129	1	90	90	NUM
admet-905	129	2	(	(	PUNCT
admet-905	129	3	2005	2005	NUM
admet-905	129	4	)	)	PUNCT
admet-905	129	5	3236	3236	NUM
admet-905	129	6	-	-	SYM
admet-905	129	7	3242	3242	NUM
admet-905	129	8	.	.	PUNCT
admet-905	130	1	[	[	X
admet-905	130	2	10	10	NUM
admet-905	130	3	]	]	X
admet-905	130	4	j.c	j.c	PROPN
admet-905	130	5	.	.	PROPN
admet-905	130	6	marshall	marshall	PROPN
admet-905	130	7	,	,	PUNCT
admet-905	130	8	a.	a.	NOUN
admet-905	130	9	dunaif	dunaif	PROPN
admet-905	130	10	.	.	PUNCT
admet-905	131	1	should	should	AUX
admet-905	131	2	all	all	DET
admet-905	131	3	women	woman	NOUN
admet-905	131	4	with	with	ADP
admet-905	131	5	pcos	pcos	PROPN
admet-905	131	6	be	be	AUX
admet-905	131	7	treated	treat	VERB
admet-905	131	8	for	for	ADP
admet-905	131	9	insulin	insulin	NOUN
admet-905	131	10	resistance	resistance	NOUN
admet-905	131	11	?	?	PUNCT
admet-905	131	12	.	.	PUNCT
admet-905	132	1	fertil	fertil	PROPN
admet-905	132	2	.	.	PUNCT
admet-905	133	1	steril	steril	PROPN
admet-905	133	2	.	.	PROPN
admet-905	134	1	97	97	NUM
admet-905	134	2	(	(	PUNCT
admet-905	134	3	2012	2012	NUM
admet-905	134	4	)	)	PUNCT
admet-905	134	5	18	18	NUM
admet-905	134	6	-	-	SYM
admet-905	134	7	22	22	NUM
admet-905	134	8	.	.	PUNCT
admet-905	135	1	http://dx.doi.org/10.5599/admet.905	http://dx.doi.org/10.5599/admet.905	VERB
admet-905	135	2	m.	m.	PROPN
admet-905	135	3	ibrahim	ibrahim	PROPN
admet-905	135	4	,	,	PUNCT
admet-905	135	5	m.	m.	NOUN
admet-905	135	6	ahmeid	ahmeid	PROPN
admet-905	135	7	admet	admet	PROPN
admet-905	135	8	&	&	CCONJ
admet-905	135	9	dmpk	dmpk	PROPN
admet-905	135	10	9(1	9(1	NUM
admet-905	135	11	)	)	PUNCT
admet-905	135	12	(	(	PUNCT
admet-905	135	13	2021	2021	NUM
admet-905	135	14	)	)	PUNCT
admet-905	135	15	49	49	NUM
admet-905	135	16	-	-	SYM
admet-905	135	17	55	55	NUM
admet-905	135	18	54	54	NUM
admet-905	135	19	[	[	X
admet-905	135	20	11	11	NUM
admet-905	135	21	]	]	PUNCT
admet-905	135	22	m.	m.	NOUN
admet-905	135	23	belani	belani	NOUN
admet-905	135	24	,	,	PUNCT
admet-905	135	25	a.	a.	NOUN
admet-905	135	26	deo	deo	PROPN
admet-905	135	27	,	,	PUNCT
admet-905	135	28	p.	p.	NOUN
admet-905	135	29	shah	shah	NOUN
admet-905	135	30	,	,	PUNCT
admet-905	135	31	m.	m.	NOUN
admet-905	135	32	banker	banker	NOUN
admet-905	135	33	,	,	PUNCT
admet-905	135	34	p.	p.	PROPN
admet-905	135	35	singal	singal	PROPN
admet-905	135	36	,	,	PUNCT
admet-905	135	37	s.	s.	PROPN
admet-905	135	38	gupta	gupta	PROPN
admet-905	135	39	.	.	PUNCT
admet-905	135	40	differential	differential	ADJ
admet-905	135	41	insulin	insulin	NOUN
admet-905	135	42	and	and	CCONJ
admet-905	135	43	steroidogenic	steroidogenic	ADJ
admet-905	135	44	signaling	signaling	NOUN
admet-905	135	45	in	in	ADP
admet-905	135	46	insulin	insulin	NOUN
admet-905	135	47	resistant	resistant	ADJ
admet-905	135	48	and	and	CCONJ
admet-905	135	49	non	non	ADJ
admet-905	135	50	-	-	ADJ
admet-905	135	51	insulin	insulin	ADJ
admet-905	135	52	resistant	resistant	ADJ
admet-905	135	53	human	human	ADJ
admet-905	135	54	luteinized	luteinize	VERB
admet-905	135	55	granulosa	granulosa	NOUN
admet-905	135	56	cells	cell	NOUN
admet-905	135	57	-	-	PUNCT
admet-905	135	58	a	a	DET
admet-905	135	59	study	study	NOUN
admet-905	135	60	in	in	ADP
admet-905	135	61	pcos	pcos	PROPN
admet-905	135	62	patients	patient	NOUN
admet-905	135	63	.	.	PUNCT
admet-905	136	1	j.	j.	PROPN
admet-905	136	2	steroid	steroid	PROPN
admet-905	136	3	biochem	biochem	PROPN
admet-905	136	4	.	.	PUNCT
admet-905	137	1	mol	mol	PROPN
admet-905	137	2	.	.	PUNCT
admet-905	138	1	biol	biol	PROPN
admet-905	138	2	.	.	PUNCT
admet-905	139	1	178	178	NUM
admet-905	139	2	(	(	PUNCT
admet-905	139	3	2018	2018	NUM
admet-905	139	4	)	)	PUNCT
admet-905	139	5	283	283	NUM
admet-905	139	6	-	-	SYM
admet-905	139	7	292	292	NUM
admet-905	139	8	.	.	PUNCT
admet-905	140	1	[	[	X
admet-905	140	2	12	12	NUM
admet-905	140	3	]	]	X
admet-905	140	4	t.m	t.m	PROPN
admet-905	140	5	.	.	PROPN
admet-905	140	6	wallace	wallace	PROPN
admet-905	140	7	,	,	PUNCT
admet-905	140	8	j.c	j.c	PROPN
admet-905	140	9	.	.	PROPN
admet-905	140	10	levy	levy	PROPN
admet-905	140	11	,	,	PUNCT
admet-905	140	12	d.r	d.r	PROPN
admet-905	140	13	.	.	PROPN
admet-905	140	14	matthews	matthews	PROPN
admet-905	140	15	.	.	PUNCT
admet-905	141	1	use	use	NOUN
admet-905	141	2	and	and	CCONJ
admet-905	141	3	abuse	abuse	NOUN
admet-905	141	4	of	of	ADP
admet-905	141	5	homa	homa	NOUN
admet-905	141	6	modeling	modeling	NOUN
admet-905	141	7	.	.	PUNCT
admet-905	142	1	diabetes	diabete	NOUN
admet-905	142	2	care	care	VERB
admet-905	142	3	27	27	NUM
admet-905	142	4	(	(	PUNCT
admet-905	142	5	2004	2004	NUM
admet-905	142	6	)	)	PUNCT
admet-905	142	7	1487	1487	NUM
admet-905	142	8	-	-	SYM
admet-905	142	9	1495	1495	NUM
admet-905	142	10	.	.	PUNCT
admet-905	143	1	[	[	X
admet-905	143	2	13	13	NUM
admet-905	143	3	]	]	X
admet-905	143	4	d.r	d.r	PROPN
admet-905	143	5	.	.	PROPN
admet-905	143	6	matthews	matthews	PROPN
admet-905	143	7	,	,	PUNCT
admet-905	143	8	j.p	j.p	PROPN
admet-905	143	9	.	.	PROPN
admet-905	143	10	hosker	hosker	PROPN
admet-905	143	11	,	,	PUNCT
admet-905	143	12	a.s	a.s	PROPN
admet-905	143	13	.	.	PROPN
admet-905	143	14	rudenski	rudenski	PROPN
admet-905	143	15	,	,	PUNCT
admet-905	143	16	b.a	b.a	PROPN
admet-905	143	17	.	.	PROPN
admet-905	143	18	naylor	naylor	PROPN
admet-905	143	19	,	,	PUNCT
admet-905	143	20	d.f	d.f	PROPN
admet-905	143	21	.	.	PROPN
admet-905	143	22	treacher	treacher	PROPN
admet-905	143	23	,	,	PUNCT
admet-905	143	24	r.c	r.c	PROPN
admet-905	143	25	.	.	PROPN
admet-905	143	26	turner	turner	PROPN
admet-905	143	27	.	.	PUNCT
admet-905	144	1	homeostasis	homeostasis	NOUN
admet-905	144	2	model	model	NOUN
admet-905	144	3	assessment	assessment	NOUN
admet-905	144	4	:	:	PUNCT
admet-905	144	5	insulin	insulin	NOUN
admet-905	144	6	resistance	resistance	NOUN
admet-905	144	7	and	and	CCONJ
admet-905	144	8	beta	beta	NOUN
admet-905	144	9	-	-	PUNCT
admet-905	144	10	cell	cell	NOUN
admet-905	144	11	function	function	NOUN
admet-905	144	12	from	from	ADP
admet-905	144	13	fasting	fast	VERB
admet-905	144	14	plasma	plasma	NOUN
admet-905	144	15	glucose	glucose	NOUN
admet-905	144	16	and	and	CCONJ
admet-905	144	17	insulin	insulin	NOUN
admet-905	144	18	concentrations	concentration	NOUN
admet-905	144	19	in	in	ADP
admet-905	144	20	man	man	NOUN
admet-905	144	21	.	.	PUNCT
admet-905	145	1	diabetologia	diabetologia	NOUN
admet-905	145	2	28	28	NUM
admet-905	145	3	(	(	PUNCT
admet-905	145	4	1985	1985	NUM
admet-905	145	5	)	)	PUNCT
admet-905	145	6	412	412	NUM
admet-905	145	7	-	-	SYM
admet-905	145	8	419	419	NUM
admet-905	145	9	.	.	PUNCT
admet-905	146	1	[	[	X
admet-905	146	2	14	14	NUM
admet-905	146	3	]	]	X
admet-905	146	4	b.	b.	PROPN
admet-905	146	5	hedblad	hedblad	PROPN
admet-905	146	6	,	,	PUNCT
admet-905	146	7	p.	p.	PROPN
admet-905	146	8	nilsson	nilsson	PROPN
admet-905	146	9	,	,	PUNCT
admet-905	146	10	l.	l.	PROPN
admet-905	146	11	janzon	janzon	PROPN
admet-905	146	12	,	,	PUNCT
admet-905	146	13	g.	g.	PROPN
admet-905	146	14	berglund	berglund	PROPN
admet-905	146	15	.	.	PUNCT
admet-905	147	1	relation	relation	NOUN
admet-905	147	2	between	between	ADP
admet-905	147	3	insulin	insulin	NOUN
admet-905	147	4	resistance	resistance	NOUN
admet-905	147	5	and	and	CCONJ
admet-905	147	6	carotid	carotid	NOUN
admet-905	147	7	intimamedia	intimamedia	NOUN
admet-905	147	8	thickness	thickness	NOUN
admet-905	147	9	and	and	CCONJ
admet-905	147	10	stenosis	stenosis	NOUN
admet-905	147	11	in	in	ADP
admet-905	147	12	non	non	ADJ
admet-905	147	13	-	-	ADJ
admet-905	147	14	diabetic	diabetic	ADJ
admet-905	147	15	subjects	subject	NOUN
admet-905	147	16	.	.	PUNCT
admet-905	148	1	results	result	NOUN
admet-905	148	2	from	from	ADP
admet-905	148	3	a	a	DET
admet-905	148	4	cross	cross	ADJ
admet-905	148	5	-	-	ADJ
admet-905	148	6	sectional	sectional	ADJ
admet-905	148	7	study	study	NOUN
admet-905	148	8	in	in	ADP
admet-905	148	9	malmö	malmö	PROPN
admet-905	148	10	,	,	PUNCT
admet-905	148	11	sweden	sweden	PROPN
admet-905	148	12	.	.	PUNCT
admet-905	149	1	diabet	diabet	PROPN
admet-905	149	2	.	.	PUNCT
admet-905	150	1	med	med	PROPN
admet-905	150	2	.	.	PROPN
admet-905	151	1	17	17	NUM
admet-905	151	2	(	(	PUNCT
admet-905	151	3	2000	2000	NUM
admet-905	151	4	)	)	PUNCT
admet-905	151	5	299	299	NUM
admet-905	151	6	-	-	SYM
admet-905	151	7	307	307	NUM
admet-905	151	8	.	.	PUNCT
admet-905	152	1	[	[	X
admet-905	152	2	15	15	NUM
admet-905	152	3	]	]	X
admet-905	152	4	d.	d.	PROPN
admet-905	152	5	rittirsch	rittirsch	PROPN
admet-905	152	6	,	,	PUNCT
admet-905	152	7	m.a	m.a	PROPN
admet-905	152	8	.	.	PROPN
admet-905	152	9	flierl	flierl	PROPN
admet-905	152	10	,	,	PUNCT
admet-905	152	11	b.a	b.a	PROPN
admet-905	152	12	.	.	PROPN
admet-905	152	13	nadeau	nadeau	PROPN
admet-905	152	14	,	,	PUNCT
admet-905	152	15	d.e	d.e	PROPN
admet-905	152	16	.	.	PROPN
admet-905	152	17	day	day	PROPN
admet-905	152	18	,	,	PUNCT
admet-905	152	19	m.s	m.s	PROPN
admet-905	152	20	.	.	PROPN
admet-905	152	21	huber	huber	PROPN
admet-905	152	22	-	-	PUNCT
admet-905	152	23	lang	lang	PROPN
admet-905	152	24	,	,	PUNCT
admet-905	152	25	j.j	j.j	PROPN
admet-905	152	26	.	.	PROPN
admet-905	152	27	grailer	grailer	PROPN
admet-905	152	28	,	,	PUNCT
admet-905	152	29	f.s	f.s	PROPN
admet-905	152	30	.	.	PROPN
admet-905	152	31	zetoune	zetoune	PROPN
admet-905	152	32	,	,	PUNCT
admet-905	152	33	a.v	a.v	PROPN
admet-905	152	34	.	.	PROPN
admet-905	152	35	andjelković	andjelković	PROPN
admet-905	152	36	,	,	PUNCT
admet-905	152	37	a.	a.	PROPN
admet-905	152	38	fasano	fasano	PROPN
admet-905	152	39	,	,	PUNCT
admet-905	152	40	p.a	p.a	PROPN
admet-905	152	41	.	.	PROPN
admet-905	152	42	ward	ward	PROPN
admet-905	152	43	.	.	PUNCT
admet-905	153	1	zonulin	zonulin	PROPN
admet-905	153	2	as	as	ADP
admet-905	153	3	prehaptoglobin2	prehaptoglobin2	NOUN
admet-905	153	4	regulates	regulate	VERB
admet-905	153	5	lung	lung	NOUN
admet-905	153	6	permeability	permeability	NOUN
admet-905	153	7	and	and	CCONJ
admet-905	153	8	activates	activate	VERB
admet-905	153	9	the	the	DET
admet-905	153	10	complement	complement	NOUN
admet-905	153	11	system	system	NOUN
admet-905	153	12	.	.	PUNCT
admet-905	154	1	am	be	AUX
admet-905	154	2	.	.	PUNCT
admet-905	155	1	j.	j.	PROPN
admet-905	155	2	physiol	physiol	PROPN
admet-905	155	3	.	.	PUNCT
admet-905	156	1	lung	lung	NOUN
admet-905	156	2	cell	cell	NOUN
admet-905	156	3	.	.	PUNCT
admet-905	157	1	mol	mol	PROPN
admet-905	157	2	.	.	PUNCT
admet-905	157	3	physiol	physiol	PROPN
admet-905	157	4	.	.	PUNCT
admet-905	158	1	304	304	NUM
admet-905	158	2	(	(	PUNCT
admet-905	158	3	2013	2013	NUM
admet-905	158	4	)	)	PUNCT
admet-905	158	5	l863	l863	PROPN
admet-905	158	6	-	-	PUNCT
admet-905	158	7	l872	l872	PROPN
admet-905	158	8	.	.	PUNCT
admet-905	159	1	[	[	X
admet-905	159	2	16	16	NUM
admet-905	159	3	]	]	X
admet-905	159	4	l.	l.	PROPN
admet-905	159	5	pacifico	pacifico	PROPN
admet-905	159	6	,	,	PUNCT
admet-905	159	7	e.	e.	PROPN
admet-905	159	8	bonci	bonci	PROPN
admet-905	159	9	,	,	PUNCT
admet-905	159	10	l.	l.	PROPN
admet-905	159	11	marandola	marandola	PROPN
admet-905	159	12	,	,	PUNCT
admet-905	159	13	s.	s.	PROPN
admet-905	159	14	romaggioli	romaggioli	PROPN
admet-905	159	15	,	,	PUNCT
admet-905	159	16	s.	s.	PROPN
admet-905	159	17	bascetta	bascetta	PROPN
admet-905	159	18	,	,	PUNCT
admet-905	159	19	c.	c.	PROPN
admet-905	159	20	chiesa	chiesa	PROPN
admet-905	159	21	.	.	PROPN
admet-905	159	22	increased	increase	VERB
admet-905	159	23	circulating	circulate	VERB
admet-905	159	24	zonulin	zonulin	NOUN
admet-905	159	25	in	in	ADP
admet-905	159	26	children	child	NOUN
admet-905	159	27	with	with	ADP
admet-905	159	28	biopsy	biopsy	NOUN
admet-905	159	29	-	-	PUNCT
admet-905	159	30	proven	prove	VERB
admet-905	159	31	nonalcoholic	nonalcoholic	NOUN
admet-905	159	32	fatty	fatty	NOUN
admet-905	159	33	liver	liver	NOUN
admet-905	159	34	disease	disease	NOUN
admet-905	159	35	.	.	PUNCT
admet-905	160	1	world	world	PROPN
admet-905	160	2	j.	j.	PROPN
admet-905	160	3	gastroenterol	gastroenterol	PROPN
admet-905	160	4	.	.	PUNCT
admet-905	161	1	20	20	NUM
admet-905	161	2	(	(	PUNCT
admet-905	161	3	2014	2014	NUM
admet-905	161	4	)	)	PUNCT
admet-905	161	5	17107	17107	NUM
admet-905	161	6	-	-	SYM
admet-905	161	7	17114	17114	NUM
admet-905	161	8	.	.	PUNCT
admet-905	162	1	[	[	X
admet-905	162	2	17	17	NUM
admet-905	162	3	]	]	PUNCT
admet-905	162	4	t.	t.	PROPN
admet-905	162	5	küme	küme	PROPN
admet-905	162	6	,	,	PUNCT
admet-905	162	7	s.	s.	PROPN
admet-905	162	8	acar	acar	PROPN
admet-905	162	9	,	,	PUNCT
admet-905	162	10	h.	h.	PROPN
admet-905	162	11	tuhan	tuhan	PROPN
admet-905	162	12	,	,	PUNCT
admet-905	162	13	g.	g.	PROPN
admet-905	162	14	çatlı	çatlı	PROPN
admet-905	162	15	,	,	PUNCT
admet-905	162	16	a.	a.	NOUN
admet-905	162	17	anık	anık	PROPN
admet-905	162	18	,	,	PUNCT
admet-905	162	19	ö.	ö.	PROPN
admet-905	162	20	gürsoy	gürsoy	PROPN
admet-905	162	21	çalan	çalan	NOUN
admet-905	162	22	,	,	PUNCT
admet-905	162	23	e.	e.	PROPN
admet-905	162	24	böber	böber	PROPN
admet-905	162	25	,	,	PUNCT
admet-905	162	26	a.	a.	NOUN
admet-905	162	27	abacı	abacı	PROPN
admet-905	162	28	.	.	PUNCT
admet-905	163	1	the	the	DET
admet-905	163	2	relationship	relationship	NOUN
admet-905	163	3	between	between	ADP
admet-905	163	4	serum	serum	NOUN
admet-905	163	5	zonulin	zonulin	PROPN
admet-905	163	6	level	level	NOUN
admet-905	163	7	and	and	CCONJ
admet-905	163	8	clinical	clinical	ADJ
admet-905	163	9	and	and	CCONJ
admet-905	163	10	laboratory	laboratory	NOUN
admet-905	163	11	parameters	parameter	NOUN
admet-905	163	12	of	of	ADP
admet-905	163	13	childhood	childhood	NOUN
admet-905	163	14	obesity	obesity	NOUN
admet-905	163	15	.	.	PUNCT
admet-905	164	1	j.	j.	PROPN
admet-905	164	2	clin	clin	PROPN
admet-905	164	3	.	.	PUNCT
admet-905	165	1	res	re	NOUN
admet-905	165	2	.	.	PUNCT
admet-905	166	1	pediatr	pediatr	PROPN
admet-905	166	2	.	.	PUNCT
admet-905	166	3	endocrinol	endocrinol	NOUN
admet-905	166	4	.	.	PUNCT
admet-905	167	1	9	9	NUM
admet-905	167	2	(	(	PUNCT
admet-905	167	3	2017	2017	NUM
admet-905	167	4	)	)	PUNCT
admet-905	167	5	31	31	NUM
admet-905	167	6	-	-	SYM
admet-905	167	7	38	38	NUM
admet-905	167	8	.	.	PUNCT
admet-905	168	1	[	[	X
admet-905	168	2	18	18	NUM
admet-905	168	3	]	]	X
admet-905	168	4	j.m	j.m	PROPN
admet-905	168	5	.	.	PROPN
admet-905	168	6	moreno	moreno	PROPN
admet-905	168	7	-	-	PUNCT
admet-905	168	8	navarrete	navarrete	PROPN
admet-905	168	9	,	,	PUNCT
admet-905	168	10	m.	m.	NOUN
admet-905	168	11	sabater	sabater	PROPN
admet-905	168	12	,	,	PUNCT
admet-905	168	13	f.	f.	PROPN
admet-905	168	14	ortega	ortega	PROPN
admet-905	168	15	,	,	PUNCT
admet-905	168	16	w.	w.	PROPN
admet-905	168	17	ricart	ricart	PROPN
admet-905	168	18	,	,	PUNCT
admet-905	168	19	j.m	j.m	PROPN
admet-905	168	20	.	.	PROPN
admet-905	168	21	fernández	fernández	PROPN
admet-905	168	22	-	-	PUNCT
admet-905	168	23	real	real	NOUN
admet-905	168	24	.	.	PUNCT
admet-905	169	1	circulating	circulate	VERB
admet-905	169	2	zonulin	zonulin	PROPN
admet-905	169	3	,	,	PUNCT
admet-905	169	4	a	a	DET
admet-905	169	5	marker	marker	NOUN
admet-905	169	6	of	of	ADP
admet-905	169	7	intestinal	intestinal	ADJ
admet-905	169	8	permeability	permeability	NOUN
admet-905	169	9	,	,	PUNCT
admet-905	169	10	is	be	AUX
admet-905	169	11	increased	increase	VERB
admet-905	169	12	in	in	ADP
admet-905	169	13	association	association	NOUN
admet-905	169	14	with	with	ADP
admet-905	169	15	obesity	obesity	NOUN
admet-905	169	16	-	-	PUNCT
admet-905	169	17	associated	associate	VERB
admet-905	169	18	insulin	insulin	NOUN
admet-905	169	19	resistance	resistance	NOUN
admet-905	169	20	.	.	PUNCT
admet-905	170	1	plos	plos	PROPN
admet-905	170	2	one	one	NUM
admet-905	170	3	7	7	NUM
admet-905	170	4	(	(	PUNCT
admet-905	170	5	2012	2012	NUM
admet-905	170	6	)	)	PUNCT
admet-905	170	7	e37160	e37160	NOUN
admet-905	170	8	.	.	PUNCT
admet-905	171	1	[	[	X
admet-905	171	2	19	19	NUM
admet-905	171	3	]	]	X
admet-905	171	4	d.	d.	PROPN
admet-905	171	5	zhang	zhang	PROPN
admet-905	171	6	,	,	PUNCT
admet-905	171	7	l.	l.	PROPN
admet-905	171	8	zhang	zhang	PROPN
admet-905	171	9	,	,	PUNCT
admet-905	171	10	f.	f.	PROPN
admet-905	171	11	yue	yue	PROPN
admet-905	171	12	,	,	PUNCT
admet-905	171	13	y.	y.	PROPN
admet-905	171	14	zheng	zheng	PROPN
admet-905	171	15	,	,	PUNCT
admet-905	171	16	r.	r.	PROPN
admet-905	171	17	russell	russell	PROPN
admet-905	171	18	.	.	PUNCT
admet-905	172	1	serum	serum	PROPN
admet-905	172	2	zonulin	zonulin	PROPN
admet-905	172	3	is	be	AUX
admet-905	172	4	elevated	elevate	VERB
admet-905	172	5	in	in	ADP
admet-905	172	6	women	woman	NOUN
admet-905	172	7	with	with	ADP
admet-905	172	8	polycystic	polycystic	ADJ
admet-905	172	9	ovary	ovary	ADJ
admet-905	172	10	syndrome	syndrome	NOUN
admet-905	172	11	and	and	CCONJ
admet-905	172	12	correlates	correlate	VERB
admet-905	172	13	with	with	ADP
admet-905	172	14	insulin	insulin	NOUN
admet-905	172	15	resistance	resistance	NOUN
admet-905	172	16	and	and	CCONJ
admet-905	172	17	severity	severity	NOUN
admet-905	172	18	of	of	ADP
admet-905	172	19	anovulation	anovulation	NOUN
admet-905	172	20	.	.	PUNCT
admet-905	173	1	eur	eur	PROPN
admet-905	173	2	.	.	PUNCT
admet-905	174	1	j.	j.	PROPN
admet-905	174	2	endocrinol	endocrinol	PROPN
admet-905	174	3	.	.	PUNCT
admet-905	175	1	172	172	NUM
admet-905	175	2	(	(	PUNCT
admet-905	175	3	2015	2015	NUM
admet-905	175	4	)	)	PUNCT
admet-905	175	5	29	29	NUM
admet-905	175	6	-	-	SYM
admet-905	175	7	36	36	NUM
admet-905	175	8	.	.	PUNCT
admet-905	176	1	[	[	X
admet-905	176	2	20	20	NUM
admet-905	176	3	]	]	X
admet-905	176	4	r.	r.	PROPN
admet-905	176	5	mathur	mathur	PROPN
admet-905	176	6	,	,	PUNCT
admet-905	176	7	a.	a.	PROPN
admet-905	176	8	ko	ko	PROPN
admet-905	176	9	,	,	PUNCT
admet-905	176	10	l.j	l.j	PROPN
admet-905	176	11	.	.	PROPN
admet-905	176	12	hwang	hwang	PROPN
admet-905	176	13	,	,	PUNCT
admet-905	176	14	k.	k.	PROPN
admet-905	176	15	low	low	PROPN
admet-905	176	16	,	,	PUNCT
admet-905	176	17	r.	r.	PROPN
admet-905	176	18	azziz	azziz	PROPN
admet-905	176	19	,	,	PUNCT
admet-905	176	20	m.	m.	NOUN
admet-905	176	21	pimentel	pimentel	PROPN
admet-905	176	22	.	.	PUNCT
admet-905	176	23	polycystic	polycystic	ADJ
admet-905	176	24	ovary	ovary	ADJ
admet-905	176	25	syndrome	syndrome	NOUN
admet-905	176	26	is	be	AUX
admet-905	176	27	associated	associate	VERB
admet-905	176	28	with	with	ADP
admet-905	176	29	an	an	DET
admet-905	176	30	increased	increase	VERB
admet-905	176	31	prevalence	prevalence	NOUN
admet-905	176	32	of	of	ADP
admet-905	176	33	irritable	irritable	ADJ
admet-905	176	34	bowel	bowel	NOUN
admet-905	176	35	syndrome	syndrome	NOUN
admet-905	176	36	.	.	PUNCT
admet-905	177	1	dig	dig	VERB
admet-905	177	2	.	.	PUNCT
admet-905	178	1	dis	dis	PROPN
admet-905	178	2	.	.	PUNCT
admet-905	179	1	sci	sci	PROPN
admet-905	179	2	.	.	PROPN
admet-905	180	1	55	55	NUM
admet-905	180	2	(	(	PUNCT
admet-905	180	3	2010	2010	NUM
admet-905	180	4	)	)	PUNCT
admet-905	180	5	1085	1085	NUM
admet-905	180	6	-	-	SYM
admet-905	180	7	1089	1089	NUM
admet-905	180	8	.	.	PUNCT
admet-905	181	1	[	[	X
admet-905	181	2	21	21	NUM
admet-905	181	3	]	]	X
admet-905	181	4	b.l	b.l	PROPN
admet-905	181	5	.	.	PROPN
admet-905	181	6	harlow	harlow	PROPN
admet-905	181	7	,	,	PUNCT
admet-905	181	8	l.b	l.b	PROPN
admet-905	181	9	.	.	PROPN
admet-905	181	10	signorello	signorello	PROPN
admet-905	181	11	,	,	PUNCT
admet-905	181	12	j.e	j.e	PROPN
admet-905	181	13	.	.	PROPN
admet-905	181	14	hall	hall	PROPN
admet-905	181	15	,	,	PUNCT
admet-905	181	16	c.	c.	PROPN
admet-905	181	17	dailey	dailey	PROPN
admet-905	181	18	,	,	PUNCT
admet-905	181	19	a.l	a.l	PROPN
admet-905	181	20	.	.	PROPN
admet-905	181	21	komaroff	komaroff	PROPN
admet-905	181	22	.	.	PUNCT
admet-905	182	1	reproductive	reproductive	ADJ
admet-905	182	2	correlates	correlate	NOUN
admet-905	182	3	of	of	ADP
admet-905	182	4	chronic	chronic	ADJ
admet-905	182	5	fatigue	fatigue	NOUN
admet-905	182	6	syndrome	syndrome	NOUN
admet-905	182	7	.	.	PUNCT
admet-905	183	1	am	be	AUX
admet-905	183	2	.	.	PUNCT
admet-905	184	1	j.	j.	PROPN
admet-905	184	2	med	med	PROPN
admet-905	184	3	.	.	PUNCT
admet-905	185	1	105	105	NUM
admet-905	185	2	(	(	PUNCT
admet-905	185	3	1998	1998	NUM
admet-905	185	4	)	)	PUNCT
admet-905	185	5	94s-99s	94s-99s	NOUN
admet-905	185	6	.	.	PUNCT
admet-905	186	1	[	[	X
admet-905	186	2	22	22	NUM
admet-905	186	3	]	]	X
admet-905	186	4	g.	g.	PROPN
admet-905	186	5	rena	rena	PROPN
admet-905	186	6	,	,	PUNCT
admet-905	186	7	d.g	d.g	PROPN
admet-905	186	8	.	.	PROPN
admet-905	186	9	hardie	hardie	PROPN
admet-905	186	10	,	,	PUNCT
admet-905	186	11	e.r	e.r	PROPN
admet-905	186	12	.	.	PROPN
admet-905	186	13	pearson	pearson	PROPN
admet-905	186	14	.	.	PUNCT
admet-905	187	1	the	the	DET
admet-905	187	2	mechanisms	mechanism	NOUN
admet-905	187	3	of	of	ADP
admet-905	187	4	action	action	NOUN
admet-905	187	5	of	of	ADP
admet-905	187	6	metformin	metformin	NOUN
admet-905	187	7	.	.	PUNCT
admet-905	188	1	diabetologia	diabetologia	NOUN
admet-905	188	2	60	60	NUM
admet-905	188	3	(	(	PUNCT
admet-905	188	4	2017	2017	NUM
admet-905	188	5	)	)	PUNCT
admet-905	188	6	1577	1577	NUM
admet-905	188	7	-	-	SYM
admet-905	188	8	1585	1585	NUM
admet-905	188	9	.	.	PUNCT
admet-905	189	1	[	[	X
admet-905	189	2	23	23	NUM
admet-905	189	3	]	]	X
admet-905	189	4	c.j	c.j	PROPN
admet-905	189	5	.	.	PROPN
admet-905	189	6	bailey	bailey	PROPN
admet-905	189	7	,	,	PUNCT
admet-905	189	8	r.c	r.c	PROPN
admet-905	189	9	.	.	PROPN
admet-905	189	10	turner	turner	PROPN
admet-905	189	11	.	.	PUNCT
admet-905	190	1	metformin	metformin	PROPN
admet-905	190	2	.	.	PUNCT
admet-905	191	1	n.	n.	PROPN
admet-905	191	2	engl	engl	PROPN
admet-905	191	3	.	.	PUNCT
admet-905	192	1	j.	j.	PROPN
admet-905	192	2	med	med	PROPN
admet-905	192	3	.	.	PUNCT
admet-905	193	1	334	334	NUM
admet-905	193	2	(	(	PUNCT
admet-905	193	3	1996	1996	NUM
admet-905	193	4	)	)	PUNCT
admet-905	193	5	574	574	NUM
admet-905	193	6	-	-	SYM
admet-905	193	7	579	579	NUM
admet-905	193	8	.	.	PUNCT
admet-905	194	1	[	[	X
admet-905	194	2	24	24	NUM
admet-905	194	3	]	]	X
admet-905	194	4	h.	h.	PROPN
admet-905	194	5	lee	lee	PROPN
admet-905	194	6	,	,	PUNCT
admet-905	194	7	g.	g.	PROPN
admet-905	194	8	ko	ko	PROPN
admet-905	194	9	.	.	PUNCT
admet-905	194	10	effect	effect	NOUN
admet-905	194	11	of	of	ADP
admet-905	194	12	metformin	metformin	NOUN
admet-905	194	13	on	on	ADP
admet-905	194	14	metabolic	metabolic	NOUN
admet-905	194	15	improvement	improvement	NOUN
admet-905	194	16	and	and	CCONJ
admet-905	194	17	gut	gut	NOUN
admet-905	194	18	microbiota	microbiota	NOUN
admet-905	194	19	.	.	PUNCT
admet-905	195	1	appl	appl	PROPN
admet-905	195	2	.	.	PUNCT
admet-905	196	1	environ	environ	PROPN
admet-905	196	2	.	.	PUNCT
admet-905	196	3	microbiol	microbiol	PROPN
admet-905	196	4	.	.	PUNCT
admet-905	197	1	80	80	NUM
admet-905	197	2	(	(	PUNCT
admet-905	197	3	2014	2014	NUM
admet-905	197	4	)	)	PUNCT
admet-905	197	5	5935	5935	NUM
admet-905	197	6	-	-	SYM
admet-905	197	7	5943	5943	NUM
admet-905	197	8	.	.	PUNCT
admet-905	198	1	[	[	X
admet-905	198	2	25	25	NUM
admet-905	198	3	]	]	PUNCT
admet-905	198	4	f.	f.	PROPN
admet-905	198	5	cabreiro	cabreiro	PROPN
admet-905	198	6	,	,	PUNCT
admet-905	198	7	c.	c.	PROPN
admet-905	198	8	au	au	PROPN
admet-905	198	9	,	,	PUNCT
admet-905	198	10	k.y	k.y	PROPN
admet-905	198	11	.	.	PROPN
admet-905	198	12	leung	leung	PROPN
admet-905	198	13	,	,	PUNCT
admet-905	198	14	n.	n.	PROPN
admet-905	198	15	vergara	vergara	PROPN
admet-905	198	16	-	-	PUNCT
admet-905	198	17	irigaray	irigaray	PROPN
admet-905	198	18	,	,	PUNCT
admet-905	198	19	h.m	h.m	PROPN
admet-905	198	20	.	.	PROPN
admet-905	198	21	cochemé	cochemé	PROPN
admet-905	198	22	,	,	PUNCT
admet-905	198	23	t.	t.	PROPN
admet-905	198	24	noori	noori	PROPN
admet-905	198	25	,	,	PUNCT
admet-905	198	26	d.	d.	PROPN
admet-905	198	27	weinkove	weinkove	PROPN
admet-905	198	28	,	,	PUNCT
admet-905	198	29	e.	e.	PROPN
admet-905	198	30	schuster	schuster	PROPN
admet-905	198	31	,	,	PUNCT
admet-905	198	32	n.d	n.d	PROPN
admet-905	198	33	.	.	PROPN
admet-905	198	34	greene	greene	PROPN
admet-905	198	35	,	,	PUNCT
admet-905	198	36	d.	d.	PROPN
admet-905	198	37	gems	gem	NOUN
admet-905	198	38	.	.	PUNCT
admet-905	199	1	metformin	metformin	NOUN
admet-905	199	2	retards	retard	NOUN
admet-905	199	3	aging	age	VERB
admet-905	199	4	in	in	ADP
admet-905	199	5	c.	c.	NOUN
admet-905	199	6	elegans	elegan	NOUN
admet-905	199	7	by	by	ADP
admet-905	199	8	altering	alter	VERB
admet-905	199	9	microbial	microbial	ADJ
admet-905	199	10	folate	folate	NOUN
admet-905	199	11	and	and	CCONJ
admet-905	199	12	methionine	methionine	NOUN
admet-905	199	13	metabolism	metabolism	NOUN
admet-905	199	14	.	.	PUNCT
admet-905	200	1	cell	cell	NOUN
admet-905	200	2	153	153	NUM
admet-905	200	3	(	(	PUNCT
admet-905	200	4	2013	2013	NUM
admet-905	200	5	)	)	PUNCT
admet-905	200	6	228	228	NUM
admet-905	200	7	-	-	SYM
admet-905	200	8	239	239	NUM
admet-905	200	9	.	.	PUNCT
admet-905	201	1	[	[	X
admet-905	201	2	26	26	NUM
admet-905	201	3	]	]	X
admet-905	201	4	e.	e.	PROPN
admet-905	201	5	diamanti	diamanti	PROPN
admet-905	201	6	-	-	PUNCT
admet-905	201	7	kandarakis	kandarakis	PROPN
admet-905	201	8	,	,	PUNCT
admet-905	201	9	c.d	c.d	PROPN
admet-905	201	10	.	.	PROPN
admet-905	201	11	christakou	christakou	PROPN
admet-905	201	12	,	,	PUNCT
admet-905	201	13	e.	e.	PROPN
admet-905	201	14	kandaraki	kandaraki	PROPN
admet-905	201	15	,	,	PUNCT
admet-905	201	16	f.n	f.n	PROPN
admet-905	201	17	.	.	NOUN
admet-905	201	18	economou	economou	PROPN
admet-905	201	19	.	.	PUNCT
admet-905	202	1	metformin	metformin	NOUN
admet-905	202	2	:	:	PUNCT
admet-905	202	3	an	an	DET
admet-905	202	4	old	old	ADJ
admet-905	202	5	medication	medication	NOUN
admet-905	202	6	of	of	ADP
admet-905	202	7	new	new	ADJ
admet-905	202	8	fashion	fashion	NOUN
admet-905	202	9	:	:	PUNCT
admet-905	202	10	evolving	evolve	VERB
admet-905	202	11	new	new	ADJ
admet-905	202	12	molecular	molecular	ADJ
admet-905	202	13	mechanisms	mechanism	NOUN
admet-905	202	14	and	and	CCONJ
admet-905	202	15	clinical	clinical	ADJ
admet-905	202	16	implications	implication	NOUN
admet-905	202	17	in	in	ADP
admet-905	202	18	polycystic	polycystic	ADJ
admet-905	202	19	ovary	ovary	ADJ
admet-905	202	20	syndrome	syndrome	NOUN
admet-905	202	21	.	.	PUNCT
admet-905	203	1	eur	eur	PROPN
admet-905	203	2	.	.	PUNCT
admet-905	204	1	j.	j.	PROPN
admet-905	204	2	endocrinol	endocrinol	PROPN
admet-905	204	3	.	.	PUNCT
admet-905	205	1	162	162	NUM
admet-905	205	2	(	(	PUNCT
admet-905	205	3	2010	2010	NUM
admet-905	205	4	)	)	PUNCT
admet-905	205	5	193	193	NUM
admet-905	205	6	-	-	SYM
admet-905	205	7	212	212	NUM
admet-905	205	8	.	.	PUNCT
admet-905	206	1	[	[	X
admet-905	206	2	27	27	NUM
admet-905	206	3	]	]	X
admet-905	206	4	h.	h.	PROPN
admet-905	206	5	xu	xu	PROPN
admet-905	206	6	,	,	PUNCT
admet-905	206	7	y.	y.	PROPN
admet-905	206	8	zhou	zhou	PROPN
admet-905	206	9	,	,	PUNCT
admet-905	206	10	y.	y.	PROPN
admet-905	206	11	liu	liu	PROPN
admet-905	206	12	,	,	PUNCT
admet-905	206	13	j.	j.	PROPN
admet-905	206	14	ping	ping	PROPN
admet-905	206	15	,	,	PUNCT
admet-905	206	16	q.	q.	PROPN
admet-905	206	17	shou	shou	PROPN
admet-905	206	18	,	,	PUNCT
admet-905	206	19	f.	f.	PROPN
admet-905	206	20	chen	chen	PROPN
admet-905	206	21	,	,	PUNCT
admet-905	206	22	r.	r.	PROPN
admet-905	206	23	ruo	ruo	PROPN
admet-905	206	24	.	.	PUNCT
admet-905	207	1	metformin	metformin	PROPN
admet-905	207	2	improves	improve	VERB
admet-905	207	3	hepatic	hepatic	ADJ
admet-905	207	4	irs2	irs2	PROPN
admet-905	207	5	/	/	SYM
admet-905	207	6	pi3k	pi3k	PROPN
admet-905	207	7	/	/	SYM
admet-905	207	8	akt	akt	PROPN
admet-905	207	9	signaling	signal	VERB
admet-905	207	10	in	in	ADP
admet-905	207	11	insulin	insulin	NOUN
admet-905	207	12	-	-	PUNCT
admet-905	207	13	resistant	resistant	ADJ
admet-905	207	14	rats	rat	NOUN
admet-905	207	15	of	of	ADP
admet-905	207	16	nash	nash	NOUN
admet-905	207	17	and	and	CCONJ
admet-905	207	18	cirrhosis	cirrhosis	NOUN
admet-905	207	19	.	.	PUNCT
admet-905	208	1	j.	j.	PROPN
admet-905	208	2	endocrinol	endocrinol	PROPN
admet-905	208	3	.	.	PUNCT
admet-905	209	1	229	229	NUM
admet-905	209	2	(	(	PUNCT
admet-905	209	3	2016	2016	NUM
admet-905	209	4	)	)	PUNCT
admet-905	209	5	133	133	NUM
admet-905	209	6	-	-	SYM
admet-905	209	7	144	144	NUM
admet-905	209	8	.	.	PUNCT
admet-905	210	1	[	[	X
admet-905	210	2	28	28	NUM
admet-905	210	3	]	]	X
admet-905	210	4	n.	n.	PROPN
admet-905	210	5	sharma	sharma	PROPN
admet-905	210	6	,	,	PUNCT
admet-905	210	7	siriesha	siriesha	PROPN
admet-905	210	8	,	,	PUNCT
admet-905	210	9	y.	y.	PROPN
admet-905	210	10	lugani	lugani	PROPN
admet-905	210	11	,	,	PUNCT
admet-905	210	12	a.	a.	PROPN
admet-905	210	13	kaur	kaur	PROPN
admet-905	210	14	,	,	PUNCT
admet-905	210	15	v.	v.	PROPN
admet-905	210	16	k.	k.	PROPN
admet-905	210	17	ahuja	ahuja	PROPN
admet-905	210	18	.	.	PUNCT
admet-905	211	1	effect	effect	NOUN
admet-905	211	2	of	of	ADP
admet-905	211	3	metformin	metformin	NOUN
admet-905	211	4	on	on	ADP
admet-905	211	5	insulin	insulin	NOUN
admet-905	211	6	levels	level	NOUN
admet-905	211	7	,	,	PUNCT
admet-905	211	8	blood	blood	NOUN
admet-905	211	9	sugar	sugar	NOUN
admet-905	211	10	,	,	PUNCT
admet-905	211	11	and	and	CCONJ
admet-905	211	12	body	body	NOUN
admet-905	211	13	mass	mass	NOUN
admet-905	211	14	index	index	NOUN
admet-905	211	15	in	in	ADP
admet-905	211	16	polycystic	polycystic	ADJ
admet-905	211	17	ovarian	ovarian	ADJ
admet-905	211	18	syndrome	syndrome	NOUN
admet-905	211	19	cases	case	NOUN
admet-905	211	20	.	.	PUNCT
admet-905	212	1	j.	j.	PROPN
admet-905	212	2	fam	fam	PROPN
admet-905	212	3	.	.	PUNCT
admet-905	212	4	med	med	PROPN
admet-905	212	5	.	.	PUNCT
admet-905	213	1	prim	prim	PROPN
admet-905	213	2	.	.	PUNCT
admet-905	214	1	care	care	VERB
admet-905	214	2	8	8	NUM
admet-905	214	3	(	(	PUNCT
admet-905	214	4	2019	2019	NUM
admet-905	214	5	)	)	PUNCT
admet-905	214	6	2691	2691	NUM
admet-905	214	7	–	–	PUNCT
admet-905	214	8	2695	2695	NUM
admet-905	214	9	.	.	PUNCT
admet-905	215	1	[	[	X
admet-905	215	2	29	29	NUM
admet-905	215	3	]	]	PUNCT
admet-905	215	4	f.	f.	PROPN
admet-905	215	5	akpinar	akpinar	PROPN
admet-905	215	6	,	,	PUNCT
admet-905	215	7	b.	b.	PROPN
admet-905	215	8	dilbaz	dilbaz	PROPN
admet-905	215	9	,	,	PUNCT
admet-905	215	10	d.a	d.a	PROPN
admet-905	215	11	.	.	PROPN
admet-905	215	12	cırık	cırık	PROPN
admet-905	215	13	,	,	PUNCT
admet-905	215	14	s.	s.	PROPN
admet-905	215	15	yilmaz	yilmaz	PROPN
admet-905	215	16	,	,	PUNCT
admet-905	215	17	s.	s.	PROPN
admet-905	215	18	kiykac	kiykac	PROPN
admet-905	215	19	,	,	PUNCT
admet-905	215	20	e.	e.	PROPN
admet-905	215	21	karahanoglu	karahanoglu	PROPN
admet-905	215	22	,	,	PUNCT
admet-905	215	23	l.	l.	PROPN
admet-905	215	24	mollamahmutoglu	mollamahmutoglu	PROPN
admet-905	215	25	.	.	PUNCT
admet-905	216	1	the	the	DET
admet-905	216	2	significance	significance	NOUN
admet-905	216	3	of	of	ADP
admet-905	216	4	anthropometric	anthropometric	ADJ
admet-905	216	5	and	and	CCONJ
admet-905	216	6	endocrine	endocrine	ADJ
admet-905	216	7	parameters	parameter	NOUN
admet-905	216	8	in	in	ADP
admet-905	216	9	ovulation	ovulation	NOUN
admet-905	216	10	induction	induction	NOUN
admet-905	216	11	with	with	ADP
admet-905	216	12	clomiphene	clomiphene	PROPN
admet-905	216	13	citrate	citrate	NOUN
admet-905	216	14	in	in	ADP
admet-905	216	15	women	woman	NOUN
admet-905	216	16	with	with	ADP
admet-905	216	17	polycystic	polycystic	ADJ
admet-905	216	18	ovary	ovary	ADJ
admet-905	216	19	syndrome	syndrome	NOUN
admet-905	216	20	.	.	PUNCT
admet-905	217	1	saudi	saudi	PROPN
admet-905	217	2	med	med	PROPN
admet-905	217	3	.	.	PUNCT
admet-905	218	1	j.	j.	PROPN
admet-905	218	2	37	37	NUM
admet-905	218	3	(	(	PUNCT
admet-905	218	4	2016	2016	NUM
admet-905	218	5	)	)	PUNCT
admet-905	218	6	1272	1272	NUM
admet-905	218	7	-	-	SYM
admet-905	218	8	1275	1275	NUM
admet-905	218	9	.	.	PUNCT
admet-905	219	1	admet	admet	PROPN
admet-905	219	2	&	&	CCONJ
admet-905	219	3	dmpk	dmpk	PROPN
admet-905	219	4	9(1	9(1	NUM
admet-905	219	5	)	)	PUNCT
admet-905	219	6	(	(	PUNCT
admet-905	219	7	2021	2021	NUM
admet-905	219	8	)	)	PUNCT
admet-905	219	9	49	49	NUM
admet-905	219	10	-	-	SYM
admet-905	219	11	55	55	NUM
admet-905	219	12	metformin	metformin	NOUN
admet-905	219	13	effects	effect	NOUN
admet-905	219	14	on	on	ADP
admet-905	219	15	zonulin	zonulin	PROPN
admet-905	219	16	level	level	NOUN
admet-905	219	17	in	in	ADP
admet-905	219	18	polycystic	polycystic	ADJ
admet-905	219	19	ovarian	ovarian	ADJ
admet-905	219	20	women	woman	NOUN
admet-905	219	21	doi	doi	NOUN
admet-905	219	22	:	:	PUNCT
admet-905	219	23	http://doi.org/10.5599/admet.905	http://doi.org/10.5599/admet.905	VERB
admet-905	219	24	55	55	NUM
admet-905	220	1	[	[	SYM
admet-905	220	2	30	30	NUM
admet-905	220	3	]	]	X
admet-905	220	4	g.	g.	PROPN
admet-905	220	5	sachdeva	sachdeva	PROPN
admet-905	220	6	,	,	PUNCT
admet-905	220	7	s.	s.	PROPN
admet-905	220	8	gainder	gainder	PROPN
admet-905	220	9	,	,	PUNCT
admet-905	220	10	v.	v.	PROPN
admet-905	220	11	suri	suri	PROPN
admet-905	220	12	,	,	PUNCT
admet-905	220	13	n.	n.	PROPN
admet-905	220	14	sachdeva	sachdeva	PROPN
admet-905	220	15	,	,	PUNCT
admet-905	220	16	s.	s.	PROPN
admet-905	220	17	chopra	chopra	PROPN
admet-905	220	18	.	.	PUNCT
admet-905	221	1	comparison	comparison	NOUN
admet-905	221	2	of	of	ADP
admet-905	221	3	clinical	clinical	ADJ
admet-905	221	4	,	,	PUNCT
admet-905	221	5	metabolic	metabolic	NOUN
admet-905	221	6	,	,	PUNCT
admet-905	221	7	hormonal	hormonal	ADJ
admet-905	221	8	,	,	PUNCT
admet-905	221	9	and	and	CCONJ
admet-905	221	10	ultrasound	ultrasound	NOUN
admet-905	221	11	parameters	parameter	NOUN
admet-905	221	12	among	among	ADP
admet-905	221	13	the	the	DET
admet-905	221	14	clomiphene	clomiphene	PROPN
admet-905	221	15	citrate	citrate	NOUN
admet-905	221	16	-	-	PUNCT
admet-905	221	17	resistant	resistant	ADJ
admet-905	221	18	and	and	CCONJ
admet-905	221	19	clomiphene	clomiphene	ADJ
admet-905	221	20	citrate	citrate	NOUN
admet-905	221	21	-	-	PUNCT
admet-905	221	22	sensitive	sensitive	ADJ
admet-905	221	23	polycystic	polycystic	ADJ
admet-905	221	24	ovary	ovary	ADJ
admet-905	221	25	syndrome	syndrome	NOUN
admet-905	221	26	women	woman	NOUN
admet-905	221	27	.	.	PUNCT
admet-905	222	1	j.	j.	PROPN
admet-905	222	2	hum	hum	PROPN
admet-905	222	3	.	.	PUNCT
admet-905	223	1	reprod	reprod	PROPN
admet-905	223	2	.	.	PUNCT
admet-905	224	1	sci	sci	PROPN
admet-905	224	2	.	.	PROPN
admet-905	225	1	12	12	NUM
admet-905	225	2	(	(	PUNCT
admet-905	225	3	2019	2019	NUM
admet-905	225	4	)	)	PUNCT
admet-905	225	5	216	216	NUM
admet-905	225	6	-	-	SYM
admet-905	225	7	223	223	NUM
admet-905	225	8	.	.	PUNCT
admet-905	226	1	[	[	X
admet-905	226	2	31	31	NUM
admet-905	226	3	]	]	PUNCT
admet-905	226	4	j.	j.	PROPN
admet-905	226	5	nawrocka	nawrocka	PROPN
admet-905	226	6	,	,	PUNCT
admet-905	226	7	a.	a.	NOUN
admet-905	226	8	starczewski	starczewski	PROPN
admet-905	226	9	.	.	PUNCT
admet-905	227	1	effects	effect	NOUN
admet-905	227	2	of	of	ADP
admet-905	227	3	metformin	metformin	NOUN
admet-905	227	4	treatment	treatment	NOUN
admet-905	227	5	in	in	ADP
admet-905	227	6	women	woman	NOUN
admet-905	227	7	with	with	ADP
admet-905	227	8	polycystic	polycystic	ADJ
admet-905	227	9	ovary	ovary	ADJ
admet-905	227	10	syndrome	syndrome	NOUN
admet-905	227	11	depends	depend	VERB
admet-905	227	12	on	on	ADP
admet-905	227	13	insulin	insulin	NOUN
admet-905	227	14	resistance	resistance	NOUN
admet-905	227	15	.	.	PUNCT
admet-905	228	1	gynecol	gynecol	ADJ
admet-905	228	2	endocrinol	endocrinol	NOUN
admet-905	228	3	23	23	NUM
admet-905	228	4	(	(	PUNCT
admet-905	228	5	2007	2007	NUM
admet-905	228	6	)	)	PUNCT
admet-905	228	7	231	231	NUM
admet-905	228	8	-	-	SYM
admet-905	228	9	237	237	NUM
admet-905	228	10	.	.	PUNCT
admet-905	229	1	[	[	X
admet-905	229	2	32	32	NUM
admet-905	229	3	]	]	PUNCT
admet-905	229	4	g.	g.	PROPN
admet-905	229	5	a.	a.	PROPN
admet-905	229	6	ilhan	ilhan	PROPN
admet-905	229	7	and	and	CCONJ
admet-905	229	8	b.	b.	PROPN
admet-905	229	9	yildizhan	yildizhan	PROPN
admet-905	229	10	.	.	PUNCT
admet-905	230	1	evaluation	evaluation	NOUN
admet-905	230	2	of	of	ADP
admet-905	230	3	zonulin	zonulin	PROPN
admet-905	230	4	,	,	PUNCT
admet-905	230	5	a	a	DET
admet-905	230	6	marker	marker	NOUN
admet-905	230	7	of	of	ADP
admet-905	230	8	intestinal	intestinal	ADJ
admet-905	230	9	permeability	permeability	NOUN
admet-905	230	10	as	as	ADP
admet-905	230	11	a	a	DET
admet-905	230	12	novel	novel	NOUN
admet-905	230	13	biomarker	biomarker	NOUN
admet-905	230	14	in	in	ADP
admet-905	230	15	polycystic	polycystic	ADJ
admet-905	230	16	ovary	ovary	ADJ
admet-905	230	17	syndrome	syndrome	NOUN
admet-905	230	18	.	.	PUNCT
admet-905	231	1	fertility	fertility	NOUN
admet-905	231	2	and	and	CCONJ
admet-905	231	3	sterility	sterility	NOUN
admet-905	231	4	110(2018	110(2018	NOUN
admet-905	231	5	)	)	PUNCT
admet-905	231	6	:	:	PUNCT
admet-905	232	1	e117	e117	PROPN
admet-905	233	1	[	[	X
admet-905	233	2	33	33	NUM
admet-905	233	3	]	]	X
admet-905	233	4	s.e	s.e	PROPN
admet-905	233	5	.	.	PROPN
admet-905	233	6	shoelson	shoelson	PROPN
admet-905	233	7	,	,	PUNCT
admet-905	233	8	j.	j.	PROPN
admet-905	233	9	lee	lee	PROPN
admet-905	233	10	,	,	PUNCT
admet-905	233	11	a.b	a.b	PROPN
admet-905	233	12	.	.	PROPN
admet-905	233	13	goldfine	goldfine	PROPN
admet-905	233	14	.	.	PUNCT
admet-905	234	1	inflammation	inflammation	NOUN
admet-905	234	2	and	and	CCONJ
admet-905	234	3	insulin	insulin	NOUN
admet-905	234	4	resistance	resistance	NOUN
admet-905	234	5	.	.	PUNCT
admet-905	235	1	j.	j.	PROPN
admet-905	235	2	clin	clin	PROPN
admet-905	235	3	.	.	PUNCT
admet-905	236	1	invest	invest	VERB
admet-905	236	2	.	.	PUNCT
admet-905	237	1	116	116	NUM
admet-905	237	2	(	(	PUNCT
admet-905	237	3	2006	2006	NUM
admet-905	237	4	)	)	PUNCT
admet-905	237	5	1793	1793	NUM
admet-905	237	6	-	-	SYM
admet-905	237	7	1801	1801	NUM
admet-905	237	8	.	.	PUNCT
admet-905	238	1	[	[	X
admet-905	238	2	34	34	NUM
admet-905	238	3	]	]	PUNCT
admet-905	238	4	z.	z.	PROPN
admet-905	238	5	cetin	cetin	PROPN
admet-905	238	6	,	,	PUNCT
admet-905	238	7	a.	a.	PROPN
admet-905	238	8	kosem	kosem	PROPN
admet-905	238	9	,	,	PUNCT
admet-905	238	10	b.	b.	PROPN
admet-905	238	11	can	can	AUX
admet-905	238	12	,	,	PUNCT
admet-905	238	13	o.	o.	NOUN
admet-905	238	14	baser	baser	NOUN
admet-905	238	15	,	,	PUNCT
admet-905	238	16	m.	m.	NOUN
admet-905	238	17	catak	catak	PROPN
admet-905	238	18	,	,	PUNCT
admet-905	238	19	t.	t.	PROPN
admet-905	238	20	turhan	turhan	PROPN
admet-905	238	21	,	,	PUNCT
admet-905	238	22	d.	d.	PROPN
admet-905	238	23	berker	berker	PROPN
admet-905	238	24	.	.	PUNCT
admet-905	239	1	serum	serum	PROPN
admet-905	239	2	zonulin	zonulin	PROPN
admet-905	239	3	level	level	NOUN
admet-905	239	4	is	be	AUX
admet-905	239	5	not	not	PART
admet-905	239	6	elevated	elevate	VERB
admet-905	239	7	in	in	ADP
admet-905	239	8	patients	patient	NOUN
admet-905	239	9	with	with	ADP
admet-905	239	10	polycystic	polycystic	ADJ
admet-905	239	11	ovary	ovary	ADJ
admet-905	239	12	syndrome	syndrome	NOUN
admet-905	239	13	without	without	ADP
admet-905	239	14	metabolic	metabolic	NOUN
admet-905	239	15	syndrome	syndrome	NOUN
admet-905	239	16	.	.	PUNCT
admet-905	240	1	arch	arch	PROPN
admet-905	240	2	.	.	PUNCT
admet-905	241	1	gynecol	gynecol	PROPN
admet-905	241	2	.	.	PUNCT
admet-905	241	3	obstet	obstet	PROPN
admet-905	241	4	.	.	PUNCT
admet-905	242	1	300	300	NUM
admet-905	242	2	(	(	PUNCT
admet-905	242	3	2019	2019	NUM
admet-905	242	4	)	)	PUNCT
admet-905	242	5	1785	1785	NUM
admet-905	242	6	-	-	SYM
admet-905	242	7	1790	1790	NUM
admet-905	242	8	.	.	PUNCT
admet-905	243	1	[	[	X
admet-905	243	2	35	35	NUM
admet-905	243	3	]	]	X
admet-905	243	4	l.s	l.s	PROPN
admet-905	243	5	.	.	PROPN
admet-905	243	6	baqer	baqer	PROPN
admet-905	243	7	,	,	PUNCT
admet-905	243	8	m.s	m.s	PROPN
admet-905	243	9	.	.	PROPN
admet-905	243	10	ahmeid	ahmeid	PROPN
admet-905	243	11	,	,	PUNCT
admet-905	243	12	a.h	a.h	PROPN
admet-905	243	13	.	.	PROPN
admet-905	243	14	al	al	PROPN
admet-905	243	15	-	-	PUNCT
admet-905	243	16	obaidi	obaidi	PROPN
admet-905	243	17	.	.	PUNCT
admet-905	244	1	evaluation	evaluation	NOUN
admet-905	244	2	the	the	DET
admet-905	244	3	effect	effect	NOUN
admet-905	244	4	of	of	ADP
admet-905	244	5	metformin	metformin	NOUN
admet-905	244	6	on	on	ADP
admet-905	244	7	hormones	hormone	NOUN
admet-905	244	8	serum	serum	NOUN
admet-905	244	9	levels	level	NOUN
admet-905	244	10	in	in	ADP
admet-905	244	11	women	woman	NOUN
admet-905	244	12	with	with	ADP
admet-905	244	13	polycystic	polycystic	ADJ
admet-905	244	14	ovary	ovary	ADJ
admet-905	244	15	syndrome	syndrome	NOUN
admet-905	244	16	.	.	PUNCT
admet-905	245	1	tikrit	tikrit	NOUN
admet-905	245	2	journal	journal	NOUN
admet-905	245	3	of	of	ADP
admet-905	245	4	pure	pure	ADJ
admet-905	245	5	science	science	NOUN
admet-905	245	6	.	.	PUNCT
admet-905	246	1	22	22	NUM
admet-905	246	2	(	(	PUNCT
admet-905	246	3	2018	2018	NUM
admet-905	246	4	)	)	PUNCT
admet-905	246	5	1	1	NUM
admet-905	246	6	-	-	SYM
admet-905	246	7	5	5	NUM
admet-905	246	8	.	.	PUNCT
admet-905	247	1	[	[	X
admet-905	247	2	36	36	NUM
admet-905	247	3	]	]	X
admet-905	247	4	l.c	l.c	PROPN
admet-905	247	5	.	.	PROPN
admet-905	247	6	morin	morin	PROPN
admet-905	247	7	-	-	PUNCT
admet-905	247	8	papunen	papunen	PROPN
admet-905	247	9	,	,	PUNCT
admet-905	247	10	i.	i.	PROPN
admet-905	247	11	vauhkonen	vauhkonen	PROPN
admet-905	247	12	,	,	PUNCT
admet-905	247	13	r.m	r.m	PROPN
admet-905	247	14	.	.	PROPN
admet-905	247	15	koivunen	koivunen	PROPN
admet-905	247	16	,	,	PUNCT
admet-905	247	17	a.	a.	NOUN
admet-905	247	18	ruokonen	ruokonen	PROPN
admet-905	247	19	,	,	PUNCT
admet-905	247	20	h.k	h.k	PROPN
admet-905	247	21	.	.	PROPN
admet-905	247	22	martikainen	martikainen	PROPN
admet-905	247	23	,	,	PUNCT
admet-905	247	24	j.s	j.s	PROPN
admet-905	247	25	.	.	PROPN
admet-905	247	26	tapanainen	tapanainen	PROPN
admet-905	247	27	.	.	PUNCT
admet-905	248	1	endocrine	endocrine	NOUN
admet-905	248	2	and	and	CCONJ
admet-905	248	3	metabolic	metabolic	NOUN
admet-905	248	4	effects	effect	NOUN
admet-905	248	5	of	of	ADP
admet-905	248	6	metformin	metformin	NOUN
admet-905	248	7	versus	versus	ADP
admet-905	248	8	ethinyl	ethinyl	PROPN
admet-905	248	9	estradiol	estradiol	PROPN
admet-905	248	10	-	-	PUNCT
admet-905	248	11	cyproterone	cyproterone	NOUN
admet-905	248	12	acetate	acetate	NOUN
admet-905	248	13	in	in	ADP
admet-905	248	14	obese	obese	ADJ
admet-905	248	15	women	woman	NOUN
admet-905	248	16	with	with	ADP
admet-905	248	17	polycystic	polycystic	ADJ
admet-905	248	18	ovary	ovary	ADJ
admet-905	248	19	syndrome	syndrome	NOUN
admet-905	248	20	:	:	PUNCT
admet-905	248	21	a	a	DET
admet-905	248	22	randomized	randomized	ADJ
admet-905	248	23	study	study	NOUN
admet-905	248	24	.	.	PUNCT
admet-905	249	1	j.	j.	PROPN
admet-905	249	2	clin	clin	PROPN
admet-905	249	3	.	.	PUNCT
admet-905	250	1	endocrinol	endocrinol	NOUN
admet-905	250	2	.	.	PUNCT
admet-905	251	1	metab	metab	PROPN
admet-905	251	2	.	.	PUNCT
admet-905	252	1	85	85	NUM
admet-905	252	2	(	(	PUNCT
admet-905	252	3	2000	2000	NUM
admet-905	252	4	)	)	PUNCT
admet-905	252	5	3161	3161	NUM
admet-905	252	6	-	-	SYM
admet-905	252	7	3168	3168	NUM
admet-905	252	8	.	.	PUNCT
admet-905	253	1	[	[	X
admet-905	253	2	37	37	NUM
admet-905	253	3	]	]	X
admet-905	253	4	r.	r.	PROPN
admet-905	253	5	fleming	fleming	PROPN
admet-905	253	6	,	,	PUNCT
admet-905	253	7	z.e	z.e	PROPN
admet-905	253	8	.	.	PROPN
admet-905	253	9	hopkinson	hopkinson	PROPN
admet-905	253	10	,	,	PUNCT
admet-905	253	11	a.m.	a.m.	PROPN
admet-905	253	12	wallace	wallace	PROPN
admet-905	253	13	,	,	PUNCT
admet-905	253	14	i.a	i.a	PROPN
admet-905	253	15	.	.	PROPN
admet-905	253	16	greer	greer	PROPN
admet-905	253	17	,	,	PUNCT
admet-905	253	18	n.	n.	PROPN
admet-905	253	19	sattar	sattar	PROPN
admet-905	253	20	.	.	PUNCT
admet-905	254	1	ovarian	ovarian	ADJ
admet-905	254	2	function	function	NOUN
admet-905	254	3	and	and	CCONJ
admet-905	254	4	metabolic	metabolic	NOUN
admet-905	254	5	factors	factor	NOUN
admet-905	254	6	in	in	ADP
admet-905	254	7	women	woman	NOUN
admet-905	254	8	with	with	ADP
admet-905	254	9	oligomenorrhea	oligomenorrhea	PROPN
admet-905	254	10	treated	treat	VERB
admet-905	254	11	with	with	ADP
admet-905	254	12	metformin	metformin	NOUN
admet-905	254	13	in	in	ADP
admet-905	254	14	a	a	DET
admet-905	254	15	randomized	randomized	ADJ
admet-905	254	16	double	double	ADJ
admet-905	254	17	blind	blind	ADJ
admet-905	254	18	placebo	placebo	NOUN
admet-905	254	19	-	-	PUNCT
admet-905	254	20	controlled	control	VERB
admet-905	254	21	trial	trial	NOUN
admet-905	254	22	.	.	PUNCT
admet-905	255	1	j.	j.	PROPN
admet-905	255	2	clin	clin	PROPN
admet-905	255	3	.	.	PUNCT
admet-905	256	1	endocrinol	endocrinol	NOUN
admet-905	256	2	.	.	PUNCT
admet-905	257	1	metab	metab	PROPN
admet-905	257	2	.	.	PUNCT
admet-905	258	1	87	87	NUM
admet-905	258	2	(	(	PUNCT
admet-905	258	3	2002	2002	NUM
admet-905	258	4	)	)	PUNCT
admet-905	258	5	569	569	NUM
admet-905	258	6	-	-	SYM
admet-905	258	7	574	574	NUM
admet-905	258	8	.	.	PUNCT
admet-905	259	1	[	[	X
admet-905	259	2	38	38	NUM
admet-905	259	3	]	]	PUNCT
admet-905	259	4	r.	r.	PROPN
admet-905	259	5	al	al	PROPN
admet-905	259	6	-	-	PUNCT
admet-905	259	7	fadhli	fadhli	PROPN
admet-905	259	8	,	,	PUNCT
admet-905	259	9	t.	t.	NOUN
admet-905	259	10	tulandi	tulandi	NOUN
admet-905	259	11	.	.	PUNCT
admet-905	260	1	laparoscopic	laparoscopic	ADJ
admet-905	260	2	treatment	treatment	NOUN
admet-905	260	3	of	of	ADP
admet-905	260	4	polycystic	polycystic	ADJ
admet-905	260	5	ovaries	ovary	NOUN
admet-905	260	6	:	:	PUNCT
admet-905	260	7	is	be	AUX
admet-905	260	8	its	its	PRON
admet-905	260	9	place	place	NOUN
admet-905	260	10	diminishing	diminish	VERB
admet-905	260	11	.	.	PUNCT
admet-905	261	1	curr	curr	PROPN
admet-905	261	2	.	.	PUNCT
admet-905	262	1	opin	opin	NOUN
admet-905	262	2	.	.	PUNCT
admet-905	263	1	obstet	obstet	PROPN
admet-905	263	2	.	.	PUNCT
admet-905	264	1	gynecol	gynecol	PROPN
admet-905	264	2	.	.	PUNCT
admet-905	265	1	16	16	NUM
admet-905	265	2	(	(	PUNCT
admet-905	265	3	2004	2004	NUM
admet-905	265	4	)	)	PUNCT
admet-905	265	5	295	295	NUM
admet-905	265	6	-	-	SYM
admet-905	265	7	298	298	NUM
admet-905	265	8	.	.	PUNCT
admet-905	266	1	[	[	X
admet-905	266	2	39	39	NUM
admet-905	266	3	]	]	X
admet-905	266	4	c.j	c.j	PROPN
admet-905	266	5	.	.	PROPN
admet-905	266	6	glueck	glueck	PROPN
admet-905	266	7	,	,	PUNCT
admet-905	266	8	n.	n.	PROPN
admet-905	266	9	goldenberg	goldenberg	PROPN
admet-905	266	10	,	,	PUNCT
admet-905	266	11	j.	j.	PROPN
admet-905	266	12	pranikoff	pranikoff	PROPN
admet-905	266	13	,	,	PUNCT
admet-905	266	14	m.	m.	NOUN
admet-905	266	15	loftspring	loftspring	NOUN
admet-905	266	16	,	,	PUNCT
admet-905	266	17	l.	l.	PROPN
admet-905	266	18	sieve	sieve	PROPN
admet-905	266	19	,	,	PUNCT
admet-905	266	20	p.	p.	PROPN
admet-905	266	21	wang	wang	PROPN
admet-905	266	22	.	.	PUNCT
admet-905	267	1	height	height	PROPN
admet-905	267	2	,	,	PUNCT
admet-905	267	3	weight	weight	NOUN
admet-905	267	4	,	,	PUNCT
admet-905	267	5	and	and	CCONJ
admet-905	267	6	motorsocial	motorsocial	ADJ
admet-905	267	7	development	development	NOUN
admet-905	267	8	during	during	ADP
admet-905	267	9	the	the	DET
admet-905	267	10	first	first	ADJ
admet-905	267	11	18	18	NUM
admet-905	267	12	months	month	NOUN
admet-905	267	13	of	of	ADP
admet-905	267	14	life	life	NOUN
admet-905	267	15	in	in	ADP
admet-905	267	16	126	126	NUM
admet-905	267	17	infants	infant	NOUN
admet-905	267	18	born	bear	VERB
admet-905	267	19	to	to	ADP
admet-905	267	20	109	109	NUM
admet-905	267	21	mothers	mother	NOUN
admet-905	267	22	with	with	ADP
admet-905	267	23	polycystic	polycystic	ADJ
admet-905	267	24	ovary	ovary	ADJ
admet-905	267	25	syndrome	syndrome	NOUN
admet-905	267	26	who	who	PRON
admet-905	267	27	conceived	conceive	VERB
admet-905	267	28	on	on	ADP
admet-905	267	29	and	and	CCONJ
admet-905	267	30	continued	continue	VERB
admet-905	267	31	metformin	metformin	NOUN
admet-905	267	32	through	through	ADP
admet-905	267	33	pregnancy	pregnancy	NOUN
admet-905	267	34	.	.	PUNCT
admet-905	268	1	hum	hum	ADJ
admet-905	268	2	.	.	PUNCT
admet-905	269	1	reprod	reprod	PROPN
admet-905	269	2	.	.	PUNCT
admet-905	270	1	19	19	NUM
admet-905	270	2	(	(	PUNCT
admet-905	270	3	2004	2004	NUM
admet-905	270	4	)	)	PUNCT
admet-905	270	5	1323	1323	NUM
admet-905	270	6	-	-	SYM
admet-905	270	7	1330	1330	NUM
admet-905	270	8	.	.	PUNCT
admet-905	271	1	[	[	X
admet-905	271	2	40	40	NUM
admet-905	271	3	]	]	X
admet-905	271	4	e.m	e.m	PROPN
admet-905	271	5	.	.	PROPN
admet-905	271	6	velazquez	velazquez	PROPN
admet-905	271	7	,	,	PUNCT
admet-905	271	8	s.	s.	PROPN
admet-905	271	9	mendoza	mendoza	PROPN
admet-905	271	10	,	,	PUNCT
admet-905	271	11	t.	t.	PROPN
admet-905	271	12	hamer	hamer	PROPN
admet-905	271	13	,	,	PUNCT
admet-905	271	14	f.	f.	PROPN
admet-905	271	15	sosa	sosa	PROPN
admet-905	271	16	,	,	PUNCT
admet-905	271	17	c.j	c.j	PROPN
admet-905	271	18	.	.	PROPN
admet-905	271	19	glueck	glueck	PROPN
admet-905	271	20	.	.	PUNCT
admet-905	272	1	metformin	metformin	NOUN
admet-905	272	2	therapy	therapy	NOUN
admet-905	272	3	in	in	ADP
admet-905	272	4	polycystic	polycystic	ADJ
admet-905	272	5	ovary	ovary	ADJ
admet-905	272	6	syndrome	syndrome	NOUN
admet-905	272	7	reduces	reduce	VERB
admet-905	272	8	hyperinsulinemia	hyperinsulinemia	NOUN
admet-905	272	9	,	,	PUNCT
admet-905	272	10	insulin	insulin	NOUN
admet-905	272	11	resistance	resistance	NOUN
admet-905	272	12	,	,	PUNCT
admet-905	272	13	hyperandrogenemia	hyperandrogenemia	PROPN
admet-905	272	14	,	,	PUNCT
admet-905	272	15	and	and	CCONJ
admet-905	272	16	systolic	systolic	ADJ
admet-905	272	17	blood	blood	NOUN
admet-905	272	18	pressure	pressure	NOUN
admet-905	272	19	,	,	PUNCT
admet-905	272	20	while	while	SCONJ
admet-905	272	21	facilitating	facilitate	VERB
admet-905	272	22	normal	normal	ADJ
admet-905	272	23	menses	mense	NOUN
admet-905	272	24	and	and	CCONJ
admet-905	272	25	pregnancy	pregnancy	NOUN
admet-905	272	26	.	.	PUNCT
admet-905	273	1	metabolism	metabolism	NOUN
admet-905	273	2	43	43	NUM
admet-905	273	3	(	(	PUNCT
admet-905	273	4	1994	1994	NUM
admet-905	273	5	)	)	PUNCT
admet-905	273	6	647	647	NUM
admet-905	273	7	-	-	SYM
admet-905	273	8	654	654	NUM
admet-905	273	9	.	.	PUNCT
admet-905	274	1	[	[	X
admet-905	274	2	41	41	NUM
admet-905	274	3	]	]	X
admet-905	274	4	b.	b.	PROPN
admet-905	274	5	singh	singh	PROPN
admet-905	274	6	,	,	PUNCT
admet-905	274	7	s.	s.	PROPN
admet-905	274	8	panda	panda	PROPN
admet-905	274	9	,	,	PUNCT
admet-905	274	10	r.	r.	PROPN
admet-905	274	11	nanda	nanda	PROPN
admet-905	274	12	,	,	PUNCT
admet-905	274	13	s.	s.	PROPN
admet-905	274	14	pati	pati	PROPN
admet-905	274	15	,	,	PUNCT
admet-905	274	16	m.	m.	NOUN
admet-905	274	17	mangaraj	mangaraj	NOUN
admet-905	274	18	,	,	PUNCT
admet-905	274	19	p.k	p.k	PROPN
admet-905	274	20	.	.	PROPN
admet-905	274	21	sahu	sahu	PROPN
admet-905	274	22	,	,	PUNCT
admet-905	274	23	p.c	p.c	PROPN
admet-905	274	24	.	.	PROPN
admet-905	274	25	mohapatra	mohapatra	PROPN
admet-905	274	26	.	.	PROPN
admet-905	275	1	effect	effect	NOUN
admet-905	275	2	of	of	ADP
admet-905	275	3	metformin	metformin	NOUN
admet-905	275	4	on	on	ADP
admet-905	275	5	hormonal	hormonal	ADJ
admet-905	275	6	and	and	CCONJ
admet-905	275	7	biochemical	biochemical	ADJ
admet-905	275	8	profile	profile	NOUN
admet-905	275	9	in	in	ADP
admet-905	275	10	pcos	pcos	PROPN
admet-905	275	11	before	before	ADP
admet-905	275	12	and	and	CCONJ
admet-905	275	13	after	after	ADP
admet-905	275	14	therapy	therapy	NOUN
admet-905	275	15	.	.	PUNCT
admet-905	276	1	indian	indian	PROPN
admet-905	276	2	j.	j.	PROPN
admet-905	276	3	clin	clin	PROPN
admet-905	276	4	.	.	PUNCT
admet-905	277	1	biochem	biochem	PROPN
admet-905	277	2	.	.	PUNCT
admet-905	278	1	25	25	NUM
admet-905	278	2	(	(	PUNCT
admet-905	278	3	2010	2010	NUM
admet-905	278	4	)	)	PUNCT
admet-905	278	5	367	367	NUM
admet-905	278	6	-	-	SYM
admet-905	278	7	370	370	NUM
admet-905	278	8	.	.	PUNCT
admet-905	279	1	[	[	X
admet-905	279	2	42	42	NUM
admet-905	279	3	]	]	PUNCT
admet-905	279	4	p.	p.	NOUN
admet-905	279	5	upadhyaya	upadhyaya	PROPN
admet-905	279	6	,	,	PUNCT
admet-905	279	7	h.	h.	PROPN
admet-905	279	8	s.	s.	PROPN
admet-905	279	9	rehan	rehan	PROPN
admet-905	279	10	.	.	PUNCT
admet-905	280	1	a	a	DET
admet-905	280	2	subgroup	subgroup	NOUN
admet-905	280	3	analysis	analysis	NOUN
admet-905	280	4	of	of	ADP
admet-905	280	5	effect	effect	NOUN
admet-905	280	6	of	of	ADP
admet-905	280	7	metformin	metformin	NOUN
admet-905	280	8	in	in	ADP
admet-905	280	9	indian	indian	ADJ
admet-905	280	10	women	woman	NOUN
admet-905	280	11	with	with	ADP
admet-905	280	12	pcos	pcos	PROPN
admet-905	280	13	.	.	PUNCT
admet-905	281	1	jk	jk	PROPN
admet-905	281	2	science	science	PROPN
admet-905	281	3	13(2011):19	13(2011):19	NUM
admet-905	281	4	-	-	SYM
admet-905	281	5	22	22	NUM
admet-905	282	1	[	[	X
admet-905	282	2	43	43	NUM
admet-905	282	3	]	]	PUNCT
admet-905	282	4	p.	p.	NOUN
admet-905	282	5	moghetti	moghetti	PROPN
admet-905	282	6	,	,	PUNCT
admet-905	282	7	r.	r.	PROPN
admet-905	282	8	castello	castello	PROPN
admet-905	282	9	,	,	PUNCT
admet-905	282	10	c.	c.	PROPN
admet-905	282	11	negri	negri	PROPN
admet-905	282	12	,	,	PUNCT
admet-905	282	13	f.	f.	PROPN
admet-905	282	14	tosi	tosi	PROPN
admet-905	282	15	,	,	PUNCT
admet-905	282	16	f.	f.	PROPN
admet-905	282	17	perrone	perrone	PROPN
admet-905	282	18	,	,	PUNCT
admet-905	282	19	m.	m.	PROPN
admet-905	282	20	caputo	caputo	PROPN
admet-905	282	21	,	,	PUNCT
admet-905	282	22	e.	e.	PROPN
admet-905	282	23	zanolin	zanolin	PROPN
admet-905	282	24	,	,	PUNCT
admet-905	282	25	m.	m.	NOUN
admet-905	282	26	muggeo	muggeo	PROPN
admet-905	282	27	.	.	PUNCT
admet-905	283	1	metformin	metformin	NOUN
admet-905	283	2	effects	effect	NOUN
admet-905	283	3	on	on	ADP
admet-905	283	4	clinical	clinical	ADJ
admet-905	283	5	features	feature	NOUN
admet-905	283	6	,	,	PUNCT
admet-905	283	7	endocrine	endocrine	NOUN
admet-905	283	8	and	and	CCONJ
admet-905	283	9	metabolic	metabolic	NOUN
admet-905	283	10	profiles	profile	NOUN
admet-905	283	11	,	,	PUNCT
admet-905	283	12	and	and	CCONJ
admet-905	283	13	insulin	insulin	NOUN
admet-905	283	14	sensitivity	sensitivity	NOUN
admet-905	283	15	in	in	ADP
admet-905	283	16	polycystic	polycystic	ADJ
admet-905	283	17	ovary	ovary	ADJ
admet-905	283	18	syndrome	syndrome	NOUN
admet-905	283	19	:	:	PUNCT
admet-905	283	20	a	a	DET
admet-905	283	21	randomized	randomized	ADJ
admet-905	283	22	,	,	PUNCT
admet-905	283	23	double	double	ADJ
admet-905	283	24	-	-	PUNCT
admet-905	283	25	blind	blind	ADJ
admet-905	283	26	,	,	PUNCT
admet-905	283	27	placebo	placebo	NOUN
admet-905	283	28	-	-	PUNCT
admet-905	283	29	controlled	control	VERB
admet-905	283	30	6	6	NUM
admet-905	283	31	-	-	PUNCT
admet-905	283	32	month	month	NOUN
admet-905	283	33	trial	trial	NOUN
admet-905	283	34	,	,	PUNCT
admet-905	283	35	followed	follow	VERB
admet-905	283	36	by	by	ADP
admet-905	283	37	open	open	ADJ
admet-905	283	38	,	,	PUNCT
admet-905	283	39	long	long	ADJ
admet-905	283	40	-	-	PUNCT
admet-905	283	41	term	term	NOUN
admet-905	283	42	clinical	clinical	ADJ
admet-905	283	43	evaluation	evaluation	NOUN
admet-905	283	44	.	.	PUNCT
admet-905	284	1	j.	j.	PROPN
admet-905	284	2	clin	clin	PROPN
admet-905	284	3	.	.	PUNCT
admet-905	285	1	endocrinol	endocrinol	NOUN
admet-905	285	2	.	.	PUNCT
admet-905	286	1	metab	metab	PROPN
admet-905	286	2	.	.	PUNCT
admet-905	287	1	85	85	NUM
admet-905	287	2	(	(	PUNCT
admet-905	287	3	2000	2000	NUM
admet-905	287	4	)	)	PUNCT
admet-905	287	5	139	139	NUM
admet-905	287	6	-	-	SYM
admet-905	287	7	146	146	NUM
admet-905	287	8	.	.	PUNCT
admet-905	288	1	[	[	X
admet-905	288	2	44	44	NUM
admet-905	288	3	]	]	PUNCT
admet-905	288	4	m.	m.	NOUN
admet-905	288	5	zahra	zahra	PROPN
admet-905	288	6	,	,	PUNCT
admet-905	288	7	m.	m.	NOUN
admet-905	288	8	shah	shah	PROPN
admet-905	288	9	,	,	PUNCT
admet-905	288	10	a.	a.	PROPN
admet-905	288	11	ali	ali	PROPN
admet-905	288	12	,	,	PUNCT
admet-905	288	13	r.	r.	PROPN
admet-905	288	14	rahim	rahim	PROPN
admet-905	288	15	.	.	PUNCT
admet-905	289	1	effects	effect	NOUN
admet-905	289	2	of	of	ADP
admet-905	289	3	metformin	metformin	NOUN
admet-905	289	4	on	on	ADP
admet-905	289	5	endocrine	endocrine	NOUN
admet-905	289	6	and	and	CCONJ
admet-905	289	7	metabolic	metabolic	NOUN
admet-905	289	8	parameters	parameter	NOUN
admet-905	289	9	in	in	ADP
admet-905	289	10	patients	patient	NOUN
admet-905	289	11	with	with	ADP
admet-905	289	12	polycystic	polycystic	ADJ
admet-905	289	13	ovary	ovary	ADJ
admet-905	289	14	syndrome	syndrome	NOUN
admet-905	289	15	.	.	PUNCT
admet-905	290	1	horm	horm	NOUN
admet-905	290	2	.	.	PUNCT
admet-905	291	1	metab	metab	PROPN
admet-905	291	2	.	.	PUNCT
admet-905	292	1	res	re	NOUN
admet-905	292	2	.	.	PROPN
admet-905	293	1	49	49	NUM
admet-905	293	2	(	(	PUNCT
admet-905	293	3	2017	2017	NUM
admet-905	293	4	)	)	PUNCT
admet-905	293	5	103	103	NUM
admet-905	293	6	-	-	SYM
admet-905	293	7	108	108	NUM
admet-905	293	8	.	.	PUNCT
admet-905	294	1	©	©	NOUN
admet-905	294	2	2021	2021	NUM
admet-905	294	3	by	by	ADP
admet-905	294	4	the	the	DET
admet-905	294	5	authors	author	NOUN
admet-905	294	6	;	;	PUNCT
admet-905	294	7	licensee	licensee	PROPN
admet-905	294	8	iapc	iapc	PROPN
admet-905	294	9	,	,	PUNCT
admet-905	294	10	zagreb	zagreb	PROPN
admet-905	294	11	,	,	PUNCT
admet-905	294	12	croatia	croatia	PROPN
admet-905	294	13	.	.	PUNCT
admet-905	295	1	this	this	DET
admet-905	295	2	article	article	NOUN
admet-905	295	3	is	be	AUX
admet-905	295	4	an	an	DET
admet-905	295	5	open	open	ADJ
admet-905	295	6	-	-	PUNCT
admet-905	295	7	access	access	NOUN
admet-905	295	8	article	article	NOUN
admet-905	295	9	distributed	distribute	VERB
admet-905	295	10	under	under	ADP
admet-905	295	11	the	the	DET
admet-905	295	12	terms	term	NOUN
admet-905	295	13	and	and	CCONJ
admet-905	295	14	conditions	condition	NOUN
admet-905	295	15	of	of	ADP
admet-905	295	16	the	the	DET
admet-905	295	17	creative	creative	ADJ
admet-905	295	18	commons	common	NOUN
admet-905	295	19	attribution	attribution	NOUN
admet-905	295	20	license	license	NOUN
admet-905	295	21	(	(	PUNCT
admet-905	295	22	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN
admet-905	295	23	)	)	PUNCT
admet-905	295	24	http://dx.doi.org/10.5599/admet.905	http://dx.doi.org/10.5599/admet.905	VERB
admet-905	295	25	http://creativecommons.org/licenses/by/4.0/	http://creativecommons.org/licenses/by/4.0/	PROPN